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SUMMARY
(Jv)
The trichothecenes are a ubiquitous group of toxic fungal 
sesquiterpenoids- Previous studies have shown that the 
12,13-epoxide present in the trichothecenes may be crucial for 
biological activity. To gain further insight into the biological 
role of the epoxide, successful employment of the Sharpless 
deoxygenation protocol has been achieved after extensive model 
studies. This procedure gave the 12,13-exomethylene compounds 
(119) and (121) from the corresponding epoxytrichothecenes, namely 
triacetoxyscirpene (63) and triacetyldeoxynivalenol (120).
In an extension to this work, Sharpless deoxygenation furnished 
the key intermediate, olefin (124), which was used to synthesise 
the 12,13-epi—epoxytrichothecene (128) via ozonolysis and reaction 
of the derived norketone (125) with dimethylsulphonium methylide. 
Both the Sharpless deoxygenation product (119) and the epi- 
epoxytrichothecene (128) were found to be essentially non-toxic, 
thus demonstrating for the first time the necessary presence of 
the epoxide and its stereochemical definition.
Further work has led to methodology for the provision of less 
readily available trichothecenes. To this end, deoxynivalenol (23) 
has been successfully synthesised from one of our culture products, 
anguidine (9), via another naturally occurring trichothecene, 
calonectrin (5). This methodology involved selective removal of 
the C-4 oxygen functionality, selective allylic oxidation at C-8, 
to establish the enone system, and introduction of the C-7 hydroxyl 
moiety.
ABBREVIATIONS
(v)
3-AcDon 3-Acetyldeoxynivalenol
AIBN Azobisisobutyrylnitrile
DHP Dihydropyran
DIBAL Diisobutylaluminium hydride
DMAP 4-(N,N-Dimethylamino)pyridine
DME Dimethoxyethane
DMF N ,N-Dimethylformamide
DON Deoxynivalenol
Eu(thd) ^  Tris(2,2,6,6—tetramethy1—3,5—heptanedionato)
europium
HMPA Hexamethylphosphoramide
LDA Lithium Diisopropylamide
MAS Monoacetoxy(4)scirpenediol
mcpba m-Chloroperbenzoic acid
Ms Methanesulphonyl
NBS N-Bromosuccinimide
PCC Pyridinium chiorochrornate
PPTS Pyridinium p-toluenesulphonate
Py Pyridine
TBDMS t-ButyldimethylSilyl
TES Triethylsilyl
THF Tetrahydrofuran
THP Tetrahydropyran
TMS Trimethylsilyl
Ts p-Toluenesulphonyl
pTSA p—Toluenesulphonic acid
INTRODUCTION
1 .
1. GENERAL INTRODUCTION
Since the isolation of penicillin from a fungal mould by
Florey and Chain in the late nineteen thirties, the search for
other potentially useful mycotoxins has been intense. Because
these compounds are the products of secondary metabolism, they
often possess very interesting and diverse structures and chemical
properties. Such secondary metabolites include the ergot alkaloids,
aflatoxins and gliotoxin (plus related epipolythiodioxopiperazines).
One of the most important classes of mycotoxin is that comprising
the trichothecenes.
The trichothecenes constitute a structurally closely related
family of sesquiterpenoids. They are produced by various species
of Fungi imperfect! and, in an isolated case, higher plants —
although it is believed that the plant further metabolises
trichothecenes produced by symbiotic fungi present in the soil.
The fact that the trichothecenes are produced by a large number
of taxonomically unrelated fungi makes them unique and very
important. These fungi can grow on cash crops such as wheat,
maize and rice: the production of these mycotoxins is therefore
very important from an economic standpoint due to their profound
biological activity in both man and domesticated animals.
Intoxication manifests itself in many ways, including severe
skin irritation, blood disorders, such as increased numbers of
white blood cells, vomiting and food refusal, damage to the
haematopoietic tissues in the bone marrow, thymus and lymph nodes,
and inhibition of the immune system. At a molecular level they
act by inhibiting protein and, occasionally, DNA synthesis.
Although the trichothecenes have been known since 1949, their
role in mycotoxicoses was not demonstrated until 1968 by Bamburg 
1 2
et al * . The Wisconsin Group isolated from mouldy corn a toxic
fungus called Fusarium tricinctum, from which a novel crystalline 
compound was obtained. This compound was named T—2 Toxin after 
the strain of Fusarium from which it was isolated. T—2 Toxin was 
found to be the agent responsible for illness and death in dairy 
cattle.
Subsequently nivalenol and fusarenon-X, from F . nivale Fn2B,
3 4 5* * and deoxynivalenol and ester derivatives, from F . roseum
g
"Graminearum11 , have been implicated in red-mould disease in Japan. 
This disease occurs at harvest time in barley and wheat when the 
temperature is low and humidity high. Intoxication by the infected 
cereal grains causes the major clinical signs of vomiting, refusal 
of food, congestion and haemorrhaging of tissues, diarrhoea and 
finally death.
It is now believed that trichothecenes were responsible for
many pre-World War II cases of mycotoxicoses, including the outbreak
of dendrochiotoxicoses in horses in Southern Russia in 1937 and
cases of alimentary toxic aleukia (ATA) or septic angina in Russia
7-11
since the 19th century
Structurally the trichothecenes consist of a tricyclic skeleton
12
(1), which is numbered in the manner proposed by Godtfredsen et al 
Features common to these compounds are the cis-fusion of both rings 
A and C to the pyran B ring and the presence of the 9,10-double bond 
and the 12,13-spiro—epoxide. Various sites of oxygenation are 
encountered, namely, at C-3, C-4, C-7, C-8 and C—15 - hence the 
large number of trichothecenes that have been isolated. Oxygenation 
can take the form of alcohols or their simple esters, such as acetates 
or iso—valerates. The presence of a ketone function of C—8 is quite 
common and one trichothecene, crotocin (20) possesses a 7,8-epoxide. 
Some important trichothecenes are shown in SCHEME 1*. In addition to
the presence of simple esters at C—4 and C—5 it is also possible 
to have macroyclic esters linking these centres as exemplified 
by (29) and (30). Such compounds are not within the scope of this 
thesis although they are very important in their own right.
*A full list of naturally occuring non—macrocyclic trichothecenes 
appears in Appendix 1.
OR
(2) R = H Trichodermol
(3) R=Ac Trichodermin
(3J Calonectrin
OAc
(9) Diacefoxyscirpenol 
(Anguidine)
(28) Verrucaro l
SCHEME 1a
HO/'
(23) Deoxynivalenol 
(Vomitoxin)
.0
OAc
(14) T-2 Toxin
H
OCrof
(20) Crotocin
SCHEME 1b
(29) Verrucarin A R=-CH(OH)CH(CH3)CH2CH20C-
(S) (R)
(30) Roridin D R=-CH-t(CH3 )CH2CH2OCHCH(OH)CH3
2. STRUCTURAL ELUCIDATION
13
Freeman and Morrison isolated the first trichothecene in
1948. It was named trichothecin after the parent fungus,
Trichothecium roseum.
14
Freeman proposed that trichothecin had either structure
(31) or (32), with a preference for (31) - a view supported by 
15
Fishman who assigned much of the stereochemistry. The main
elements of structural evidence were:—
(i) it was an ester which on hydrolysis gave a ketonic 
alcohol, trichothecolone, and crotonic acid;
(ii) it was readily hydrogenated using palladium on carbon
at atmospheric pressure: two moles of hydrogen were
taken up — one by the ester double bond, the other by 
the parent alcohol double bond;
(iii) it contained a reactive carbonyl group—hydrazones and 
semicarbazones could be prepared;
(iv) it was u.v. active at 225 nm suggestive of an 
unsaturated ketone;
(v) Kuhn—Roth oxidation showed the presence of 3 C-methyl 
groups;
(vi) i.r. spectroscopy showed bands at 1670 cm 1 {otfj3- 
unsaturated ketone), 1710 and 1177 (a, /3- unsaturated 
ester), 1650 (C=C);
(vii) reaction with hydrochloric acid gave a chlorohydrin (33):
(although Freeman undertook x—ray crystallographic analysis 
of (33), no reference was made to the relative stereochemistry 
in trichothecin: in the light of later work the product
from acid treatment should be (34) - see under Chemistry);
7.
OR
(31) (32)
Cl
OR
i
l
Cl
OR
(33) (34)
R=Crotonyl
8.
(viii) oxidation of trichothecolone gave a diketone, proposed
to be (35), which indicated the presence of a secondary 
alcohol in the starting material: the new carbonyl group,
vmax 1*735 cm-'*', was probably a cyclopentanone;
(ix) dehydrogenation of fully reduced trichothecolone gave 
p—xylene, p—xylenol, 2,3—dimethylcyclopentanone and
2,3-dimethylcyclopent-2-enone;
(x) the action of hot alkali on the oxidised trichothecolone 
gave p-xyloquinone and p-xyloquinol as outlined in 
SCHEME 2.
16 IV
While working on trichodermin, Godtfredsen ’ arrived at a 
similar partial structure to that of trichothecin through a greater 
use of n.m.r. spectroscopy. Indeed Godtfredsen showed that
trichodermin and trichothecin were related by vigorous oxidation of 
the former to trichothecolone acetate. These findings should have led to 
the conclusion that the structure of trichodermin was (36). However, 
this structure was in conflict with the observation that reduction of the 
hydrolysis product of trichodermin, trichodermol (37), using lithium 
aluminium hydride, gave a diol which has a new quaternary methyl group 
(by "^H n.m.r. spectroscopy) and which on acetylation and oxidation gave 
a monoacetate and monoketone respectively. These results suggested the 
presence of a spiro-epoxide moiety in trichodermol — a conclusion supported 
by ^H n.m.r. spectroscopy with an observed coupling constant of 4Hz for the 
AB spin system at d 2.79 and 3.09.
The correct structure of trichodermol (2), and hence trichodermin 
(3), was finally established by x-ray crystallographic analysis of the 
p—bromobenzoate of trichodermol^*
(35)
H^oXXOH
SCHEME 2
10.
OR
(37) R=H
(36) R=Ac
OR
(2) R=H
(3) R=Ac
11.
Based on this basic structure, trichothecin and trichothecolone
were reassigned as (22) and (21). Similarly, verrucarol1s original
4- 4- / Qfx \ 2° . . 16,17,21,22structure (39) was reassigned as (28)
In the light of these revised structures the original findings
14 15
of Fishman and Freeman can be reinterpreted. Observations
(i)— (iv) and (ix) are consistent with the correct structure. The
oxidation product in (viii) is (38) which still contains the five
membered ketone. It is possible for this new ketonic group to be
unreactive due to steric congestion by the proximate epoxide and
methyl groups. Observations (vii) and (x) can be rationalised on
the basic of skeletal rearrangements. These rearrangements will be
discussed later.
It should be noted that although Freeman tested for epoxides,
23
using the method of Ross , by measurement of the rate of liberation
of hydroxyl ions in the presence of sodium thiosulphate , these tests
were generally inconclusive. From models it can be seen that the
epoxide is highly shielded against attack by external nucleophiles.
Since the early 1960's structure elucidation by chemical
1 13degradation has largely given way to H and C n.m.r. spectroscopic 
analysis. Some important typical chemical shifts are given in Table 1. 
(The values for C—3, C—4 and C—15 Eire for appropriately oxygenated 
species).
(21) R=H
(22) R=Crotony l
(39)
(38)
(28)
H 6 (ppm) Commerrts
2 4.0
3 4.1 Shifted 1 ppm if acylated
4 4.5 Shifted 1 ppm if acylated
10 5.5 Allylic coupling to H16 
Shifted 1 ppm if part of enone
11 4.0-4.5 broad doublet
13 2.9 AB quartet, J = 4 Hz
14 0.8
15 4.0 Often AB quartet, J = 12—13 Hz
16 1.7 Broadened due to allylic 
coupling with H 10
TABLE 1
14.
3. CHEMISTRY
3.1 REARRANGEMENTS
Due to the special spatial relationship of the epoxide and the 
tetrahydropyran oxygen, certain facile rearrangements can occur under 
suitable acidic or, less commonly, basic conditions to give the 
apotrichothecene skeleton.
17
In acid, the mechanism proposed (SCHEME 3) involves initial
protonation of the epoxide followed by internal nucleophilic attack
by the pyran oxygen to give intermediate oxonium ion (40). This
intermediate can then collapse in one of two ways; either by attack
by an external nucleophile or by loss of the proton at C-3 leading
to a new double bond.
This arrangement is consistent with "^H n.m.r. studies which showed
the absence of the epoxide AB quartet and H—2, and the presence of a
primary alcohol. This primary alcohol could be oxidised by normal
means to the corresponding acid.
The formation of (40) may be important for biological activity,
since it has been shown that destruction of the epoxide, for example
by lithium aluminium hydride reduction to the tertiary alcohol, renders
24
the molecule inactive . In such cases X could denote a growing
peptide or DNA chain which would bind to the trichothecene.
Rearrangements under basic conditions are less common and require
17
presence of a C-4 ketone function. For example, trichodermone (41) 
can be isomerised easily in the presence of sodium carbonate to give 
the tricyclic enone (42) (SCHEME 4). It should be noted that after 
opening of the pyran ring via the enol of (27), the subsequent
product possesses a tetrahydrofuran ring which arises from "abnormal"
25
epoxide ring opening . A possible explanation of this could be that
formation of the tetrahydrofuran ring occurs at a much greater rate
26than that of the pyran ring to give (43)
15.
H
H
©
■Uf
* r
X=Cl,Br,I,OH
SCHEME 3
16.
H
H
0
(43) (42)
SCHEME 4
17.
3.2 9,10 - DOUBLE BOND
The chemistry of the 9,10-double bond is in the main unremarkable.
It can be hydrogenated easily by using palladium on charcoal or calcium
.u w - 14,15,17,20,21,22,27 „ J Jcarbonate at atmospheric pressure . Reduction leads
24
to diminished biological activity , so there may be a steric
27
requirement for the double bond. The double bond can be ozonolysed
to give the 9,10—ketone—aldehyde after reduction of the ozonide.
Epoxidation of the double bond can be achieved using
m-chloroperbenzoic acid. Orientation of the epoxide can be influenced
by the presence of an hydroxyl at C-15. If the C-15 alcohol is
esterified, epoxidation occurs from the less hindered /?—face of 
28 29
the double bond * . However, if the C—15 alcohol is free epoxidation
can be directed by hydrogen bonding between the alcohol and the peracid 
to give the ol epoxide. In practice a mixture of epoxides results, 
although the presence of the free C-15 alcohol allows formation of 
the bridged ether (44) (SCHEME 5).
On prolonged boiling in water the 9,10—double>bond can attack 
the epoxide to give the hydrate (45) (SCHEME 6).
3.3 "PERIPHERAL" CHEMISTRY
In addition to the integral pyran and epoxide oxygen functions, 
the trichothecenes can be further substituted at C—3,C-4,C-7,C—8 and 
C—15. Much work has been carried out on these centres including:-
(i) interconversions of the trichothecenes either by various
hydroxyl protection/deprotection methods or by the 
selective introduction or removal of oxygenation;
(ii) introduction of "unnatural" esters for biological
testing;
(iii) introduction of totally synthetic macrocyclic side chains
linking C—4 and C-15.
18.
mcpba
OH
SCHEME 5
° /  Ri A
H20
HO-
SCHEME 6
20.
3 -3 -1 - C - RING AND C-15 HYDROXYL CHEMISTRY
(a) PROTECTION/DEPROTECTION METHODS 
Interconversions of trichothecenes are often necessary to
facilitate the provision of compounds that are often only available
in small amounts from culture. For example, monoacetoxyscirpenol (48)
can be made from anguidine (9), a readily available fungal metabolite.
30
Roush employed two methods starting from the diol (46), 
obtained from anguidine by THP ether formation of the free C-3 alcohol 
followed by alkaline hydrolysis of the C-4 and C-15 acetates. The 
first method (SCHEME 7) involved regioselective acetylation at C—4 
using 1—acetylimidazole, which gives the monoacetate (47) in 58% 
yield along with 19% of the diacetate (which can be recycled if 
desired).
The second, more elegant method (SCHEME 8) involved protection
of the C-15 alcohol as the bridged bromo—ether (49) — this permitted
acetylation solely at C-4. Suitable deprotection of C-3 and C-15
gave (48). Attempted selective hydrolysis of anguidine under a
variety of conditions lead almost exclusively to the C-15 mono-acetate 
27,31
In addition to the various mono- and di-acetates of scirpenetriol
that have been prepared, various "unnatural" esters have been created.
29
For example, Kaneko et al prepared chloroacetates, bromoacetates, 
crotonates and methacrylates, as well as acetates, propionates and 
butyrates for biological testing.
(b) OXIDATIONS
Oxidations of C—3,C—4 and C—15 alcohols to the respective ketones
and aldehydes have been accomplished by various means.
Oxidation at C-15 to the aldehyde proceeds in good yield by the
27
use of dipyridine chromium trioxide (Collins' Reagent) or pyridinium
21.
(9)
(iii)
OAc
(47)
(iv)
OAc
(48)
-OH
(iJDHP.H® (ii)NaOH,MeOH;(iii)Ac.imid.;(iv)H®.
SCHEME 7
22.
0>-0THPOV-OTHP
OH
(46)
(48)
(i)NBSJMeCN;(ii)Ac20,py.;(iii)Zn(Ag)JHFi Et'0H,Et20;
(iv)AcOH,H20 JHF.
SCHEME 8
23.
29
chlorochromate . As expected, this oxidation can proceed selectively
in the presence of the free C—3 or C—4 alcohols. Attempts to oxidise
the aldehyde further to the corresponding carboxylic acid under acidic 
27
conditions failed . For example, treatment of aldehyde (50) with
chromium trioxide in glacial acetic led to epoxide opening by the
9,10-double bond to give (51). However, the C-15 aldehyde has been
29oxidised by using neutral KMnO^ in aqueous acetone 
27
Sigg et al used chromium trioxide in glacial acetic acid to
oxidise C—3 of anguidine. In addition to the desired ketone (52), the
aldehydic—acid (53) was also obtained.
29
Kaneko et al successfully oxidised C—3 and C—4 by Swern
oxidation using trifluoroacetic anhydride and dimethyl sulphoxide.
27
Sigg also oxidised C—4 of (54) in good yield using Jones' 
reagent to give (55).
(c) REDUCTIVE DEOXYGENATION
Deoxygenation reactions of C-3, C-4 and C-15 are important for
ready access to a variety of trichothecenes. For example, deoxygenation
at C—3 leads into the verrucarol series, at C—4 to calonectrin, and
at C—3 and C—15 to trichodermin.
27
Sigg published two methods of deoxygenation at C—4. Zinc
reduction of the anguidine oxidation product (52) gave the C-3 ketone
(57) in poor yield. However, treatment of the bismesylate (56) with
sodium methoxide in refluxing methanol gave (57) in good yield
Sodium borohydride reduction of this ketone followed by acetylation
should give the natural trichothecene calonectrin (5), a compound
unknown to Sigg in 1965. Compound (57) has also been synthesised
32
by the action of silver carbonate—Celite reagent (Fetizon oxidation).
Interestingly, although the C-4-acetoxy-C-3-ketone can be reduced
to the C—3 ketone, the C—3—mesyl—C—4—ketone could not be reduced to 
27
the C—4 ketone . This may be due to the steric hindrance preventing
24.
AcO--
OH
(50) (51)
OAc
(9)
(i)Cr03,Ac0H.
(52)
(i)
H
CHOAcO
(55)
25.
0 >  -OMS
AcOJones'
(54) (55)
OMs
26.
OAc(52)
(57)
(iv)
0
(58)
(i)Znj (ii)Na0Me;(iii)Ac20Jpy.;(iv)AgC03/Celit-e.
27.
access of the large zinc atoms to the relatively inaccessible C-3 
substituent.
Other methods for alcohol deoxygenation include conversion of
the free hydroxyl into the mesylate, followed by lithium aluminium
hydride reduction. However, and as expected, such conditions also
27result in epoxide ring opening
More recently deoxygenations at C-3 and C-4 have been accomplished
successfully by Barton deoxygenation of the appropriate thioester with
33
tributyltin hydride . First to employ such a strategy was 
34
Fraser-Reid , who synthesised both verrucarol and trichodermol from 
anguidine.
Conversion of anguidine (9) into verrucarol (28) was 
straightforward since the C—4 and C-15 hydroxyl groups were already 
suitably protected as acetates. Thus Barton deoxygenation of 
anguidine gave diacetyl verrucarol (6), which on methanolysis gave 
verrucarol in an overall yield of 85%.
Attempts by Fraser-Reid to convert verrucarol (28) into 
trichodermol (2) via Barton deoxygenation of a suitably protected 
C—4 derivative (59) resulted only in partial deoxygenation.
Deoxygenation at C-15 was ultimately achieved by conversion of (59) 
into the chloride (60) followed by treatment with tributyltin hydride 
in the presence of benzoyl peroxide. Suitable deprotection at C-4
then gave trichodermol.
27 21
Sigg and Gutzwiller also reduced the C-15 alcohol via the
mesylate and derived iodide. Treatment of the C—15 iodo compound
with zinc gave the C—15 methyl group (SCHEMES 9 and 10).
Potlock and Tamm have also employed Barton deoxygenation for
reductions at C—3 and C—4.
28.
AcO
OAc OAc
OH
(28)
(i)Barton deoxygenation;(ii)NaOMe.
(59) 0R 
R=Ac or TBDMS
(60)
OIL
(iii)
(i) MsCl.DMF, A ;( ii)  Bu3SnH, (C6H5C0)202; 
(iii) Deprotect.
30.
0 /--OMs
MsO
OMs OMs
(i)Nal;(ii)Zn. •'
SCHEME 9
31.
(i)
OMs
vS " 0
OMs
(i) NaT; (ii)Zn.
SCHEME 10
32.
35
Potlock synthesised deoxyverrucarol (61) from both verrucarol
qc
(28) and anguidine (9) (SCHEME 11 and 12). Tamm made both 
calonectrin (5) and 3—deacetyl calonectrin (62) from anguidine (9)
(SCHEME 13).
3.3.2. A-RING MODIFICATION
Some of the most important trichothecenes have oxygenation at 
C-7 or C-8 as in T—2 Toxin (14) or vomitoxin (23) so functionalisation 
of the A ring has also received much attention.
27Enone (64) was first synthesised by Sigg et al using t-butyl
chromate on triacetoxyscirpene (63) in a yield of less than 20%.
29
An improvement by Kaneko involved initial allylic oxidation of 
anguidine with SeO^ to give the 3,8-diol (65) which could be oxidised 
to the enone (66) using MnO^ or pyridinium chlorochromate in an overall 
yield of 31% (SCHEME 14). The 8/3- alcohol is obtained since the /3—face 
is more accessible to attack by Se0„.j 2
21
Gutzwiller treated trichodermyl mesylate (67) similarly with
SeO^ followed by CrO^ oxidation to give enone (68) in modest yield.
8o: -oxygenated species can be obtained by allylic bromination
37using NBS followed by acetolysis. For example, Dillen et al treated
anguidine with NBS in dry dichloromethane to give a 9:2 mixture of
8/3— and 80!—bromides (69) and (70) — again with preference for
attack from the less hindered (3—face. Treatment of (69) with silver
acetate in refluxing acetic acid gave an approximately equal mixture
of neosolaniol triacetate (72) and its 8/3—epimer (71): this last
finding indicates a planar intermediate at C-8 during acetolysis.
Although both SeO^ allylic oxidation and NBS allylic bromination
are non-stereoselective, the natural 8 a-alcohol can be obtained from
29its epimer by oxidation to the enone followed by DIBAL reduction
33.
(28)
OH
AcO
(iii)
(61)
S
(i)Ac20,py.iCH2Cl2;(ii)Ph0CClJDMAPJCH2Cl2;
(iiDBuBSnH.AIBN.-OivJKzCOB^MeOH.
SCHEME 11
(9) OAc
AcO
OH
0 >  -OCOPh
AcO
OCOPh
(61)
S
(i)NH40HJMe0HJH20;(ii)Ph0CCli DMAP<CH2Cl2; 
(iiiJBusSnH, AIBN;(iv)K2C03jMG0H.
SCHEME 12
(9)
(ii)
OAc
(iii)
AcO
0> -OTHp(jv)
(v) AcO
(iii)
(62) (5)
(i)DHP/PPTSJCH2Cl2 ;(ii)NaOH/MeOH;
(iii)Ac20,py.,CH2Cl2;(iv)(Imid.)2C=SJC2H4C(2;
(v)Bu3SnH,AIBN;(vi)PPTS,MeOH.
OTHP
OAc
SCHEME 13
36.
(14)
-OH
(23)
(63)
AcO
-OAc
(64)
(i)tButyl chromate
37.
HO
>
(65)
AcO
OAc
(66)
SCHEME 14
(iii)
OMs
(i)Se02;(ii)PCC;(iii)Cr03.
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-OH
AcO
AcOOAc OAc
(69) Ri=Br R2=H
(70) Ri=H R2=Br
AcO
(71)Ri=OAc R2=H
(72)Ri =H R2=OAc
(i)NBS#CH2Cl2 ;(ii)AgOAc,AcOH,^.
39.
Synthesis of 8-keto- a -substituted compounds are rare; indeed,
38there has been to date only one such synthesis reported. Grove
treated enone (64) with lead tetra—acetate to give nivalenol
tetra-acetate (73) in very poor yield. The tetra-acetate (73) has
39been reduced back to (44) by Tatsuno et al using zinc.
Another pair of redox reactions have been carried out on
38 /
nivalenol diacetate (27) . Reduction of the enone using sodium
borohydride gave the all a-triol (17). The enone could be reformed 
in good yield by selective oxidation.
40.
AcO
OAc
(64)
AcO OAc
-OH
(iii) . H0
(iv)
-OH
OAc
(27) (17)
(i) Pb(OAck; (ii)Zn. 
(iii)NaBHA;(iv)Mn02.
41.
4. TOTAL SYNTHESIS
Due to the complexity of the trichothecene nucleus, total
synthesis of these compounds presents a formidable challenge.
If successfully achieved, total synthesis would additionally
provide a means of obtaining compounds isotopically labelled
at specific centres for detailed metabolic studies. With the
exception of Roush's recent introduction of a label at C-13 of 
40
anguidine , such labelled compounds have been only otherwise
41available by feeding labelled precursors to growing fungi
The disadvantages of total synthesis are that overall yields
are low and, with one notable exception, the synthetic targets
are obtained in racemic form. In addition, a general route for
the provision of a variety of polyoxygenated trichothecenes has
yet to be developed.
Although not within the brief of this project, it is important
to note various landmarks in the total synthesis of these mycotoxins.
Trichodermin (3) was the first trichothecene to succumb to 
42total synthesis . The key reaction of Colvin et al in forming
the basic tricyclic skeleton was intended to be an aldol reaction
of keto—aldehyde (74). However, this cyclisation refused to proceed
under a wide variety of conditions. This problem was circumvented
by oxidation of (74) followed by treatment with acetic anhydride
to give the enol lactone (75). C-ring formation was accomplished
by reaction of (75) with lithium hydridotri-t-butoxyaluminate
which gave (76) in 10% yield. Relatively straightforward chemistry
then led to completion of the synthesis of trichothermin (3).
In view of the low yield for the critical cyclisation step in
43Colvin's synthesis, Still developed an improved synthesis of 
trichodermol (2) - the hydrolysis product of trichodermin via a
42.
(74) (75)
(76)
(3)
(i)Cr03,py.,H20;(ii) Ac20,Na0Acj 
(iii)LiAlH(0But)3/Et20.
(77)
(i) >
(i) H2SO4(aq.)
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biomimetically patterned approach where the key bond—forming reaction
was between C—11 and what would become the pyran oxygen. This was
accomplished by acid treatment of epoxide (77) to give an
intermediate glycol which was trapped by the electrophilic enone
double bond to give the tricycle (78).
Due to the importance of macrocylic trichothecenes, the synthesis
of the parent alcohol, verrucarol (28), has received much attention.
First to complete the total synthesis of verrucarol was 
44
Schlessinger who created the tricylic skeleton by an intra-molecular 
reaction on triol (79). On treatment with pTSA (79) underwent 
cyclisation to the diene (80).
45
Roush's synthesis of verrucarol also had the C-ll-pyran
oxygen bond-forming reaction as its cornerstone. Tricycle (82)
was formed by trapping of the carbonium ion formed on treatment of
the allylic alcohol (81) with PPTS, followed by hydrochloric acid
in acetone.
46
Trost employed a ring expansion strategy in his synthesis
of verrucarol. The a-bromohemiacetal (83) was induced to rearrange
using tetrabutylammonium bromide, thus establishing the trichothecene
skeleton (84) at an early stage of the synthesis. Indeed the only
major problem that remained to be overcome was inversion of the
stereochemistry at C—4.
Intramolecular aldol cyclisation has been used for the C—2—C—3
47
bond formation of calonectrin (5) by Kraus and of 12,13—epoxy-
48
trichothec-9-ene (1) by Fujimoto et al
Kraus treated the keto-aldehyde (85) with sodium methoxide 
in refluxing methanol to give a mixture of C- 3 epimeric alcohols (86). 
The correct stereochemistry was established in a subsequent step by 
oxidation of the alcohol to the ketone followed by stereo—selective 
reduction with sodium borohydride.
45.
HO HO—  
CHb OBu
(79)
(80)
(28)
(i) Li AlH4,DliEj(ii)TsOH,CH2Cl2.
46.
OH
OH
(81)
(ii) OH
OH
>
OH
(82)
'OH
OH
>
OH
(28)
(i)PPTS,aq.C6H6;(ii)1N HC(,acetone.
47.
OH
IV
i
i
— 0
i
I
(83) (84)
(28)
(i) BmNBijTHF
48.
Q>
TBDMSO
OH
(85) (86)
-OAc
(5)
(HNaOMe^MeOH, A .
49.
Fujimoto treated the keto—aldehyde monohydrate (87) with sodium 
methoxide to give the tricycle (88). The C-3 alcohol was removed by 
conversion into the iodide followed by hydrogenolysis with Raney nickel.
A second synthesis of 12,13—epoxytrichothec—9—ene was achieved
49by Kamikawa et al using a biomimetic approach , the basic 
trichothecene skeleton being obtained upon treatment of the allylic 
alcohol (89) with acid to give the dione (90).
The only other total synthesis of a trichothecene to date has
50
been that of anguidine (9) by Brooks . This synthesis is unique 
in two respects; firstly it is the only synthesis of a trioxygenated 
member of the family to have been achieved and secondly, and perhaps 
more importantly, it is the only enantioselective total synthesis of 
a trichothecene. This enantioselectivity was built around the C—ring 
fragment (92), which was produced by stereoselective reduction of the 
homomorphic dione (91) using bakers1 yeast. Further elaboration led 
to the cyclisation precursor (93), ring closure of which was effected 
under acid catalysis to give (94).
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(87) (88)
OH
(1)
(i) NaOMe.MeOH, A .
(90)(89)
(1)
(i) H+;(ii)mcpba,Na2HP04.
0
(91)
OH
(92)
AcO
OTBDMS
HO CH3
-OAc
(93) (94)
(9)
(i)Bakers' yeast;(ii)TsOH,CH2Cl2 ;(iii)Ac2 0 ,py.
5. BIOSYNTHESIS
The basic trichothecene nucleus contains fifteen carbon atoms,
suggesting that it is sesquiterpenoid in nature. This was recognised
51
by the earliest workers in this field; Fishman et al and Jones
52 1 yj
and Lowe observed that three molecules of [[2— C ]]—mevalonate were
incorporated into trichothecin (22), concluding that a double
1,2-methyl shift had occurred.
Since both groups were using the incorrect apotrichothecene
structure in their analysis, a reinterpretation of their findings
17
was carried out by Godtfredsen and Vangedal . They concluded that
labelling had occurred at C-4, C-10 and C-14 in trichothecolone (21),
The presence of a label at C—10, however, was later disproven
by Achilladelis et al33*54. (4R)-£ 4-3H,2-34C []-Mevalonic acid was
fed to Trichoderma sporulosum, when two of the three tritium labels
were found to be retained in the isolated trichodermol (2) — one at
C—10, the other at C—2. These results were confirmed by Machida 
55
and Nozoe who also selectively isolated C-8 of trichodermol (2)
14
as CO^. Both groups' findings support the hypothesis that C-8 
and C—10 of the trichothecenes originate from C-2 and C—4 of 
mevalonate respectively.
Further evidence has also been provided by the work of Achini
56 " 57 58et al , Muller et al and Evans et al . That the trichothecenes
were derived from farnesyl pyrophosphate was shown by Hanson and
Archilade11is33. A 1.5% incorporation of [ 1— ] farnesyl
pyrophosphate was observed in trichothecin (22) isolated from
Trichothecium roseum.
Three possible folding mechanisms have been postulated namely,
concerted cyclisation of (95) or of (96), or stepwise cyclisation
via a 7-bisabolene derivative (97).
The intermediacy of a If—bisabolene derivative was disproven by
feeding [2-3H ,2-^C ]] geranyl pyrophosphate to Trichothecium roseum^’
54.
(2) (21) R=H
(22)R=Crofonyl
(95) (96)
(97)
55-
The culture products trichothecin (22) and trichodermol (2) were 
found to contain the tritium label at C-2. It can be concluded 
from this experiment that:-
3
(i) the central C « - X 1  mevalonic acid proton is retained;
(ii) this proton is involved in a hydride shift; and
(iii) there is no 7—bisabolene intermediate since its
formation would necessitate the loss of the isotopic 
label.
A stepwise cyclisation can be further ruled out by the 
observation that labelled (X-bisabolol, /3— and 7—bisabolenes
and monocyclofarnesol Eire incorporated non-specifically and in 
low yield^.
Given that the biosynthesis of trichothecenes apparently involves
concerted cyclisation of farnesyl pyrophosphate followed by subsequent
1,2—methyl and hydride shifts, the mode of folding has yet to be
determined. Feeding 2-^4c 3  - and £2-^H, 2-^4C ^  -
farnesyl pyrophosphate resulted in the loss of one tritium in the
former case and retention in the latter in the isolated trichothecin
(22)'^*^. This indicates a /?-folding pattern as in (95) -
a —folding should result in no loss of tritium in either case.
The culmination of these labelling studies was the proposed
54 60
biosynthetic mechanism outlined in SCHEME 15 * . The postulated
intermediate trichodiene (98) was isolated from a strain of
62 63
Trichothecium roseum ’ along with trichodiol (99) and
12,13-epoxy—trichothec-9-ene (1). Labelled trichodiene was found
55 63to be incorporated into trichothecolone (21) and trichothecene (22) *
Whether epoxidation of the 12,13-double bond occurs before or
after formation of the basic tricycle has yet to be established, since
it is conceivable that trichodiol (99) could result from further
55
metabolism of 12,13-epoxy-trichothec-9-ene . The true intermediate
56.
O^PP/nz
(95)
>
Enz
(98)
V
(99)
(100)
H V
(1 )
(101)
SCHEME 15
57.
could be diol (100)which then cyclises to give (101). Evidence for
this pathway has been provided by the isolation of verrucarin K (102)
64
by Breitenstexn and Tamm in 1977 . Even although the cyclisation
step apparently requires 2-cis—farnesyl pyrophosphate, all trans-
farnesol could conceivably act as a precursor, by trans—cis isomerLsoustv-jnrv.
05 00
Overton and Roberts , and Suzuki and Marumo working on non—
trichothecene producing culture systems have shown that such
isomerations can occur through a farnesal intermediate. However, Evans 
07
and Hanson found that, although all trans—farnesyl pyrophosphate did
act as a precursor, farnesol itself was not metabolised in a cell-free
culture of Trichothecium roseum. Additionally, they were unable to
detect any radiolabelled farnesal.
An alternative mechanism leading to trichodiene via a cyclopropene
07
as outlined in SCHEME 16 was suggested by Evans and Hanson
One further noteworthy point concerning cyclisation is that the
two starter methyls of farnesyl pyrophosphate are non—equivalent since
it has been shown by labelling that only the methyl derived from C-2
52 54
of mevalonic acid is involved in the migratory process *
With the basic trichothecene nucleus in place, peripheral 
oxygenation occurs. The mechanism of this oxygenation along with more 
in-depth consideration of trichothecene biosynthesis are to be found 
in Reference 68.
SCHEME 16
(102)
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6. STRUCTURE AND BIOLOGICAL ACTIVITY
The trichothecenes have a broad spectrum of biological activity
ranging from skin rashes through to serious blood disorders. At a
molecular level they act by inhibition of protein synthesis, or less
69commonly, DNA synthesis. Ueno et al showed that this inhibition
was a reversible process since washing the infected cells restored
their activity.
The trichothecenes can be sub-divided on the basis of where
protein synthesis is inhibited, i.e. on whether they show T-,E- or 
70
I—type activity . This classification is very general and there is 
a large degree of overlap.
T—Type trichothecenes inhibit the termination of protein synthesis 
and are typically unsubstituted or have a small substituent, e.g. 
a C-4 alcohol.
Compounds with a C-4 ester are generally E-type - that is they
inhibit protein elongation. Trichodermin (3) and trichothecolone
(21) are members of this class.
Compounds which inhibit protein initiation are termed I-types.
Such compounds tend to have C-15 esters along with C-3 or C-4 esters,
71
Claridge et al tested all of the acetates of scirpenetriol for
biological activity and showed that the 15—acetoxydiol (103) to be
the most toxic monoacetate.
This classification would appear to depend on the effective size
of the trichothecene. Smaller trichothecenes are T-type, intermediate
ones are E-type, whereas the larger ones are I-types.
I-types also include T-2 toxin (14), anguidine (9) and also, as
one might expect, the macrocyclic diesters.
Although the extent of peripheral substitution is important for
relative toxicity, the 12,13-epoxide is vital for any biological
24
activity. This was demonstrated by Grove and Mortimer , who tested 
the lithium alumimium hydride product (104) for toxicity, finding it
OH
(103)
AcO^
OAc
(104)
OH
--OH
OAc
(105) (106)
(107) R=Ac
(108) R = C(Ac
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to be essentially non—toxic. The rearranged apotrichothecene (105)
was also shown to be inactive, as was the hydrate (106).
As the epoxide is essential for biological activity, it would
seem that an additional process to reversible protein inhibition is
in play since any process involving the epoxide is more likely to be
irreversible. Such a process may involve ring opening via nucleophile
attack through the 9 y10—double bond or through an apotrichothecene
intermediate. The latter is possibly more likely since the reduction
24
of the 9,10—double bond results in only a four fold reduction in 
toxicity suggesting that it has more of a structural role. Also by 
analogy with the chemical process, apotrichothecene rearrangement 
is likely to be more facile in biological systems. Direct ring 
opening by nucleophiles other than hydride does not occur readily 
due to shielding of the epoxide by the A ring, so this route can be 
discounted.
In conclusion the 12,13-epoxide and 9,10-double bond are
important for biological activity. The more oxygenated compounds
tend to be more toxic and esterification, especially at C-15,
influences toxicity. In an extension to structure activity
29
relationships, Kaneko et al tested a variety of compounds with 
unnatural oxygenation patterns and ester functions. They found that 
the diones (107) and (108) were most active in certain tumours.
DISCUSSION
63.
7. TRICHOTHECENE PRECURSORS FROM CULTURE
The starting materials for most of the trichothecene manipulations 
carried out in this study were obtained from a shake culture of a 
Fusarium species. Two trichothecenes were obtained, namely,
3 (X —hydroxy—4 $  ,15-diacetoxy-12,13-epoxytrichothec-9-ene (anguidine)
(9) and 3a ,15-dihydroxy—4/J-acetoxy-12,13-epoxytrichothec-9-ene 
(monoacetoxyscirpenediol, MAS) (48). The yields of these metabolites 
were high, typically in the range of 250-300 mg/1 of each after an 
11 day culture time. A shorter culture period of 7 days resulted in 
more anguidine being isolated, with a corresponding drop in the 
amount of MAS.
The provision of both anguidine and MAS from culture means that 
various mono-ols and diols of scirpene can be obtained in a maximum 
of three steps from one or other metabolite (Table :.2). This 
minimises the amount of functional manipulation that would otherwise
be required if only one trichothecene was obtained from culture.
30For example, Roush has developed two methods to convert anguidine 
into MAS (SCHEME 7 and 8)* the higher yielding of which requires 
six steps.
Other trichothecenes used in this study were 3a  ,7a ,15-trihydroxy—
12,13-epoxytrichothec-9-en-8-one (deoxynivalenol, DON or, eponymously, 
vomitoxin) (23) and 3a -acetoxy-7a ,15-dihydroxy-12,13-epoxytrichothec- 
9—en—8—one (3-AcDON) (24), which were generally gifted to us by 
Dr. J. Gilbert (M.A.F.F., Norwich)
*See Introduction (3.3.1)
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OAc
(9) R=Ac
(48) R=H
--OR
(23) R=H
(24) R=Ac
Starting Material
Desired 
Mono—ol
Desired
Diol No. of Steps
Anguidine C—3 - 0
MAS C—4 - 2
MAS C—15 - 3
MAS - C—3,C—4 2
MAS - C—3,C—15 0
Anguidine - C-4,C—15 2
TABLE 2
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8. EPOXIDE DEOXYGENATION
8.1 INTRODUCTION
Trichothecene transformation products such as (104) and (105)
which involve the destruction of the epoxide have been shown to be
devoid of significant biological activity24 . Limited studies on
72deoxynivalenol (23) with rats in vivo and rumen micro-organisms 
73
in vitro have additionally shown that the major biological
transformation, and probably detoxification process, is one of
deoxygenation of the epoxide to the corresponding exomethylene (148).
Since such a biological process is very rare in animals it has been
proposed that the deoxygenation process in rats is actually due to
74rumen micro-organisms present in the gut of the rat . When rats
that had been previously fed with antibiotics were then fed with
deoxynivalenol no such transformation was observed.
The first chemical deoxygenation of an epoxytrichothecene was
21
carried out by Gutzwiller et al . Treatment of verrucarol (28) with
lithium aluminium hydride and then heating the tertiary alcohol
obtained in refluxing acetic anhydride gave diene (149) in a low
overall yield. Such a method could not, of course, be applied to
more complex trichothecenes, such as those which possess keto or
ester functionalities.
Efficient chemical deoxygenation of the epoxide requires a non—
nucleophilic and non—acidic strategy. The epoxide is sterically
hindered to nucleophiles (other than hydride) by the cis-fused
A—ring as can be seen from FIGURE 150. Also rearrangements of the
trichothecenes occur with facility in acidic media to give the
biologically inactive apotrichothecenes (3.1).
75Roush attempted nucleophilic ring opening tinder a wide range 
of conditions which included use of KSeCN in methanol, ethanol and 
dimethyl sulphoxide, KSitCH^)^ in HMPA,Fe(C0)$ in tetramethylurea,
67.
AcO
OAc
OAcV.
AcO
(104) (105)
(148)
AcO
(28) (149)
(i)LiAlH4;(ii)Ac20, A .
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NU:V
\ U R
4
(150)
(151) (152)
SCHEME 17
(ii)
(153)
(i)NaSPh,EtOH;(ii)mcpba,CH2Cl2 ;(iii)Na(Hg),MeOH.
OTHP
OTHP
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and diethyl phosphorotelluorate, before achieving success with
a 40—50 fold excess of sodium benzenethiolate in refluxing ethanol.
Deoxygenation of the epoxide moiety in the bromo—ether (151) was
accomplished by oxidation of the ring-opened product (152) to the
sulphone using m—chloroperbenzoic acid and then reductive treatment
of this hydroxysulphone with sodium amalgam to give the alkene (153)
in an overall yield of 50% (SCHEME 17). Such an excess of thiolate
would be incompatible with ester or enone functions present in more
complex trichothecenes: its use is therefore limited to suitably
protected substrates.
Deoxygenation via reduction of halohydrins derived from treatment
of the epoxide function with mineral acids has been attempted but as
expected the sole or major product is that of rearrangement. Treatment
of deoxynivalenol triacetate (120) with HBr in acetic acid followed by
zinc reduction of the so produced bromohydrin gave the desired diene
(121) in only 9% yield, along with 22% of the apotrichothecene 
76
(154) . Use of the same protocol by Roush on triacetoxyscirpene (63)
77gave solely the product of rearrangement
8.2 TRICHOTHECENE RING B/C MODEL CONSTRUCTION
At the outset of this study there was therefore scope for the 
development of an efficient, mild epoxide deoxygenation method which 
did not involve the use of nucleophiles nor of acidic media. Rather 
than use valuable culture products for initial studies, a model 
compound for the B/C ring system was developed — this being both C—6 
acetate epimers of the bicyclo £ 3,2,1 ^  octanol (117).
The starting point for the synthesis was 2-allyl-2-methyl- 
cyclohexanone (110) which was made by treatment of the thermodynamic 
silyl enol ether (109) of 2-methyl-cyclohexanone with methyl lithium 
followed by allyl bromide in THF. The second ring was established by
70.
(121)
■OAc
(120)
OAc
(154)
OAc
OAc
OAc
(63)
(i) HBr,AcOH; (ii)Zn.
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(117a) R i=H,R2= O A c 
(117b) R2=H,Ri= O A c
OSiMeB
(109) (110)
(iv)
(v)
1:2
Ox/OH
(155)
OH
(i)TMSClJEt3N,DMF;(ii)MeLi;(ii i)CH2=CHCH2B rJ H F ;
(iv)03JCH2a 2;(v)Ef3N;(v i)Na0MeJMe0H.
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ozonolysis of the vinyl double bond to give the keto-aldehyde (111) 
followed by aldol condensation to give an epimeric mixture of 
keto—alcohols (112). Reduction of the ozonide necessitated a 
non—aqueous work—up since in the presence of moisture the keto—aldehyde 
formed a hydrate (155). Formation of such five—membered hydrates is a 
very facile process and in our hands its cleavage could not be affected 
either by aldol conditions or by distillation. The ozonide could be 
reduced by use of triphenylphosphine, dimethyl sulphide or trimethyl 
phosphite, but these methods required distillation of the keto—aldehyde 
prior to its use. Ozonide reduction using triethylamine proved most 
successful: simple filtration of the reaction mixture through a short
column of silica gel and concentration provided the pure keto—aldehyde 
ready for the aldol condensation.
Many aldol conditions were tried including use of trichloroacetic
78
acid or LDA in THF, all of which were unsuccessful . Cyclisation was 
ultimately achieved by the use of excess sodium methoxide in refluxing 
methanol, the only satisfactory conditions found. This gave a 2:1 
epimeric mixture of C—6 and (X —alcohols. The epimers can be 
distinguished on the basis of coupling patterns in their n.m.r. 
spectra — the CL—epimer gives the expected double—double—doublet at 
64.45 whereas the ft—epimer gives rise to only a double—doublet , no 
coupling being observed between H—5 and H—6. From models, it can be 
seen that the dihedral angle between H—5 and H—6 is close to 90° in 
the /?—epimer.
The C-6 epimers can also be distinguished on the basis of their
13 79 13
C n.m.r. spectra. Stothers and Tan studied the C n.m.r. spectra
of a number of bicyclo £ 3,2,1] octanols including the 6-exo (/?) and
6—endo (a) alcohols. They found that the signal of the carbon bearing
the 6-exo alcohol was downfield of the 6-endo epimer: this trend is
supported by the complete series of model compounds used in the present
study (Table 3).
C—6 C n.m.r. shifts of m o d e l 3,2,1 ]bicyclic compounds
Ketoalcohols (112) Ketoacetates (113)
a 6 65.9 68.6
0 69.4 71.7
Hydroxyolefins (114) Acetoxyolefins (115)
a 71.3 73.6
0 73.7 76.6
Epoxyalcohols (116) Epoxyacetates (117)
a 71.2 73.8
0 74.1 75.2
TABLE 3
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C—1, C—5, C—6 and C—8 signals in these compounds were assigned 
straightforwardly on the basis of expected chemical shifts and 
off—resonance decoupled spectra. The remaining signals, for the 
methylenes, appeared as triplets in the off—resonance decoupled 
spectra. Only one of the triplets was clean. This was assigned 
to C—7, an assignment confirmed by an upfield shift of the C-7 
signal on acetylation, with very little change seen in the signals 
for the remaining methylenes. The most upfield triplet was assigned 
to C—3, and C—2 and C—4 were distinguished on the basis of shielding 
effects from the C—6 alcohol. Stothers and Tan, by comparison of the 
C—6 octanols and the unsubstituted bicyclooctane, found that the 
endo epimer had a more pronounced deshielding effect than the 
exo—epimer on the 7-carbon of the cyclohexane ring, i.e. C-4.
The more upfield of the remaining two signals was therefore assigned 
to C-4.
The observation that C-2, C-3 and C-4 do not give clear triplets 
in the off—resonance decoupled spectra can be attributed to the fact 
that the protons on these carbons form a closely coupled system, with 
second order affects being responsible for broadening and additional
i-..• 80splitting
The keto—alcohols (112) decomposed slowly on standing, possibly 
by a retrot-aldol process on the acidic sites on the glassware, so the 
alcohols were protected as acetates (113) for easy storage and also in 
preparation for the ensuing Wittig reaction.
Reaction of the separate keto-acetates (113) with excess 
methylenetriphenyl phosphorane proceeded uneventfully, with 
accompanying cleavage of the C-6 acetates to give the hydroxyolefins 
(114). Wittig reaction could also be performed on an epimeric 
mixture of the starting ketones, since chromatographic separation of 
the respective hydroxyolefins could be achieved readily. (Easy 
separation of the bicyclic alcohol derivatives, such as the norketone,
75.
exomethylene and spiro—epoxide is possible. This is not the case with 
the corresponding acetates, which possess very similar R^ . values).
Epoxidation of the individual hydroxyolefins (114) with
m-chloroperbenzoic acid gave single epoxides as judged by t.l.c.
analysis and n.m.r. spectroscopy. The orientation of the epoxide
in both cases is that with the epoxide oxygen on the side nearer the
two-carbon bridge, as in (116). This is analogous to Colvin's
42
synthesis of trichodermin (3) , where treatment of alkene (156)
gave the epoxide with the natural trichothecene configuration due 
to the directing effect of the free C-3 alcohol. This result was 
also expected on the basis of molecular models, which suggested that 
attack of the peracid was more likely to occur from the side of the 
sterically less hindering two-carbon bridge.
The bicyclic epoxide with the opposite, "unnatural" configuration
81(118) was prepared by the action of dimethylsulphonium methylide on 
the keto—acetate (113b): the epoxyalcohol obtained was used for
comparison with the "natural" epoxide.
It was thought that the "natural" epoxyaleohol might possess 
intramolecular hydrogen bonding from the hydroxyl to the epoxide 
oxygen. However i.r. spectroscopic dilution studies did not support 
this view.
The best evidence that m-chloroperbenzoic acid epoxidation of 
the olefin gives the "natural" epoxide configuration came from n.m.r. 
spectroscopy. The epoxide methylene protons in the "natural" epoxide 
occur as a broad singlet at 52.75, suggesting that they are in similar 
chemical environments. This is in contrast to the "unnatural" epoxide 
protons, which Eire observed as an AB quartet at 52.9.
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Further evidence came from lanthanide shift studies on both 
epoxides. From Table 4 it can be seen that the greatest change in 
shifts was observed in the "natural" epoxide. For example, shift 
values for H-6 in the natural epoxide ranged from 54.1 through
(112a) R=H r  (112b)
(i) (i)
(113a) <h  R=Ac (113b)
(ii) (ii)
v V
(114a) (114b)
(iii)
0>--0R
(116a)— i 
(117a)> R=HR=Ac
\/
(i)
(116b)
(117b)
(i)Ac20,py.;(ii)Ph3P=CH2JTHF;(iii)mcpbaJCH2Cl2,Na2HP04
77.
OH OAc
(156) (3)
(i)mcpba;(ii)Ac20,py
(116b)
OH
(118)
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SHIFT STUDIES
Total shift reagent added (mol,eq.) 
“Natural11 epoxide “Unnatural" epoxide
. 0.0 0.2 0.4 0.0 0.2 0.4
H-5 2.0 6.0 12.8 1.95 4.5 8.0
H-6 4.1 8.75 15.1 4.2 8.2 13.5
H-7 2.2 6.1+4.6 12.15+7.8 2.3 4.6+3.8 8.4+5.7
H-8’ 2.75 4.15 6.0 2.9 4.15 5.8
CH3
0.8 2.1 3.9 0.8 1.55 2.6
Observed Shifts (ppm)
(The shift reagent used in this study was Resolve-Al, (EuCthd)^).. 
100 mg of the compound to be studied was dissolved in CDCl^ and 
its 90 MHz ^H n.m.r. spectrum recorded. The shift reagent was then 
mixed with the contents of the n.m.r. tube and the spectrum rerun).
TABLE 4
68.75 to 615.10 as against 64.20 through 68.20 to 613.50 for the 
"unnatural" epoxide. These results suggest that the shift reagent 
is better chelated with the hydroxyl and epoxide oxygen facing each 
other, thereby producing a greater change in shift.
As with the keto—alcohols (112) the epoxyalcohols also decompose 
slowly on standing, so they were separately protected as acetates (117). 
These acetates were then the starting materials for epoxide 
deoxygenation studies.
8.3 DEOXYGENATION STUDIES
Attempted deoxygenation of the model epoxides by Ganem's protocol,
83using dimethyl diazomalonate (DDM) and rhodium (II) acetate catalysis ,
gave unsatisfactory results. This system, under a variety of conditions
with benzene or toluene as solvents and varying the amount of catalyst
and DDM used, failed to give more than 43% of the desired exomethylene
compounds (115). Starting epoxides were also recovered from the reaction
mixture, suggesting that the low yield for reaction may be due to steric
hindrance of the active species generated from DDM in its approach to the
epoxide. By analogy with the decomposition of DDM to malonyl carbene
84
under copper catalysis or irradiation , it is likely that the active 
species for epoxide deoxygenation is also the carbene, which can complex 
with the epoxide. The intermediate ylid formed, (157), can then collapse 
to give the olefin and dimethyl oxomalonate - an isolable co-product 
(SCHEME 18). The low yield for the reaction could be due to self- 
quenching of the carbene to give the dimer (158). It is interesting
to note that the hindered epoxide from adamantylidene-adamantane was
recovered unchanged by Ganem.
Attention was then focussed on the WCl_/nBuLi deoxygenation systemD
85developed by Sharpless in 1972 . He made low valent tungsten halide
derivatives by reacting WClg with either alkyllithiums or lithium 
iodide in varying stoichiometries as outlined in Table 5. Considering
0 A-E » >  ;
(117b)
(i)DDM,Rh2(0Ack, benzene
E E
\/
»C©
>_ _
A  E JSf
(157)
SCHEME 18
E\  / E
£ = C
E
(158)
(115b)
0 —
E=C02Me
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THF
WC1_ + 2RLi ------ *- I
o
THF
WC10 + 3RLi ------ *- II
D
THF
WC1_ + 4RLi --------- IIID
THF
WC1„ + 2Li dispersion ------------ IV
o
130°
WCl^ + 3LiI
6 in vacuo, no solvent V
vo
130
WC1„ + 2LiI
6 in vacuo, no solvent VI
TABLE 5
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the reaction of the epoxide with WClg/BuLi (1.2) the proposed 
86
mechanism (SCHEME 19) involves co-ordination of the active species
(possibly WCl^) to the epoxide, followed by insertion of the tungsten
into the epoxide C—0 bond and then collapse of the four membered
metallocycle (160) to give the olefin and oxotungsten species (161).
This mechanism explains why epoxides which are sterically hindered
to nucleophilic attack may be successfully deoxygenated. For example, 
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Deslongchamps successfully deoxygenated the hindered epoxide in (162) 
in 95% yield. Interestingly Sharpless also proposes similar 
intermediates to (160) for the reverse process, i.e. for the reaction 
of chromyl chloride, osmium tetroxide and other oxo metal compounds 
with olefins.
If the co-ordinated complex (159) is attacked by chloride ions 
present in solution it is possible to form chlorohydrins - here the 
low valent tungsten is acting as a Lewis acid. However, the 
chlorohydrin is not an intermediate in the deoxygenation process since 
reduction of chlorohydrins is a much slower process and also results 
in complete loss of stereochemistry. Chlorohydrin formation can be 
circumvented either by use of less acidic reagents II, III or IV or 
by heating the reaction mixture under reflux.
88Lithium aluminium hydride has been used by Fujiwara et al 
to generate low valent tungsten species from WClg* This system 
has been claimed to be as effective as that of Sharpless. Although 
not relevant here, Sharpless deoxygenation shows a high degree of 
stereoselectivity, mitigating against a radical mechanism.
In|present study, use of WClg/nBuLi at room temperature (after 
generation of the active deoxygenating species at - 78°C) on the 
13—acetoxyepoxide gave a mixture of the desired olefin (115b) and 
the chlorohydrin (163), even after prolonged stirring over three 
days. On the other hand, heating the reaction mixture under reflux 
for 6 hours gave solely the desired olefin, in over 90% yield for both
83.
C l\  i v/ Cl
w A
cr c^i
A '
R R
R
R
(159)
0  
\  I
W.
R
(160)
>
W
/ \
vi (161)
/
R R
SCHEME 19
o
(162)
84
OAc (i)
(163)
r f >
(117b)
(115b)
OAc OAc*7 N
reflux
(117b) (115b)
(117a)
(i) nBuLi,WCUJHF
reflux
-OAc
SCHEME 20
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epimeric epoxides (SCHEME 20).
Acetylation of either culture product gave the immediate precursor,
3(X jA (3 ,15—triacetoxy—12,13—epoxytrichothec—9—ene(63) , for Sharpless
deoxygenation. Gratifyingly, this procedure gave the desired olefin (119)
in near quantitative yield. Similarly, triacetyldeoxynivalenol(120),
obtained by acetylation of 3—AcDON, gave diene (121) in a more modest
yield of 40% after deoxygenation: this reaction had to be carried
out twice in order to effect full consumption of starting material.
Chromatographic separation of the starting epoxide and desired diene
was not possible since both components had very similar polarity on
t.l.c. Subsequent reactions were followed by g.l.c. analysis with
the epoxide having the longer retention time. The relatively modest
yield for this reaction is a reflection of performing the reaction
twice, of the scale of reaction (20-30 mg) and perhaps of the degree
89 90
of functionality present ’
The diene (119) derived from triacetoxyscirpene was tested for
biological activity. This was done by determining the minimum
concentration of the diene to inhibit cell division of human
91
epithelial tumour cells (HEp2) using serial dilution . The starting 
epoxide (63) required a minimum dose of 3.4 mg/ml, whereas diene (119) 
required 550 mg/ml; in other words, the diene possessed less than 
0.7% of the toxicity of the epoxide; it is in essence non-toxic.
This finding further demonstrates the necessary presence of the 
epoxide for full biological activity.
-OH
OAc
(9) R=Ac 
(48) R=H
(63)
OAc
OAc
(119)
0 OAc
(ii)
(i)Ac20,py.
(ii)nBuLiJWCl6 J H F
(Hi) A c20,EI-3N/ DMAP
-OAc
(121)
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9. SYNTHESIS OF AN EPI—EPOXYTRICHOTHECENE (128)
To probe further the role of the 12,13—epoxide moiety, it was
decided to investigate whether the orientation of the epoxide was
critical or whether its mere presence was sufficient for biological
activity. To this end it was decided to synthesise the isomeric
epi—epoxide from culture products.
The synthetic plan involved making good use of our deoxygenation
protocol on a suitably protected substrate to furnish an exomethylene
compound, which could in turn be ozonolysed to the norketone. The
epi—epoxide could then be introduced by treatment of the norketone with
dimethylsulphonium methylide.
This plan requires protection of the A-ring double bond from
ozonolysis. It was decided to do this by formation of a bridged
bromo—ether using the 9,10-double bond and the unmasked C—15 alcohol 
30 44 45 47
* * * : 4-acetoxyscirpenediQl (48), one of our culture products,
is already suitably functionalised. Treatment of the diol (48) with NBS
in dry MeCN gave the bromo-ether (122) in 92% yield. Formation of the
bromo—ether was evidenced in the n.m.r. spectrum by the absence of
the olefinic C-10 proton at 5.5 and also by the sharpening and upfield
13
shift of the C—16 methyl signal ( 5 1.72 — > 51.26); C n.m.r.
spectroscopy showed no olefinic carbon signals at 140.3 (C—9) and 
5118.8 (C-10). In addition, the mass spectrum showed the presence
of the parent ion with'a doubling of peaks due to the natural isotopes
79 81
of bromine ( Br and Br).
The brominating species is thought to be molecular bromine, which
is produced by a fast ionic reaction between NBS and trace amounts of
Qp
HBr . The mechanism can then proceed by formation of the bridged 
bromonium ion (164), followed by subsequent intramolecular attack by 
the free C-15 hydroxyl to give the bridged bromo-ether (122) and HBr.
The HBr produced re-enters reaction 1 to maintain a low, steady—state
88.
[1] HBr +
O
N-Br
0
O
~H + Br2
0
-OH
OAc
(48)
OAc
(164)
+ HBr
(122)
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concentration of bromine. Bisbromination does not occur due to the
low standing concentration of Br^, and in any case, the rate of
bromo—ether formation, being intramolecular, would be expected to be
many orders of magnitude greater.
Treatment of the alcohol (122) with pyridine and acetic anhydride
gave the diacetate (123) in quantitative yield. Sharpless deoxygenation^
then gave the desired alkene (124) ( 6 5.25 and 4.82, H-13) in a yield of 
90
98% . This reaction further demonstrates the mildness and selectivity
of this deoxygenation procedure. Indeed, this work has shown the system
to be compatible with esters, bromo—ethers, alkenes and enones.
Independent work by R o ush^ has shown that it can also be used with
free hydroxyl groups present if a larger excess of WC1„ and nBuli is
6
used. This protocol is not however compatible with the THP ether
protecting group which undergoes cleavage under these conditions.
A literature search revealed that despite the mildness and compatibility
with other functionalities which we have observed, the Sharpless system
has to date had surprisingly little application. In an elegant use of
94
this system by Roberts et al , humulene tris-epoxide (165) could be 
selectively deoxygenated to give mono-epoxide (166), in effect 
functionalising the least reactive double bond!
Conversion of the exomethylene compound (124) into norketone (125) 
required prolonged exposure of the sterically hindered alkene to 
ozone — shorter reaction times resulted in mixtures of starting alkene 
and norketone. The intermediate ozonide was reduced using triethylamine
to give norketone (125) in 87% yield. I.r. spectroscopy showed the new
_1 13
carbonyl at 1770 cm and the C-12 signal in the C n.m.r. spectrum
occurred at 6207.8; both these facts are indicative of a strained,
bridging carbonyl. Interestingly the norketone stains a very distinctive
blue colour in t.l.c. on visualisation with eerie sulphate.
1
Treatment of the norketone with excess dimethylsuphonium methylide
h
R1in the THF gave the epi-epoxydiol (126) in 35% yield, acetate esters
90.
OAc
(122) R=H (124)
(123) R=Ac
(165)
(ii)
(166)
(i)Ac2 0 Jpy.;(ii)nBuLiJWCl6 ,THF.
OAc
(124)
(iv) (v)
v
-OTES
(130)
OAc
(125)
(iii)
(126)
(131) (132)
(i)0 3 ,CH2Cl2 ;(ii)Et3N;(iii)Me3S+rnBuLiJHF;
(iv)K2C03,Me0H;(v)TESCl, py. ,DMAP; 
(vi)Bu4NFJHF.
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having been cleaved by the ylid. An eight-fold excess of the ylid
was used to ensure that a mixture of C3/C4 acetates and alcohols did
not result. A higher yield and a much cleaner reaction was achieved by
use of triethylsilyl protecting groups rather than acetates. The
triethylsilyl groups were introduced by methanolysis of the Sharpless
deoxygenation product (124) followed by treatment with triethylsilyl
chloride and DMAP in pyridine in an overall yield of 73%. Ozonolysis
of the bissilyloxy olefin (130) gave norketone (131) (13C 5211.2 (C-13).
V 1765 cm ^) in 84% yield, 
max
Treatment of the norketone with 1.4 equivalents of dimethylsulphonium 
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methylide gave the desired epoxide (132) in 64% yield. Use of a greater 
excess of ylid resulted in the formation of a slightly more polar by­
product. Although not fully characterised this material was believed 
to be the thiomethyl alcohol (133) (by M.S.) which arises from attack 
on the intermediate betaine (167) by an external nucleophile at the 
sulphur-bearing methyl (SCHEME 21), rather than internal attack at the 
methylene carbon which would give the epoxide and dimethyl sulphide.
Since the production of this by-product can be eliminated by the use 
of less ylid, this suggests that the external nucleophile is the ylid 
itself and not the iodide counter ion.
Fluoride ion cleavage of the silyl ethers gave the epi-epoxydiol 
(126) identical to that obtained from norketone diacetate.
Completion of the synthesis was relatively straightforward. 
Acetylation of diol (126) gave (127). Restoration of the 9,10-double 
bond was achieved by treatment of the bromo—ether with a zinc—silver
QQ
couple . Finally, acetylation of the unmasked C-15 alcohol gave 
95
triacetate (128)
The epi—epoxytriacetate was slightly more polar and had a higher 
melting point than the natural epimer (169—170°C vs 122—3°C). An 
inspection of its n.m.r. spectrum showed an upfield shift of the 
epoxide protons, perhaps due to shielding by the C—4 acetate or to
93.
(131)
Brr
(132)
R=OTES
SCHEME 21
(i)
OTES 
(132)
OH
(126)
Br
H
-OAc 
OAc
(128)
(i)Bu4 NFJHF;(ii)Ac2 0 1py.;(iii)Zn(Ag)>THF,Et0 HJEt2 0
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relief of Bteric congestion from the A—ring. Superimposition of both 
1H n.m.r. spectra of the respective epoxides (FIGURE A) showed very 
little variation in pattern and chemical shift apart from the epoxide 
resonances. The configuration of the epoxide ring was confirmed 
conclusively by x-ray crystallographic analysis of the triacetate*
(FIGURE B). This clearly shows the epoxide with the oxygen away 
from the two—carbon bridge, i.e., the C12—C13 bond is anti—periplanar 
to the 0(1) - C2 bond.
As already mentioned, the mechanism for the formation of the epoxide
(SCHEME 21) involves nucleophilic attack of the sulphonium ylide at the
carbonyl to give an intermediate betaine (167). An internal displacement
by the alkoxide gives the epoxide. This particular stereochemistry
results from ease of attack at the carbonyl from the less hindered
two—carbon bridge. This is analogous to Colvin's synthesis of 
42
trichodermin where the epoxide with the unnatural stereochemistry (169) 
was obtained by treatment of norketone (168) with dimethylsulphonium 
methylide.
96
A recent paper by Volatron and Eisenstein has discussed the 
theoretical aspects of this Corey-Chaykovsky reaction and in particular, 
why a sulphonium ylid should give the epoxide and a sulphide whereas 
a phosphonium ylid gives the Wittig products of an olefin and phosphine 
oxide. By use of ab initio calculations they found that both 
thermodynamic and kinetic factors were responsible for the products 
observed.
For the Wittig reaction, only four-membered covalent rings were 
found to be stable intermediates. In the case of phosphorus there were 
two isomeric oxaphosphetanes (197) and (198) with the oxygen either in 
the apical or equatorial position of phosphorus. Interconversion of
*X-ray crystallographic analysis kindly performed by Dr. A.A. Freer 
(Glasgow).
X-ray Structure of Epi-Epoxytrichothecene (128)
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FIGURE B
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OAc
(168) (169)
Reactants
P-C
(197)
: p - o
c— c
Products
-R
(170)
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the apical oxaphosphetane to the equatorial oxaphosphetane requires 
an input of only 3 kcal/mol. This interconversion results in a 
weakening of the P-C bond, making ring opening to Wittig products 
easier. Such an interconversion is difficult in the case of sulphur, 
so kinetically the ease of ring opening of the oxaphosphetanes favours 
Wittig products.
Thermodynamically, for the sulphonium ylid, formation of the epoxide 
and sulphide is favoured by 39.1 kcal/mol over the formation of the olefin 
and sulphoxide. In contrast, for the phosphonium ylid, formation of the 
olefin and phosphine oxide is favoured by 14.6 kcal/mol over the 
formation of a epoxide and phosphine.
Deoxygenation of the epoxide to the olefin with phosphine was 
also shown to be a favourable process, although an input of energy is 
required to overcome the initial activation barrier. Indeed epoxide 
deoxygenations with Ph^P are commonly performed at temperatures in excess 
of 100°C9?.
The epi—epoxide triacetate (128) was also tested for biological
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activity by the same method used for the diene (119) . The minimum
concentration of the epi-epoxide to inhibit cell division was 920 mg/ml,
in other words the epi-epoxide possessed less than 0.4% of the toxicity
of the natural isomer. This finding clearly demonstrates the need to
have the epoxide in the correct orientation for biological activity.
This provides further evidence that the toxicological process may involve
intermediate (170) which arises from attack at the epoxide by the pyran
oxygen. Such an intermediate is not possible with the epi-epoxide since
the geometry is not correct for a Spj2 type of displacement. Additionally,
it is suspected that the epi-epoxide may be resistant to apotrichothecene 
17rearrangement for the same reason, i.e., the C-0 bond of the pyran ring 
is no longer anti—periplanar to the epoxide C—0 bond.
Independently of this work, Roush40 has also made use of the Sharpless 
deoxygenation procedure directly on anguidine (9) to give the exomethylene
100.
(171). Further elaboration of the exomethylene gave the key
intermediate (172). Ozonolysis of the derived C-4 triethyl silyl
ether (173) gave norketone (174) (SCHEME 22). This compound was used
to introduce a radiolabel specifically at C-13 by a Wittig reaction 
14
with Ph^P= CH^ to give labelled (173). Reconstruction of anguidine
was accomplished straighforwardly by desilylation at C-4, followed
by epoxidation of the alkene using m-chloroperbenzoic acid to give
a single epoxide (49). Regeneration of the 9,10—double bond,
acetylation of the diol (46) and hydrolysis of the THP ether gave
radiolabelled anguidine (SCHEME 23). This is the first time that a
trichothecene has been prepared enantiomerically pure and specifically
labelled with ^ C .
Norketone (174) also provided the starting point for Roush's
98
independent synthesis of 12—epi—anguidine (175) by a similar 
methodology employed by us.
In addition, he has prepared 12,13—deoxy—12,13—methanoanguidine 
(176), with an isosteric cyclopropane ring, from exomethylene (172) 
via Simmons—Smith cyclopropanation. No biological data ko-ve been 
published as yet on the epi-epoxide or cyclopropane.
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-OH
(9) (171)
(ii),(iii) ^
(iv)
(173) R=TES ^-<(V)
(vi)
(vii)
(174)
SCHEME 22
(i)nBuLi,WCl6 ,THF;(ii)DHP,H+;(iii)NaOH;
(iv)NBS,CH3 CN,NaHC0 3 ;(v)TESCl,DMAP,py.;
(vi)0 3 ,Me0 H;(vii)Me2S.
102.
-OTHP-OTHP
>
OTES OR
(174)
G i iL /  (172)R=H <-*
(46) '(49)
-OH
OAc
(9)
SCHEME 23
(i)Ph3P=CH2jHF;(ii)Bu4 NFJHF;(iii)mcpba,CH2Cl2 ,
Na2 HP0 4 ;(iv)Zn(Ag)JHF,Et0 H;Et2 0 ;
(v)Ac2 0 ,py.,DMAP;(vi)Ac0 H,H2 0 ,THF.
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-OH
(174) (175)
-OH
(172) (176)
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10. TRICHOTHECENE INTERCONVERSIONS
10.1 INTRODUCTION
Although widespread in distribution, provision of some trichothecenes 
from culture can be low yielding. Partial synthesis, from readily 
available trichothecenes, is an attractive alternative, carrying with 
it the additional possibilities of specific isotopic labelling and of 
analogue synthesis.
Partial synthesis may involve the following elements*:
(i) use of protecting group chemistry, as illustrated by the 
conversion of anguidine (9) into 4—acetoxyscirpenediol
(48)30;
(ii) reductive chemistry involving peripheral oxygenation, as 
exemplified by the conversion of anguidine into verrucarol 
(28) via Barton deoxygenation3^ ;
(iii) oxidative chemistry to introduce oxygenation at peripheral 
sites.
Chemical manipulation involving the first two elements has been 
well documented. However, with the exception of allylic oxidation at
C—8, methodology involving the third element has received little
. . .. 21,27,29,37
attention .
It was decided to attempt the synthesis of deoxynivalenol (23)
from anguidine : this synthesis proved to involve all three of the
above elements. Deoxynivalenol, which is arguably the most important
trichothecene in terms of natural contamination of feedstuffs, has yet
to succumb to either partial or total synthesis.
The synthetic plan (SCHEME 24) involved reductive elimination of
the C-4 oxygen moiety by some means to give calonectrin (5) or a
derivative thereof. Having established the correct level of oxygenation
in the C-ring, it remained to functionalise the A-ring to give the
*See also Introduction (3.3)
OAc
(9)
(48)
(28)
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-OH
OAc
OH
(23)
>
(5)
-OAc
(9)
SCHEME 24
-OH
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correct substitution pattern for deoxynivalenol. This necessitated 
selective allylic oxidation at C-8 and introduction of the 7a-hydroxyl 
group.
10.2 SYNTHESIS OF CALONECTRIN
Calonectrin has previously been prepared by total synthesis in 
47
racemic form and by conversion, via a Barton deoxygenation procedure,
36
of an anguidine derivative
Tamm's partial synthesis involved formation of the THP ether of 
the C—3 alcohol of anguidine, followed by saponification of the C—4 
and C—15 acetates to give diol (177). Regioselective acetylation of 
the diol to the C—15 mono—acetate and then reaction with N,N—thio— 
carbonyldiimidazole gave thiocarbamate (178). Treatment of this 
thiocarbamate with Bu^SnH in refluxing dichloromethane gave the C—3 
THP derivative of calonectrin (179). Completion of the synthesis was 
straightforward: THP ether cleavage using pyridinium tosylate, followed
by acetylation gave calonectrin in an overall yield of 30% from anguidine. 
This modest yield is mainly a reflection of the regioselectivity in 
acetylation and the THP ether cleavage step (SCHEME 25).
By use of 4—acetoxyscirpenediol (48), which can be obtained in 
good yield from culture, it was envisioned that an improvement on this 
synthesis could by achieved since 4-acetoxyscirpenediol is already 
suitably functionalised for easy access to C—4. The C—4—C—5 
bistriethylsilyl ether (145) was prepared in near quantitative yield 
by treatment of the diol with triethylsilyl chloride and DMAP in 
pyridine. However, selective hydrolysis of the C-4 acetate 
using K^COg in aqueous methanol gave a poor yield of the C-4 mono—ol 
(146) since the triethylsilyl groups were also partially cleaved. 
Additionally, preliminary studies on C-4 thioester formation using 
phenylchlorothiocarbonate looked unpromising since the residual acid
107.
AcO
OAc OH
(177)
0 /--OTHP
OC(imid)
(178)
(vi)
(5)
SCHEME 25
(i)DHP,PPTS/ CH2 Cl2 ;(ii)NaOH/ MGOH;
(iii) Ac20,py.JCH2Cl2;(iv)(imid)2C=S,C2H4Cl2;
(v)Bu3 SnH,AIBN;(vi)PPTS,MeOH.
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OAc
(48)
0>-0TES
0>-OTES
 >
(5)
(iJTESCl^DMAP^  py.; (ii) K2CO3 ^ MeOH ;
(iii) PhOCSCl,DMAR,py.JCH 2Cl2
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chloride had a similar polarity to its derived thioester (147). These 
problems could have certainly been overcome by use of a different 
C-3—C-15 protecting group and by use of a different "Barton ester" 
eg a thiocarbonyl—imidazole derivative. However, a re-examination 
of the literature provided the basis of a novel approach to the synthesis 
of calonectrin.
27
Sigg et al found that upon treatment with sodium methoxide in
refluxing methanol the C—3—C—4 bismesylate (56) gave solely the C—3
47
ketone (57). In addition, Kraus found that reduction of the C—3
ketone (180) was highly stereoselective, giving the product with
natural C—3 stereochemistry (181), hydride being delivered from the
less hindered exo face of the £ 3,2,1 ^  bicyclic subunit.
Sigg's observation can be rationalised on the basis of an ElcB
elimination, whereby the more exposed C-3 proton is abstracted selectively
by methoxide ion. The anionic intermediate (182) then collapses to give
the C-3 mesyl enol ether (183), which on in situ hydrolysis gives the
C-3 ketone (57). The rigid ring structure rules out the possibility
of an E2 trans elimination as a trans—coplanar system cannot be attained
Indeed, by analogy with Cristol's work on cis and trans 2,3—dichoro—
norbornanes^^, cis elimination may be more facile than trans elimination.
Additionally, the presence of a a-mesyl group may serve to stabilise
the formation of a carbanion due to its electron-withdrawing nature:
Cristol found that dehydrochlorination of exo—2—p—toluenesulphonyl—
endo-3-chloronorbornane (184) showed a rate enhancement of up to 8
orders of magnitude over the corresponding dichloro derivative (185).
In order to prepare a suitable 3,4 bismesylate it was necessary
to protect selectively the C-15 alcohol. This was readily achieved by
27
hydrolysis of anguidine (9) to scirpenetriol (7) , followed by
30 44 45 47
treatment of the triol with N-bromosuccinimide in MeCN * * *
to give the bridged bromo-ether diol (134). Treatment of the diol
110.
(56) (57)
-OH
(180) (181)
(i)Na0 Me,Me0 H;(ii)Ac2 0 ,py.;
(iii)NaBH4 ,MeOH.
111.
OMs
>
i " H
OMs
(56)
OMs
©
c
(182)
r H
OMs
/
OMs
(183)
c?
(57)
Cl
OTs
Cl
(184) (185)
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27with methanesulphonyl chloride in pyridine gave the bismesylate (135)
in an overall yield of 92% from anguidine.
Treatment of the bismesylate with sodium methoxide in refluxing
methanol gave the expected C-3 ketone (136) in 83% yield ( v 1770cm "S
max
^H n . m . r . 62.25, ABq, J 9 Hz, H-4).
Quantitative and stereoselective reduction of the ketone was achieved
by treatment with NaBH^ in aqueous methanol. The stereochemistry at C—3
was assigned by "^H n.m.r. spectroscopy on the basis of the observed
double—double—doublet at 65.20 in the derived C—3 acetate (138),
analogous with the published spectrum of calonectrin. Such a spectroscopic
result was also anticipated from the n.m.r. spectra of the
bicyclo[[ 3,2,1 Joctanols prepared for epoxide deoxygenation studies which
also showed a double-double-doublet for the a-epimers but only a
double-doublet for the /?—epimers.
Completion of the synthesis of calonectrin was straighforward.
Acetylation of the borohydride reduction product (137), restoration
of the C—15 alcohol and 9,10-double bond by treatment of the bromoether
99
with zinc/silver couple and finally acetylation of the C—15 alcohol 
gave calonectrin in an overall yield of 55% from culture products.
This material proved to be spectroscopically identical to natural 
calonectrin^.
10.3 SYNTHESIS OF DEOXYNIVALENOL FROM CALONECTRIN
Calonectrin (5) possesses the correct degree of oxygenation in the
C—ring for the synthesis of deoxynivalenol (23). Further elaboration
requires selective allylic oxidation at the C—8 methylene group followed
by introduction of the lex hydroxy substituent.
Functionalisation at C-8 has been accomplished by treatment of
29
anguidine with SeC>2 , which gave the 8p alcohol (65) in 39% yield 
Subsequent oxidation of the allylic alcohol using PCC gave the enone
0 > -0 H
113,
(9) (7)
(134) R = H —i.....
(135) R = Ms
(136)
(v)
(137) R=H —|
(138)R=Ac
0 > -0 H
(iv)
0
(vii)
(5)
(i)NaOH;(ii)NBS,MeCN;(iii)MsCl,py.;
(iv)NaOMe/MeOH;(v)NaBH4 JMeOH; 
(vi)Ac2 0 Jpy.;(vii)Zn(Ag)JHFJEfOH,EhO.
114.
-OH
(5) (23)
OAc
-OH
(9) (65)
-OH
(66)
(i)Se02 ;(ii)PCC.
115.
(66) in an overal yield of 31% from anguidine.
Allylic oxidation by treatment of anguidine with N—bromosuccinimide,
followed by silver trifluoroacetate has been reported to give a mixture
29
of 8 a  and 8p  alcohols (16,65) in a 24% overall yield . Acetolysis of
the C-8 bromo epimers gave the C-8 acetates (71,72) in a 37% overall
37
yield from anguidine . Application of a multistep procedure by these
methods on calonectrin would, therefore, be unlikely to give the desired
enone in over 35% yield.
It was thus desirable to establish the enone in a single high
yielding step. Use of t-butyl chromate on triacetoxyscirpene (63)
27
has been reported to give the enone (64) in under 20% yield . It was
decided to investigate other chromium based oxidants, in particular the
dipyridine.CrO^ complex (Collins' reagent) .  Treatment of triacetoxy—
scirpene with 60 equivalents of freshly prepared Collins' reagent in
dry dichloromethane for 4 days gave the enone (64) in an excellent yield
of 60%. Similar yields could be obtained upon oxidation of calonectrin
to the desired enone (139) (“4i n.m.r. 56.54, dq,J 1.5, 5.8Hz, H—10;
EtOH
\ 225 nm (€ 8900)). However, on one occasion enone (139) was
max
obtained in 74% after stirring overnight. This suggests that all 
reagents must be scrupulously dry and that the Collins' reagent should 
be used as soon as is prepared — even careful storage of the reagent 
in a desiccator for a few days leads to diminished activity.
The mechanism of this oxidation is believed to involve abstraction 
of an allylic and axial hydrogen atom to give allylic radical (186).
In the case of trichothecene only one hydrogen abstraction is possible - 
abstraction of a C-16 hydrogen would give a less stable primary radical. 
The allylic radical can then be oxidised further to the isomeric enones 
(187) and (188). No trace of (188) was observed. This may be due to 
the fact that in going to (187) the favourable overlap of the 7T-system 
with the C-0 cr* orbital would be destroyed in going to (188).
OAc
(9)
-OH
OAc
(65) Ri=OH R2=H 
{16) Ri = H R2=OH
OAc
(69)Ri=Br R2=H
(70)Ri = H R2=Br
(iii)
v
OAc
(71)Ri=OAc R2=H
(72)Ri =H R2=OAc
(i) NBS,CH2Cl2j (ii) CF3COOAg;(iii)AgOAc,AcOH.
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AcO
OAc
-OAc
(63) (64)
-OAc
(5) (139)
(i) py2 -CrOB, CH2CI2
AcO
V
H H
N/
H
(186)
CrO
\ /
CrO H
AcO
AcO
(11
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With the A-ring enone now suitably established, completion of the 
synthesis of deoxynivalenol requires introduction of the l a  hydroxyl 
moiety. It was decided to do this by conversion of a suitably protected 
C-3/C-15 species to the silyl enol ether, followed by selective 
epoxidation with m-chloroperbenzoic acid -a method discovered by 
Brook^-®^ gmd developed by Rubottom^-^^.
Hydrolysis of the C-3 and C-15 acetates using K^CO^ in aqueous
methanol, followed by silylation of the diol using trimethylsilyl
chloride and pyridine gave the bis—TMS ether (141). Addition of this
compound to three equivalents of LDA in THF at —78°C, with in situ
104
trapping of the derived enolate by TMSC1 , gave the silyl enol ether 
(142) (^H n.m.r. 65.70, br.d , J 6Hz , H-10). Treatment of this silyl 
enol ether with m-chloroperbenzoic acid in hexane at - 20°C gave a 1:2 
mixture of the desired l a —silyloxy ketone (143) (the tris—TMS ether 
of deoxynivalenol) and the ring opened product (144) in a combined 
yield of 75%. The products obtained can be rationalised by 
consideration of the mechanism of this oxidation.
It is believed that epoxidation of the silyl enol ether gives a 
mixture of a — and /?- silyloxyepoxides. The /0-silyloxyepoxide 
predominates due to greater accessibility of the epoxidising agent to 
the /3—face. The respective silyloxyepoxides then undergo ring opening 
in the presence of a cataytic amount of acid to give the oxocarbenium 
species (189) and (190). The oxocarbenium species (189), from the 
a —epoxide, undergoes a facile 1,4-silyl shift to give the desired 
l a -silyloxyketone (143). Rather than undergo a facile 1,4-silyl 
shift, the 1/3 hydroxyl group in the oxocarbenium species (190), arising 
from /0-face epoxidation, instead attacks the proximate 12,13-epoxide 
to give the 6-membered ether (144), after loss of the C-8 silyl group 
in hydrolytic work-up. No 1,4-silyl shift was observed to take place; 
such a process is further disadvantaged by the rigid ring structure
AcO
>  TMSO
(142)
1 : 2(143)
(i)K2C03 ,Me0H;(ii)TMSCl,py.;
(iii) LDA JMSCl ,THF; (iv)mcpba,hexane.
120.
OTMS
-OTMS
121.
-OTMS
mcpba
0 >-OTMSOr-OTMS
TMSO
TMSO
0>-0TM S0>-0TMS
TMSO TMSO
TMSO
(190)
(189)
-OTMSTMSO
TMSO
/ k  >^0>-0TM S
TMSO J  
TMSO-^
(143) (144)
TMSO
(190)
123.
holding the (3-hydroxyl too far away from the C-8 silyloxy group for 
easy migration.
The presence of the pyran ring was evidenced by a n.m.r. coupling
constant of 11.5 Hz and a shift of 53.93 and 3.60 for the C—13 AB
quartet in comparison with 4-5 Hz and 53.0-2.5 for the epoxide.
Evidence for the presence of an intermediate silyloxyepoxide has
recently been provided independently by Davis and Paquette.
Davis treated the silyl enol ether of isobutyrophenone (191) with
2-(phenylsulphonyO-3— (p-nitrophenyl) oxaziridine (193) — an aprotic
and neutral epoxidising agent — to give the silyloxyepoxide (192) which
was stable at room temperature. Rearrangement of the silyloxyepoxide
105
could be effected by treatment with a trace of pTSA
Amazingly, Paquette's silyloxyepoxide (195), obtained upon treatment
of (194) with buffered m—chloroperbenzoic acid, was crystalline and
therefore amenable to x—ray crystallographic analysis. Rearrangement
of the silyloxyepoxide in this case could also be effected by treatment
100
with a catalytic amount of benzoic acid
The synthetic tris—TMS ether of deoxynivalenol (143) proved to be
107
identical by GCMS with a sample prepared from natural deoxynivalenol 
Quantitative cleavage of the TMS ether groups in (143) was achieved 
using HF in aqueous MeCN. The synthetic deoxynivalenol (23) was 
characterised fully as its triacetate (120)1^ * ^ ^ .
In conclusion an efficient synthesis of calonectrin has been 
developed and the first synthesis of deoxynivalenol has been achieved. 
Similar methodology on the triacetoxyscirpene enone (64) should give 
entry into the neosolaniol series of compounds (196). Additionally 
enone (64) is suitably functionalised for possible, further elaboration 
to T-2 Toxin (14). Indeed it should now be possible to obtain a wide 
range of trichothecenes by partial semi-synthesis. Roush's recent 
synthesis of C-13 labelled anguidine40 also means that calonectrin
and deoxynivalenol, inter alia, can now be synthesised in specifically 
radiolabelled form.
125.
TMSO 
Ph
TMSO 0
(193) y,
(191) (192)
/°v(193) PhS02 N—CHPh-N02-p
(i)
MeO^
(Ph)02S 0 OTMS
Me02C
(Ph)02S (i)TMS 
(195)
v
Me02C
(Ph)02S TMSO '0
(i)mcpba, buffer ;(ii)PhC02H,CH2 Cl2.
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(143) (23)
-OH
(ii) >
(i)HF,MeCN,H20;
(ii)Ac20 ,E t3N,DMAP, 
CH2 CI2 .
-OAc
(120)
(196)
OAc
AcO
-OR
EXPERIMENTAL
127.
INSTRUMENTATION
Melting points were determined on a Kofler hot stage melting
point apparatus and are uncorrected. Bulb to bulb distillations
were carried out on a Buchi GK3-50 Kugelrohr. Recorded boiling ranges
refer to the indicated air-bath temperature. n.m.r. spectra were
recorded either on a Perkin-Elmer R32 spectrometer operating at 90 MHz,
or a Varian XL100 spectrometer operating at 100 MHz or on a Bruker WP
13
200 SY spectrometer operating at 200 MHz. C n.m.r. spectra were 
recorded on either a Varian XL100 spectrometer operating at 25 MHz or 
a Bruker WP 200 SY spectrometer operating at 50 MHz. Infra-red spectra 
were determined on a Perkin—Elmer 580 spectrometer, ultra-violet 
spectra on a Perkin-Elmer 550SE spectrophotometer and optical rotations 
on an Optical Activity AA-100 auto-digital polarimeter. Low and high 
resolution mass spectra were recorded on VG updated MS 12 and MS 902 
instruments respectively. Elemental analyses were performed on a 
Carlo Erba 1106 elemental analyser. Instruments and conditions used 
for GLC and GCMS studies are described in the relevant experimental 
sections.
PURIFICATION OF CHEMICALS
Reactions were usually carried out under an atmosphere of nitrogen.
All solvents and reagents used were analytical grade where possible.
THF and ether were distilled freshly from sodium/benzophenone ketyl.
N,N-Dimethylformamide and acetonitrile were distilled from blue silica
o
gel and stored over 4A molecular sieves. Dichloromethane was distilled
o
from Po0-_, filtered through Grade I basic alumina and stored over 4A 
2 5
molecular sieves. Allyl bromide was distilled from anhydrous CaCl^ and 
o
stored over 4A molecular sieves. Diisopropylamine was distilled from
o
K0H and stored over 4A molecular sieves. Petroleum ether, hexane and
o
pentane were distilled from CaH and stored over 4A molecular sieves.
128.
DMAP was recrystallised from cyclohexane. NBS was recrystallised
from water and dried over Po0__. Bii NF was prepared from its hydrate
2 5 4
by heating at 100°C on Kugelrohr under high vacuum for 2 hours.
Dry column flash chromatography and flash chromatography refer to 
techniques already described -^*-0,111^
SPECTRAL ANALYSIS
Chemical shifts are reported in parts per million (5) relative 
to Me^Si (0.00 ppm), using Me^Si or the 7.25 ppm residual chloroform
peak and the 77.0 ppm CDCl^ peak as internal references for and
13 1
C n.m.r. spectra respectively. H n.m.r. data are reported using
the following convention: chemical shift £  integrated intensity^
multiplicity, s=singlet, d=doublet, t=triplet, q=quartet, coupling
constant (Hz), assignment]].
The n.m.r. signals for H-2, H-3, H-4, H-5 and H-7 protons for
the model compounds generally occur as a multiplet between 52.3 and
1.5 and are omitted from the experimental section for clarity.
13
The multiplicities of the 50 MHz C spectral resonances were
determined by use of DEPT spectra with pulse angles, 0=90° and
135° The multiplicities of the 25 MHz ^ C  spectral resonances
13 1
were determined by use of C— H couplings in the off—resonance 
spectra.
GENERAL ACETYLATION PROCEDURE
Unless otherwise stated acetylations were performed by dissolving 
the starting alcohol (250 mg) in ether (4 ml) and then adding excess 
Ac^O (2 ml) and pyridine (1 ml). After standing at room temperature 
overnight excess Ac^O and pyridine were removed by azeotroping with 
toluene (4x) and then CCl^ (2x).
NUMBERING SYSTEMS
Numbering of the trichothecenes follows the conventional system 
as follows:
16,
The model bicyclic compounds are numbered thus:
In addition the exo epoxide is defined as that with the 
8-8' C-C bond axial, i.e. with the epoxide oxygen on the same 
side as the 2—carbon bridge. Conversely the endo epoxide is 
defined as that with the 8-8" C-C bond equatorial.
OSiMes
(109)
1—Trimethylsilyloxy-2-methylcyclohex-l-rene (109)
To a solution of TMSC1 (38 ml, 0.3 mol) and Et^N (83.1 ml,
0.6 mol) in DMF (90 ml) was added 2—methylcyclohexanone (30.3 ml, 
0.25 mol). The resulting mixture was heated under reflux with 
stirring for 48 h in a nitrogen atmosphere. It was then allowed 
to cool, and diluted with pentane (200 ml) and washed with cold 
aqueous NaHCO^ (3 x 300 ml), cold aqueous HC1 (1.5 M, 50 ml) and 
cold aqueous NaHCO^ (1 x 50 ml). The organic extract was then 
dried (Na^SO^) and concentrated in vacuo. Distillation of the 
crude residue gave the silyl enol ether (109) as a colourless oil 
(37.95 g, 83%), b.p. 66-68°C/10 mmHg3 lit.93 82-84°C/16 mmHg.
1H n.m.r. (CDC13 , 90 MHz) 8 1.90 and 1.50 (11H, m, H-3, H-4, H-5 
H—6 + CH3 ), 0.05 (9H, s, -OTMS).
(110)
2-Ally1-2-methylcyclohexanone (110)
MeLi (1.33 M in ether, 57.7 ml, 76.8 mmol) was added with 
stirring to silyl enol ether (109) (12.8 g, 69.1 mmol). After 
0.5 h. the reaction mixture was concentrated in vacuo > the vacuum being 
released with nitrogen. Dry THF (50 ml) was then added, followed 
by redistilled allyl bromide (6.5 ml, 76.0 mmol) dropwise with 
stirring. After 5 m .  the reaction mixture was poured on to pentane.
The organic layer was washed with saturated NaHCO , dried (Na SO )
O t A
and concentrated in vacuo. Distillation of the residue yielded the
allyl ketone (110) (9.52 g, 77%) as a colourless oil, b.p. 78—80°C/
10 mmHg. v (CC1J 2970, 2940, 2880, 1720, 1640, 1450, 1380, 1315, 
max 4
1255, 1130, 920 cm-1
XH n.m.r. (CDC13 , 90 MHz) 6 5.75 (1H, m, -CH=CH2 ), 5.00 
(1H, m, -CH=OT2 ), 2.38 (4H, m, H-6 + - CH2CH=CH2 ), 1.80 (6H, 
m, H—3, H—4 + H—5).
Mass spectrum, m/z found: 152.1190 (^^H^gO re9uires 152.1201).
132.
CHO
(111)
(1—Methyl—2—oxocyclohexyl) ethanal (111)
Ozone was bubbled through a solution of the allyl ketone (110)
(3.97 g, 26.1 mmol) in dry CH^Cl^ (50 ml) at - 78°C. On turning 
blue, the solution was then purged with nitrogen to expel excess 
ozone. The ozonide was reduced by the addition of Et^N (6.9 ml,
52.2 mmol) at —78°C followed by stirring overnight at room temperature. 
The solution was then filtered through a short column of chromatographic 
silica gel and concentrated in vacuo to yield the keto-aldehyde (111) 
(3.69, 92%) as a pale yellow oil, which was used without further 
purification.
1H n.m.r. (CDC13> 90 MHz) 69.70 (1H, m, CHO), 2.5 (2H, m,
CHgCHO), 2.4 (2H, m, H-6) 1.25 (3H, s, CH3 ).
133-
-OH
H
OH
(1 1 2a) (1 1 2 b)
( ±) l-Methyl-6a-hydroxybicyclo [] 3,2,1 octan—8—one (112a) and 
(-£) l-Methyl-6/3-hydroxybicyclo 3,2,1 ]] octan-8—one (112b)
A solution of the keto-aldehyde (111) (2.81 g, 0.018 mol) in 
methanol (90 ml) was added to a solution of freshly prepared sodium 
methoxide (from sodium (2.87 g, 0.124 mol) in methanol (200 ml) ).
The mixture was heated under reflux for 0.5 h, cooled and then poured 
on to iced water (200 ml). Excess methanol was removed by 
concentration in vacuo and the residual, aqueous portion extracted with 
ether (3 x 100 ml). The combined organic extracts were dried (MgSO^) 
and concentrated in vacuo to give a crude mixture of ol— and /3— 
alcohol epimers in a ratio of 1:2 (by n.m.r. spectroscopy). 
Purification by dry column flash chromatography yielded 351 mg (12.5%) 
of pure a-alcohol (112a), 760 mg (27%) of pure /3-alcohol (112b) along 
with 589 mg (21%) of an epimeric mixture - i.e., a total yield of 
1.70 g (60.5%).
The a-epimer (112a) was characterised as a white crystalline solid:
m.p. 95-6°C (ether-pet.ether); 0.29 (1:1 EtOAc-pet.ether);
V (CC1J 3630, 2960, 2930, 2860, 1750, 1500, 1360, 1235 (br), 
max 4
1095, 1075, 1040, 970, 955, 895 cm"1 .
134.
1H n.m.r. (CDC13> 90 MHz) 64.45 (1H, ddd, J 10,5,5 Hz, H-6);
2.4 (1H, m, H—5), 1.95 (3H, s, CHg).
13C n.m.r. (CDC13 , 25 MHz) 6 221.9 (C-8), 65.9 (C-6), 52.2 (C-5),
48.7 (C-l), 45.2 (C-2), 42.3 (C-7), 31.8 (C-4), 19.3 (C-3 + CHg).
Mass spectrum, m/z found: 154.0995 (M+ , C Hn 0 requires
9 14 c
154.0994).
Microanalysis, found: C, 70.20; H, 9.25% requires
C, 70.10; H, 9.15%).
The /3-epimer (112b) was characterised as a white crystalline
solid: mp 69-71°C (ether-pet.ether); 0.22 (1:1 EtOAc-pet.ether);
V (CC1J 3620, 3450 (br), 2940, 2930, 2860, 1750, 1450, 1380, 
max 4
1255 (br), 1215, 1180, 1155, 1080, 1030, 970, 955 cm-1.
■hfl n.m.r. (CDC13 , 90 MHz) 64.25 (1H, dd, J 9,4 Hz, H-6),
2.3 (1H, m, H—5), 1.00 (3H, s, CH3 ).
13C n.m.r. (CDC13> 25 MHz) 6 221.4 (C-8), 69.4 (C-6), 55.9 (C-5),
47.9 (C-l), 43.9 (C-2), 43.8 (C-7), 34.0 (C-4), 19.1 (C-3 + CH3 ).
Mass spectrum, m/z found: 154.1001 (M+ , requires
154.0994).
Microanalysis, found: C, 70.07; H, 9.15% requires
C, 70.10; H, 9.15%).
135.
--OAc
(it) 1—Methyl—6(X -acetoxybicyclo 3,2,1 ^ joctan—8—one (113a)
Keto-alcohol (112a) (270 mg, 1.75 mmol) was acetylated by the
normal procedure. Purification by dry column flash chromatography
(EtOAc-pet.ether) gave 314 mg (91%) of the keto-acetate (113a) as a
colourless oil: bp 85°C (0.5 mmHg, Kugelrohr); R^ » 0.44 (1:1
EtOAc-pet.ether); v (NaCl) 2960, 2940, 2920, 2860, 1750, 1450,max
1380, 1235, 1185, 1140, 1090, 1070, 1035, 980, 910 cm-1.
^  n.m.r. (CDC13> 90 MHz) 65.2 (1H, ddd, J 10,5,5 Hz, H-6
2.65 (1H, m, H—5), 2.1 (3H, s, CH3C0), 0.98 (3H, s, CH3 ).
13C n.m.r. (CDC13> 2 5 MHz) 5219.6 (C-8), 170.6 (CH3C0), 68.8
(C-6), 50.0 (C-5), 48.0 (C-l), 45.1 (C-2), 39.4 (C-7), 32.4 (C-4),
20.9 (CH3C0), 19.1 (C-3 + CH3 ).
Mass spectrum, m/z found: 196.1102 (M+ , C.1.1H.1_0 requires
— “ XX Xo O
196.1099).
Microanalysis, found: C, 67.19; H, 7.96% (C.._H., _0o requires
XX Xo o
C, 67.32; H, 8.22%).
136.
OAc
(113b)
(±) 1—Methyl—6/3 —acetoxybicyclo3,2,1 ~\octan—8—one (113b)
Keto—alcohol (112b) (394 mg, 2.59 mmol) was acetylated by the 
normal procedure. Purification by dry column flash chromatography 
(EtOAc-pet.ether) gave 440 mg (87%) of the keto-acetate (113b) as a 
colourless oil: bp 85°C (0.5 mmHg, Kugelrohr); R^ . 0.44 (1:1
EtOAc-pet.ether); 1/ (ccl4 ) 2960, 2940, 2860, 2850, 1750, 1450, 
1375, 1360, 1235, 1180, 1150, 1080, 1025, 985 cm”1 .
^  n.m.r. (CDC13> 90 MHz) §5.08 (1H, dd, J 9,4 Hz, H-6),
2.35 (1H, m, H—5), 2.00 (3H, s, CHgCO), 1.02 (3H, s, CH3 ).
13C n.m.r. (CDC1 , 25; MHz) 6220.2.(C-8), 170.5 (CH CO),
O o
71.7 (C-6), 52.3 (C-5), 47.6 (C-l), 43.8 (C-2), 40.8 (C-7),
34.0 (C-4), 21.1 (CH3C0), 19.0 (C-3 + CH3 ).
Mass spectrum, m/z found: 196.1094 (M+ , C_..H.1_0_ requires
—  —  JLJ. _Lt> o
196.1099).
Microanalysis, found: C, 67.09: H, 8.31% (C_.1H.1_0o requires
J.X lb o
C, 67.32 H, 8.22%).
137.
--OH
(114a)
(±) l-Methyl-6a -hydroxy-8-methylenebicyclof 3,2,1 ~|octane (114a)
To a suspension of methyltriphenylphosphonium bromide (1.43 g,
4.0 mmol) in THF (35 ml) was added with stirring and under nitrogen,
a solution of nBuLi (2.2 M in hexane, 2.0 ml, 4.4 mmol). The
mixture was stirred for 10 m. when a solution of the keto-acetate
(113a) (314 mg, 1.6 mmol) in THF (10 ml) was added. The mixture
was then heated under reflux for 1 h. when it was cooled, diluted
with water and extracted with ether. The organic extracts were
washed with dilute HC1 and brine, dried (MgSO^) and concentrated
in vacuo. Purification by dry column flash chromatography (ether—
pet.ether) gave 130 mg (53%) of the desired olefin (114a) as a white
crystalline solid: mp 70-72°C (pet.ether); 0.5 (EtOAc—pet.ether);
V (CC1J 3625, 3070, 2950, 2920, 2870, 1660, 1440, 1370, 1230, 1105, 
max 4
1040, 980, 955, 940 cm-1.
1H n.m.r. (CDC13 , 90 MHz) 54.65 and 4.53 (2H, 2 x s, C=CH2 ),
4.3 (1H, ddd, J 10,5,5 Hz, H-6), 2.55 (1H, m, H-5), 1.00 (3H, s, 
ch3).
13C n.m.r. (CDC13 , 25 MHz) 5162.3 (C-8), 98.7 (C=CH2 ), 71.3 
(C—6), 48.7 (C—5), 45.2 (C-7), 43.2 (C-2), 42.6 (C-l), 29.7 (C-4),
138.
23.1 (CH3 ), 20.3 (C-3).
Mass spectrum, m/z found: 152.1204 (M+ , C-.JH-.JD requires— — 1U lb
152.1201).
Microanalysis, found: C, 78.83; H, 10.72% (C.1/.H.1_0 requires
J L U  l o
C, 78.90; H, 10.59%).
139.
(114b)
(±) 1—Methyl—6j3 —hydroxy—8—methylenebicyclo£ 3,2,1 3 octane (114b)
Olefin (114b) was prepared in an analogous manner to (114a)
from keto-acetate (113b) (840 mg, 4.28 mmol) and methyltriphenylphosphonium
bromide (3.83 g. 10.71 mmol). Purification by dry column flash
chromatography (ether-pet.ether) gave 324 mg (50%) of olefin (114b)
as a white crystalline solid: mp 49-52°C (60-80 pet.ether); 0.43 (1:1
EtOAc-pet.ether); v (CC1J 3610, 3580, 3070, 2980, 2930, 2870,
max 4
2860, 1665, 1465, 1450, 1445, 1390, 1370, 1120, 1020, 960, 930, 915,
-1885 cm
Hi n.m.r. (CDCl^, 90 MHz) 64.75 and 4.68 (2H, 2 x s, 0=0^)*
4.05 (1H, dd, J 8,4 Hz, H-6), 2.4 (1H, m, H-5), 1.08 (3H, s, CH3 ).
13C n.m.r. (CDC13 , 25 MHz) 6161.4 (C-8), 99.6 (C=CH2 ), 73.7
(C—6), 53.5 (C—5), 48.5 (C-7), 43.8 (C-l), 41.9 (C-2), 32.7 (C-4),
23.0 (CH3 ), 20.1 (C—3).
Mass spectrum, m/z found: 152.1197 (M+ , Cn_H1o0 requires
— — -LU lb
152.1201).
Microanalysis, found: C, 78.75; H, 10.65% (C^qH^ 0 requires:
C, 78.90; H, 10.59%).
140.
(115a)
(— ) 1—Methyl-6o: —acetoxy-8—methylenebicyclo3,2,1 ] octane (115a)
To a suspension of WC1_ (439 mg, 1.11 mmol) in THF (4 ml) at
o
—78°C was added nBuLi (2.58 M in hexane, 1.28 ml, 3.3 mmol). The
cooling bath was removed and the mixture allowed to come to room
temperature when the solution became dark brown and homogeneous.
This solution was temporarily replaced in the cooling bath at —78°C
whereupon epoxide (117a) (117 mg, 0.56 mmol) in THF (6 ml) was added. The
cooling bath was removed, and the reaction mixture was heated under
reflux for 6 h. On cooling to room temperature, it was diluted with
hexane, washed once with a solution 2 M in NaOH and 1.5 M in sodium
tartrate, and once with water. The organic extract was dried (MgSO^)
and concentrated in vacuo. Purification by dry column flash
chromatography (ether-pet.ether) gave 98 mg (91%) of olefin (115a) as
a colourless oil: bp 85°C (1 mm Hg, Kugelrohr); 0.62 (1:1
EtOAc—pet.ether); v (CC1.) 3080, 2960, 2940, 2880, 2860, 2850
max 4
1740, 1670, 1470, 1450, 1400, 1375, 1360, 1280, 1250 (br), 1215, 1155, 
1105, 1080, 1030, 940, 925, 890 cm-1.
1H n.m.r. (CDClg, 90 MHz) <55.05 (1H, ddd, J 10,5,5 Hz, H-6),
OAc
141.
4.7 and 4.6 (2H, 2 x s, C=CH2), 2.85 (1H, m, H-5), 2.05 (3H, s,
CH3C0), 1.04 (3H, s, CH3 ).
13C n.m.r. (CDC1 , 25 MHz) 5170.8 (CH CO), 160.6 (C-8), 99.6 
(C=CH2), 73.6 (C-6), 46.5 (C-5), 42.9 (C-2), 42.1 (C-7), 42.0 (C-l),
30.3 (C—4), 22.9 (CH3 ), 20.9 (CH^O), 19.9 (C-3).
Mass spectrum, m/z found: 194.1319 (M+ , C H_ 0 requires
—  —  i c  l o  2
194.1307).
Microanalysis, found: C, 74.04; H, 9.36% (CloH1o0
1  o  2
requires: C, 74.19; H, 9.34%).
Olefin (115a) was identical in all respects to that prepared 
by acetylation of alcohol (114a) in the normal way (91% yield).
142.
OAc
(115b)
(±) 1—Methyl—6/? -acetoxy—8-methylenebicyclof 3,2,1 ^ octane (115b)
Olefin (115b) was prepared in an analogous manner to (115a) from
epoxyacetate (117b) (77 mg, 0.37 mmol) and WC1„ (291 mg, 0.73 mmol).
6
Purification by dry column flash chromatography (ether—pet.ether) gave
65 mg (91%) of olefin (115b) as a colourless oil: bp 50°C (0.05 mmHg,
Kugelrohr); R 0-62 (1:1 EtOAc-pet.ether); v 3040, 2950, 2930, 2870 
i max *
2860, 1730, 1670, 1445, 1375, 1360, 1245, 1155, 1145, 1025, 890 cm”1 .
hi n.m.r. (CDC13 , 90 MHz) 6 4.9 (1H, dd, J 9,4 Hz, H-6), 4.7 and
4.6 (2H, 2 x s, C=CH2 ), 2.5 (1H, m, H-5), 1.95 (3H, s, CHgCO),
1.04 (3H, s, CH3 ).
13C n.m.r. (CDC13 , 25 MHz) 6170.8 (CHgCO), 161.0 (C-8), 98.9 
( C=CH2 ), 76.6 (C-6), 50.0 (C-5), 45.0 (C-7), 43.8 (C-l), 42.1 (C-2),
32.8 (C—4), 22.7 (CHg), 21.4 (CH CO), 20.1 (C-3).
Mass spectrum, m/z found: 194.1314 (M+ , C H 0 requires
—  —  i c  l O  c
C, 194.1307).
Microanalysis, found: C, 74.09; H, 9.63% (C^2H18°2 re(luires
C, 74.19; H, 9.34%).
Olefin (115b) was identical in all respects to that prepared by 
acetylation of alcohol (114b) in the normal way (87% yield).
143.
Use of the above protocol with stirring of the reaction mixture 
at ambient temperature for 72 hours resulted in production of a 1:1 
mixture of the olefin (115b) and chlorohydrin (163).
The chlorohydrin was identified from its n.m.r. spectrum as 
follows:
XH n.m.r. (CDC13 , 90 MHz) 5 5.03 (1H, dd, J 9, 5 Hz), 4.02 and
3.66 (2H, ABq, J 12 Hz, H-8'), 2.08 (3H, s, CH3C0), 1.06 (3H, s, CH3).
144.
(116a)
(-) Spiro f l-methyl-6a -hydroxybicycloH 3,2,1 J octane-exo-8,81 -oxirane *] 
(116a)
A mixture of the hydroxyolefin (114a) (225 mg, 1.34 mmol),
m-chloroperbenzoic acid (490 mg, 2.41 mmol, assuming 85% purity) and
Na^HPO^ (2.28 g) in 70 ml CH^Cl^ was stirred overnight at room
temperature. The reaction mixture was then poured into water and
extracted with ether (3x). The combined extracts were washed with
dilute NaHCOg and then brine, dried (MgSO^) and concentrated
in vacuo. Purification by dry column flash chromatography (ether,
then ether-EtOAc) gave 217 mg (87%) of hydroxyepoxide (116a) as a
colourless oil: bp 120°C (0.1 mm Hg, Kugelrohr); R^ . 0.29
(1:1 EtOAc-pet.ether); v (CC1J 3620, 3500 (br), 3040, 2940,
max 4
2880, 2860, 1490, 1465, 1450, 1445, 1375, 1250 (br), 1110, 1090,
1040, 945, 910, 890 cm-1.
^  n.m.r. (CDC13 , 90 MHz) 54.65 (1H, ddd, J 10,5,5 Hz, H-6),
2.72 (2H, s, H-8'), 0.73 (3H, s, CH3 ).
13C n.m.r. (CDClg, 25 MHz) 572.6 (C-8), 71.2 (C-6), 46.6 (C-5),
45.8 (C-8'), 44.3 (C-7), 40.2 (C-2), 39.9 (C-l), 26.9 (C-4), 19.6
(C-3), 18.7 (CH3).
Mass spectrum, m/z found: 168.1148 (M+ , C H 0 requires 168.1150).
— — IU lb 2
145-
(116b)
(40 Spirof~ 1-methy 1-6/3 -hydroxybicyclof 3,2,1 1 octane-exo-8,81 -oxirane ~| 
(116b)
Epoxide (116b) was prepared in an analogous manner to (116a) from
hydroxyolefin (114b) (250 mg, 1.64 mmol), m—chloroperbenzoic acid (540 mg,
2.30 mmol, assuming 85% purity) and Na^HPO^ (2.55 g) in CH^Cl^ (70 ml).
Purification by dry column flash chromatography (ether, then ether-EtOAc)
gave 242 mg (88%) of hydroxyepoxide (116b) as a white amorphous solid:
mp 95-98°C (40:60 pet.ether); R„ 0.18 (EtOAc-pet.ether) V (CC1.)
f max 4
3600, 3500 (br), 3040, 2940, 2880, 2860, 1470, 1450, 1405, 1375, 1260, 
1130, 1115, 1090, 1030, 970, 930, 915, 850 cm"1 .
^  n.m.r. (CDC13> 90 MHz) (54.10 (1H, dd, J 8, 4 Hz, H-6), 2.75 
(2H, s, H—8'), 0.80 (3H, s, CHg).
13C n.m.r. (CDC13 , 25 MHz) 674.1 (C-6), 72.1 (C-8), 50.7 (C-5),
47.6 (C—7), 44.8 (C-8‘), 41.6 (C-l), 38.9 (C-2), 29.3 (C-4), 19.3 (C-3),
18.6 (CH3 ).
Mass spectrum, m/z found: 168.1150 (C.JH.1_0_ requires 168.1150).
— — JLU 16 2
Microanalysis, found: C, 71.39; H, 9.61% (C1r.H-_0o requires
10 16 2
C, 71.38; H, 9.59%).
(117a)
(±) SpixgC l-methyl-6a -acetoxybicyclof 3,2,1 1 octane-exo-8,8*-oxirane 1 
(117a)
Acetylation of* hydroxyepoxide (116a) (122 mg, 0.73 mmol) in the
normal manner gave 125 mg (82%) of* the epoxyacetate (117a) as a colourless
oil: bp 110°C (2 mmHg, Kugelrohr); R^ . 0.52 (1:1 EtOAc—pet.ether);
V . (CC1J 3040, 2960, 2940, 2880, 2840, 1740, 1450, 1375, 1360, 1245,RlHX 4
1210, 1110, 1090, 1040, 950, 910 cm”1 .
1H n.m.r. (CDC13> 90 MHz) 6 5.33 (1H, ddd, J 9,5,5 Hz, H-6), 2.73 
(2H, s, H-81), 2.08 (3H, s, CH3C0), 0.75 (3H, s, CH3 ).
13C n.m.r. (CDC13 25 MHz) 6170.8 (CH3C0), 73.8 (C-6), 71.8 (C-8),
45.7 (C-8'), 44.7 (C-5), 41.4 (C-7), 40.0 (C-2), 39.5 (C-l), 27.4 (C-4),
20.9 (CHgCO), 19.3 (C-3), 18.5 (CH3 ).
Mass spectrum, m/z found: 210.1254 ( ^ 2^18^3 requires 210.1256).
147.
OAc
(117b)
(±) Spiro (~ l-methyl-6/ff -acetoxybicyclo Q 3,2,1 ] octane-exo-8,81-oxirane 
(117b)
Acetylation of hydroxyepoxide (116b) (153 mg, 0.91 mmol) in the
normal manner gave 155 mg (81%) of the epoxyacetate (117b) as a colourless
oil: bp 100°C (1.0 mmHg, Kugelrohr); R 0.52 (1:1 EtOAc-pet.ether);
V (NaCl) 3040, 2930, 2870, 2850, 1730, 1460, 1445, 1365, 1295, 1245,max » > > > > » » » » »
1210, 1165, 1150, 1025, 990, 970, 935, 910, 860, 845 cm"1 .
1H n.m.r. (CDC13> 90 MHz) 55.0 (1H, dd, J 8,4 Hz, H-6), 2.75
(2H, s, H—8 1), 2.04 (3H, s, CHgCO), 0.82 (3H, s, CH3 ).
13C n.m.r. (CDC13 , 25 MHz) 5 170.0 (CH3C0), 75.2 (C-6), 70.5 (C-8),
46.7 (C-5), 43.8 and 43.0 (C-7 + C-8'), 40.6 (C-l), 38.0 (C-2), 28.4
(C—4), 20.3 (CH3C0), 18.3 (C-3), 17.3 (CH3 ).
Mass spectrum, m/z found: 210.1241 (C H 0 requires 210.1256).
—  —  i c  ± o  o
Microanalysis, found: C, 68.61; H, 8.68% (C10H 0 requires
J .^ 1 J L o  o
C, 68.53; H, 8.63%).
148.
(118)
(I) SpiroT 1-methyl—6/? -hydroxybicyclof 3,2,1 octane—endo—8.8' 
oxirane ] (US)
To a stirred suspension of Me^S+I (833 mg, 4.08 mmol) in THF
(15 ml) under nitrogen was added nBuLi (2.4 M in hexane, 1.91 ml, 4.59
mmol). The solution became clear; it was stirred at 0°C for 1 h.
when a solution of ketone (113b) (200 mg, 1.02 mmol) in THF (10 ml)
was added. After stirring for a further hour the mixture was diluted
with ether, washed with saturated NH^Cl solution and brine, dried
(MgSO^) and concentrated in vacuo. Purification by dry column flash
chromatography (EtOAc-pet.ether) gave the title compound (118) as a
colourless oil (64 mg, 37%): R„ 0.21 (1:1 EtOAc-pet.ether); v
f max
(CC14 ) 3620, 3450, (br), 3050, 2930 (br), 2870, 1490,1465, 1460,
1450, 1440, 1400, 1370, 1355, 1340, 1320, 1260, 1210, 1165, 1140,
1110, 1050, 1020, 960, 900, 855 cm"1.
^  n.m.r. (CDC13 , 90 MHz) 54.15 (1H, dd, J 8.0, 3.5 Hz,.H-6), 2.97 
and 2.75 (2H, ABq, J 4.5 Hz, H-8'), 0.74 (3H, s, CH3 ).
1 O
C n.m.r. (CDC13 , 25 MHz) 571.9 (C-6), 68.7 (C-8), 52.5 (C-8'),
49.1 (C-5), 46.4 (C—7), 39.2 (C-l), 36.0 (C-2), 26.3 (C-4), 20.9 (CH3)
19.6 (C—3).
Mass spectrum, m/z found: 168.1149 (M+ , C-._H-._0,, requires
— — 10 lb d.
168.1150).
150.
(9) R=Ac (48)R=H
Culture of Fusarium species 
Isolation of 3 a  —hydroxy-4/ft, 15-diacetoxy—12,13-epoxytrichothec—9—ene 
(anguidine, DAS) (9) and 3a, 15—dihydroxy—4/3-acetoxy—12,13—epoxytrichothec— 
9-ene(MAS,4—acetoxyscirpenediol) (48)
Seed Medium g Production Medium g
Malt extract 2 NH4H2P°4 1
Yeast 2 K2HP04 .3H20 3.93
Peptone (Oxoid) 2 MgS04 .7H20 0.2
KH2P04 2 NaCl 0.5
MgS04 .7H20 2 Sucrose 40
FeS04 -7H20 0.2 Glycerol 10
NH .Cl 
4 3 Deionised Water 1 L
Glucose 20
Deionised Water 1 L
500 ml Conical flasks containing 100 ml of the seed medium were
innoculated with the Fusarium species which had been maintained 
on slants of Sabouraud dextrose agar for 7 days. The seed culture 
was shaken for 2 days in the dark (27°C, 160 rpm) and then was 
used to innoculate conical flasks (30-40) containing 100 ml of the
151.
production medium. The production culture was then fermented for 
11 days in the dark (27°C, 160 rpm). Continuous EtOAc extraction 
of the whole culture,without altering the pH, for 24 h. gave a brown 
oily residue (3-4 g) upon drying and concentration in vacuo.
Purification by dry column flash chromatography (EtOAc-pet.ether) 
gave typically 200-300 mgl 1 each of anguidine (9) and 
4-acetoxyscirpenediol (48).
30
4—Acetoxyscirpenediol (48) was characterised as a white amorphous
20 22 
solid: 0 ] D +9.4 (c 1.3, acetone), lit. £ a  Dd +10-° (c 1.2, acetone);
R_ 0.08 (1:1 EtOAc-pet.ether), 0.24 (97:3 CHC1 -MeOH); v (CC1J 3630, 
f 3 max 4
3490 (br), 2960, 2930, 2905, 1720, 1445, 1435, 1375, 1255, 1160, 1105,
1075, 1060, 1045, 1030, 1020, 960, 910 cm”1 .
1H n.m.r. (CDC13 , 200 MHz) 65.56 (1H, dq, J 5.5, 1.4 Hz, H-10),
5.52 (1H, d, J 3.2 Hz, H-4), 4.25 (1H, dd, J 4.9, 3.2 Hz, H-3), 4.19
(1H, br.d, J 5.5 Hz, H-ll), 3.79 and 3.61 (2H, ABq, J 12.3 Hz, H-15),
3.67 (1H, d, J 4.9 Hz, H-2), 3.05 and 2.77 (2H, ABq, J 4.0 Hz, H-13),
2.15 (3H, s, CH3C0), 2.10-1.96 (4H, m, H-7 + H-8), 1.72 (3H, br.s, H-16),
0.84 (3H, s, H—14).
13C n.m.r. (CDC13> 50 MHz) 5173.0 (CH^O), 140.3 (C-9), 118.8 (C-10),
84.4 (C—4), 79.0 (C-2), 77.5 (C-3), 68.0 (C-ll), 64.6 (C-12), 62.6 (C-15),
48.7 (C-5), 47.3 (C-13), 44.8 (C-6), 28.0 (C-8), 23.3 (C-16), 21.2 (C-7),
21.0 (CH3C0), 6.6 (C—14).
Mass spectrum, m/z found: 306.1467 (M+-H20, ^^7^22^5 re(lu;*-res
306.1467).
27 109
Anguidine (9) was characterised * as a white crystalline solid:
mp 161—3°C (ether), lit. 162-4°C; [a]^°-24.5° (c 1.16, CHC13 ), lit.
C a ] p 4- 27° (c 1.28, CHC13); Rf 0.1 (1:1 EtOAc-pet. ether) , 0.43 (97:3
CHC1 -MeOH); V 3560, 2970, 2920, 1750, 1725, 1450, 1435, 1375, 1365,
3 max
1240 (br), 1160, 1110, 1080, 1050, 1040, 990, 960 cm”1 .
152.
XH n.m.r. (CDC13 , 100 Mz) 6 5.47 (1H, dq, J 5.6, 1.8 Hz, H-10),
5.14 (1H, d, J 2.9 Hz, H-4), 4.13 (1H, dd, J 5.0, 2.9 Hz, H-3), 4.05 
(1H, br.d, J 5.0 Hz, H-ll), 4.14 and 4.00 (2H, ABq, J 12.2 Hz, H-15),
3.64 (1H, d, J 4.9, H-2), 3.01 and 2.72 (2H, ABq, J 3.9 Hz, H-13),
2.09 (3H, s, CH3C0), 2.00 (3H, s, CH^O), 2.01-1.80 (4H, m, H-7 + H-8),
1.67 (3H, br.s, H-16), 0.76 (3H, s, H-14).
13C n.m.r. (CDC13> 25 MHz)6l72.5 (CH^O), 170.5 (CH^O), 140.5 
(C—9), 118.6 (C-10), 84.8 (C-4), 79.0 (C-2), 78.4 (C-3), 68.0 (C-ll),
64.4 (C—12), 63.7 (C-15), 48.8 (C-5), 47.2 (C-13), 44.0 (C-6), 28.0
(C-8), 23.2 (C—16), 21.3 (C-7), 21.0 (2xCH3C0), 6.9 (C-14).
Mass spectrum, m/z found: 306.1473 (M+-AcOH, C1 requires
304.1467
153.
--OAc
OAc
(63)
3 a  ,4/fl ,15-Triacetoxy-12,13-epoxytrichothec-9-ene (triacetoxyscirpene) 
(63)
Anguidine (9) (315 mg, 0.86 mmol) was acetylated by the usual 
procedure. Purification by dry column flash chromatography
(EtOAc-pet.ether) gave 332 mg (95%) of the triacetate as a white
o 20
crystalline solid: mp 122-3 C (benzene-n-hexane); Q a +36.7
27 23
(c 0.99, acetone); lit, +44 (c 1-0, acetone); 0.35
(1:1 EtOAc-pet.ether): v (CC1 ) 2970,2940, 2910, 1750, 1370, 1240,
max 4
1230, 1170, 1090, 1060, 1040, 970 cm"1.
1H n.m.r. (CDC13 , 200 MHz) 65.75, (1H, d, J 3.3 Hz, H-4), 5.49
(1H, dq. J 5.6, 1.3 Hz, H-10), 5.19 (1H, dd, J 4.9, 3.3, Hz H-3),
4.26 and 4.06 (2H, ABq, J 12.3 Hz, H-15), 3.99 (1H, br.d, J 5.6 Hz,
H—11), 3.87 (1H, d, J 4.9 Hz, H-2), 3.08 and 2.81 (2H, ABq, J 4.0 Hz,
H-13), 2.15 (3H, s, CH3C0), 2.11 (3H, s, CH^O), 2.07 (3H, s, CT^CO),
1.73(3H, br.s, H-16), 0.77 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 6 170.5 (2 x CH^O), 170.0 (CH^O),
140.7 (C-9), 118.2 (C-10), 79.3 (C-2), 78.3 (C-3), 77.5 (C-4), 67.9
(C-ll), 64.1 (C—12), 63.4 (C-15), 48.7 (C-5), 47.1 (C-13), 44.0 (C-6),
27.8 (C-8), 23.1 (C—16), 21.2 (C-7), 20.9 (CH CO), 20.8 (2 x CH CO),
o o
154.
6.5 (C—14).
Mass spectrum, m/z found: 348.1588 (M+-CH_COQH, C__H_ .0.
o 19 24 o
requires 348.1573).
155.
--OAc
OAc
(119)
3 a  ,4(3 ,15—Triacetoxytrichothec-9,12—diene (119)
To a suspension of WCl^ (200 mg, 0.504 mmol) in THF (2 ml)
b
at —78°C was added n .BuLi (2.5 M in hexane, 0.5 ml,1.25 mmol).
The cooling bath was removed and the mixture allowed to come to
room temperature when the solution became dark brown and homogeneous.
This solution was temporarily replaced in the cooling bath whereupon
the epoxide (63) (100 mg, 0.245 mmol) in THF (3 ml) was added. The
reaction mixture was heated under reflux for 6 h. On cooling to
room temperature it was diluted with hexane, washed once with a
solution 2 M in NaOH and 1.5 M in sodium tartrate, and once with
water. The organic extract was dried (MgSO,^)and concentrated
in vacuo. Purification by dry column flash chromatography
(EtOAc-pet.ether) gave 93 mg (97%) of diene (119) as a white
crystalline solid: mp 120-1°C (Et^O-hexane); [ a ^ ^ + 2 . 7 0
(c 1.13, CHC1 ); R- 0.40 (1:1 EtOAc-pet.ether); v ^ (CC1.) 2980,o I max 4
2920, 1750, 1450, 1440, 1370, 1250, 1230, 1085, 1060, 1040, 990, 970, 
915 cm \
Hi n.m.r. (CDClg, 200 MHz) 6 5.75 (1H, d, J 3.1 Hz, H-4), 5.42
156.
(1H, dq, J 5.4, 1.4 Hz, H-10) 5.21 (1H, s, H-13a), 4.83 (1H, s, H-13b),
4.81 (1H, dd, J 4.8, 3.1 Hz, H-3), 4.42 (1H, d, J 4.8 Hz, H-2), 4.22 
and 4.02 (2H, ABq, J 12.2 Hz, H-15), 4.00 (1H, br.d, J 5.4 Hz, H-ll), 
2.12 (3H, s, CHgCO), 2.06 (3H, s, CH3C0) 2.04 (3H, s, CH3C0), 1.66 
(3H, br.s, H—16), 0.97 (3H, s, H-14).
13C n.m.r. (CDClg, 50 MHz) <5170.7 (CH3C0),170.2 (2 x CH3C0),
149.0 (C—12), 140.3 (C—9), 118.5 (C-10), 109.1 (C-13), 79.4 (C-2),
78.6 (C—3), 77.4 (C-4) 67.6 (C-ll), 63.8 (C-15), 52.0 (C-5), 43.8 
(C—6), 27.8 (C-8), 23.2 (C-16), 21.0 (CH^O), 20.9 (CHgCO), 20.8 
(CHgCO), 20.5 (C—7), 10.9 (C-14).
Mass spectrum, m/z found: 332.1613 (M+ - CHgCOOH, C^gH^O^.
requires 332.1624).
Microanalysis, found: C, 64.26; H, 7.14% (C H 0„ requires:
d.1 *10 /
C, 64.27; H, 7.19%).
157.
AcO
--OAc
(120)
3a ,7g ,15-Triacetoxy-12,13-epoxytrichothec-9-en—8—one (120)
METHOD 1 (from natural 3-AcDON)
To a solution of 3-acetyldeoxynivalenol (24) (34 mg, 0.101 mmol)
in dry CH^Cl^, (3 ml) was added excess triethylamine (1.13 ml) and
acetic anhydride (0.8 ml) along with a few crystals of DMAP. The
mixture was stirred for 2 d .  at room temperature when it was diluted
with ether, washed once with saturated NaHCO^ solution and once with
water. The organic layer was dried (MgSO^) and concentrated in vacuo.
Purification by flash chromatography (EtOAc-pet.ether) gave 40 mg (94%)
of the triacetate (120) as a white crystalline solid: mp 153—7°C
(EtOAc—pet.ether) lit7^ 156-7°C; 0.64 (1:1 EtOAc—pet.ether);
V (CC1 ) 3010, 2980, 2960, 2930, 1755, 1705, 1450, 1430, 1370, 
max 4
1225 (br), 1180, 1075, 1060, 1045, 1035, 960 cm"1 .
1H n.m.r. (CDC13 , 200 MHz) 56.53 (1H, dq, J 5.9, 1.6 Hz, H-10),
6.03 (1H, s, H—7), 5.19 (1H, ddd, J 11.0,4.5,4.5 Hz, H-3), 4.72 (1H, d 
J 5.9 Hz, H—11), 4.31 (2H, ABq, J 12.2 Hz, H-15), 3.88 (1H, d,
J 4.5 Hz, H—2), 3.10 and 2.78 (2H, ABq, J 3.5 Hz, H-13), 2.34 (1H, dd,
J 15.2, 4.5 Hz, H-4a), 2.18 (3H, s, CH^O), 2.12 (3H, s, C H ^ O ) , 1.88
158.
(3H, s, CH3CO), 1.82 (3H, br.s, H-16), 0.93 (3H, s, H-14).
13
C n.m.r. (CDCl^ 50 MHz) 5191.9 (C-8), 170.1 (CH3C0)? 170.0
(CH3C0), 169.6 (CH3C0), 136.9 (C-9), 136.8 (C-10), 78.7 (C-7), 74.6
(C-2), 70.6 (C-ll), 70.2 (C-3), 64.5 (C-12), 62.3 (C-15), 50.0 (C-5),
47.6 (C—13), 45.6 (C-6), 40.7 (C-4), 20.8 (2 x C H ^ O ) , 20.5 (CHgCO),
15.3 (C—16), 13.6 (H-14).
Mass spectrum, m/z found: 422.1557 (M+ , Co1H__0rt requires
_ - 21 26 9
422.1577).
METHOD 2 (from semi-synthetic deoxynivalenol, (23) )
Semi-synthetic deoxynivalenol (23) (24 mg, 0.081 mmol) was
acetylated in a similar manner to 3-AcDON (24) using Et*N (1.35 ml),
©
Ac^O (1 ml) and CH^Cl^ (4 ml) and a few crystals of DMAP.
Purification by flash chromatography gave the title compound as a
o ©
white crystalline solid: mp 152—6 C (EtOAc—pet.ether), lit. 156—7 C;
[ a ] p ° + 75° (c 0.2, CHC13 ); Rf 0.64 (1:1 EtOAc-pet.ether).
Mass spectrum, m/z found: 422.1551 (M+ , requires
422.1577).
Micro analysis, found: C, 59.79; H, 6.09% (^21^26^9 re9,J^ re£?
C, 59.69; H, 6.21%).
1 13
This material also possesses identical H and C n.m.r., and
i.r. spectra to that previously prepared by acetylation of natural 
3-AcDON (24).
159.
--OAc
(121)
3a  ,7a  ,15—Triacetoxytrichothec-9,12-dien-8-one (121)
To a suspension of WC1„ (190 mg, 0.474 mmol) in THF (2 ml) at
o
-78°C was added n . BuLi (2.5 M in hexane ,0.5 ml, 1.25 mmol) . The 
cooling bath was removed and the mixture allowed to come to room 
temperature when the solution became dark brown and homogeneous.
One half of this solution was taken up in a syringe and added to 
a solution of the epoxide (120) (50 mg, 0.118 mmol) in THF (3 ml) 
at —78°C. The reaction mixture was then heated under reflux for 
6 h. and on cooling it was diluted with hexane, washed once with a 
solution 2 M in NaOH and 1.5 M sodium tartrate, and once with water. 
The organic phase was dried (MgSO^) and concentrated in vacuo.
^H n.m.r. showed that the crude material contained desired product 
and starting material in a ratio of 3:2 which could not be separated 
chromatographically as both compounds had similar R^'s. The crude 
mixture was recycled through the above procedure once again. 
Purification by flash chromatography (3:2 Et^O-hexane) gave 19 mg 
(40%) of diene (121) as a white solid, attempted recrystallisation 
of which under a variety of conditions failed: 0.64 (1:1 EtOAc—
pet.ether); v (CC1 ) 2960, 2930, 2860, 1750, 1705, 1450, 1370 max 4 » » » » » »
1225 (br), 1180, 1090, 1070, 1055, 1040, 920 cm"1 .
1H n.m.r. (CDC13> 200 MHz) 66.50 (1H, dq, J 5.7, 1.5 Hz, H-10),
5.87 (1H, s, H—7), 5.28 (1H, s, H-13a), 4.95 (1H, ddd, J 11.5, 4.5,
4.5 Hz, H—3), 4.88 (1H, s, H-13b), 4.69 (1H, br.d, J 5.7 Hz, H-ll),
4.49 (1H, d, J 4.5 Hz, H-2), 4.37 and 4.25 (2H, ABq, J 12.0 Hz, H-15)
2.37 (1H, dd, H 14.9, 4.5 Hz, H-4a), 2.21 (3H, s, CH3C0), 2.15 (3H,
s, CH3C0), 1.91 (3H, s, CH3C0), 1.83 (3H, dd, J 1.5, 0.7 Hz, H-16),
1.23 (3H, s, H-14).
13
C n.m.r. (CDC1 , 50 MHz) 6192.5 (C-8), 170.2 (CH CO), 170.0
O
(CH3C0), 169.0 (CH3C0), 149.9 (C-12), 137.1 (C-9), 136.8 (C-10),
110.0 (C—13), 79.0 (C—7), 74.9 (C-2), 71.0 (C-ll), 70.4 (C-3), 62.4
(C—15), 51.1 (C-5), 47.8 (C-6), 41.5 (C-4), 21.0 (CH^O), 20.9 (CH^O)
20.6 (CH3C0), 19.1 (C—16), 15.6 (C-14).
Mass spectrum, m/z found: 406.1603 (M+ , ConHo_0o requires
- — 21 26 8
406.1628).
Both the starting epoxide (120) and olefin (121) were 
indistinguishable by t.l.c. analysis. Therefore, deoxygenations 
were followed by GLC analyses. These were carried out with a 
Perkin-Elmer F-ll gas chromatograph equipped with a silanized gas 
column (61 x X" ID) packed with OV-17 coated onto Gas—Chrom Q,
100—120 mesh. The column was heated to 250°C, and the nitrogen 
carrier gas pressure maintained at 14 psi. Under these conditions 
epoxide (120) and olefin (121) had retention times of 19 m. and 
15 m. respectively.
161.
OAc
(122)
--OH
4/3 -Acetoxy-3 oc -hydroxy-10 0  -bromo-9 a , 15-oxa-12,
13—epoxytrichothecane (122)
To a solution of 4/? —acetoxy—30^15—dihydroxy—12,
13-epoxytrichothec-9-ene (48) (253 mg, 0.78 mmol) in dry
acetonitrile (20 ml) was added recrystallised NBS (146 mg,
0.82 mmol). The mixture was stirred under nitrogen for 1 h .
when it was concentrated under vacuum. Purification by dry
column flash chromatography (EtOAc-pet.ether) gave 288 mg (92%)
of the bromo-ether (122) as a white amorphous solid:
£ a  ] o 29 *4 (c 0 •65» CHC13); Rf 0.32 (1:1 EtOAc-pet. ether ) ;
V (CClJ 3555, 2980, 2940, 2875, 1740, 1730, 1450, 1375, 
max 4
1050, 960 cm-1.
XH n.m.r. (CDC13 , 200 MHz) 6 5.04 (1H, d, J 3.2 Hz, H-4),
4.25 (2H, m, H-10, H-ll), 4.21 (1H, dd, J 5.0, 3.2 Hz, H-3),
3.82 (1H, dd, J 9.6, 2.7 Hz, H-15a), 3.79 (1H, d, J 5.0 Hz, H-2),
3.70 (1H, d, J 9.6 Hz, H-15b), 3.05 and 2.73 (2H, ABq, J 3.8 Hz,
H—13), 2.10 (3H, s, CH3C0), 2.20 (1H, dd, J 12.6, 10.0 Hz, H-8/3 ), 
2.15-1.95 (1H, m, H-7/? ), 1.85-1.65 (1H, m, H-8a ), 1.60-1.40 
(1H, m, H-7a ), 1.26 (3H, s, H-16), 0.61 (3H, s, H-14).
13
C n.m.r. (CDC1 50 MHz), 6172.2 (CH CO), 83.1
o o
79.7 (C—4), 78.1 (C—2), 73.7 (C-9), 68.3 (C-ll), 66.0 (
64.1 (C—12), 54.2 (C-10), 46.4 (C-13), 46.1 (C-5), 41.8
27.9 (C—8), 24.2 (C-16), 20.9 (CH^O), 19.2 (C-7), 5.8 
Mass spectrum, m/z found: 404.0668 and 402.0655
(M+ , C17H2306Br requires 404.0659 and 402.0678).
(C-3), 
C-15), 
(C-6) 
(C-14)
163.
0>--0Ac
(123)
3 a  ,40 -Piacetoxy-10/3 -bromo-9a , 16—oxa—12,13—epoxytrichothecane 
(123)
METHOD 1
Acetylation of the bromo-ether (122) (278 mg, 0.625 mmol)
by the normal procedure gave 305 mg (99%) of the diacetate (123)
as a white low-melting amorphous solid after purification by dry
column flash chromatography (EtOAc-pet.ether).
f a  "I -18.2 (6 1.0, CH01o); R_ 0.40 (1.1 EtOAc-pet. ether); v. ^U J D 3 f * max
(CC14 ) 2980, 2940, 2875, 1750, 1370, 1240, 1220, 1050 cm”1 .
^  n.m.r. (CDC13> 2.00 MHz) 65.57 (1H, d, J 3.6 Hz. H-4),
5.25 (1H, dd, J 4.9, 3.6 Hz, H-3), 4.28 (1H, dd, J 8.6, 1.8 Hz,
H—11), 4.12 (1H, dd, J 8.6, 2.4 Hz, H-10), 3.99 (1H, dd, J 9.8,
2.8 Hz, H—15a), 3.96 (1H, d, J 4.9 Hz, H-2) 3.71 (1H, d, J 9.8 Hz, H- 
15b), 3.07 and 2.75 (2H, ABq, J 3.9 Hz, H-13), 2.30-2.16 (1H, dd,
J 12.7, 7.6 Hz, H-80), 2.10 (3H, s, CH^O), 2.09 (3H, s, CH^O), 
1.88-1.62 (1H, m, H-7a ), 1.60-1.40 (1H, m, H-8a ), 1.28 (3H, s,
H—16), 0.55 (3H, s, H-14).
13C n.m.r. (CDC13> 50 MHz) 6170.6 (CH3C0), 169.8 (CH^O),
164.
78.4 (C—4), 78.0 (C-2), 77.8 (C-3), 73.7 (C-9), 68.5 (C-ll),
66.0 (C—15), 63.8 (C-12), 54.2 (C-10), 46.4 (C-13), 46.1 (C-5),
41.9 (C-6), 27.9 (C-8), 24.2 (C-16), 20.9 (CHgCO), 20.7 (CH^CO),
19.4 (C—7), 5.5 (C—14).
Mass spectrum, m/z found: 446.0770 and 444.0794 (M+ ,
C_rtH_,_0„Br requires 446.0764 and 444.0784).
19 2b /
METHOD 2 (from anguidine)
To a solution of anguidine (9) (262 mg, 0.72 mmol) in THF 
(13.5 ml) and methanol (8.5 ml) was added aqueous sodium hydroxide 
(0.4M, 100 ml, 40 mmol). The mixture was stirred for 15 m. when 
it was passed through a column packed with Amberlite IR120(H) 
ion-exchange resin (10 g). The product was eluted with a MeOH/ 
water mixture (1:4, 40 ml). After concentration in vacuo the 
scirpenetriol obtained was used without further purification.
The crude triol (0.72 mmol, assumed) was dissolved in dry 
acetonitrile (21 ml) and to this solution was added recrystallised 
NBS (135 mg, 0.76 mmol). The reaction mixture was stirred under 
nitrogen for 1 h. when it was concentrated in vacuo. The crude 
bromo-ether obtained (134) was acetylated directly by the normal 
procedure to give 300 mg (94% overall) of the desired bromo—ether 
diacetate (123) after purification by dry column flash chromatography. 
This material was identical by ^H n.m.r. (90 MHz), i.r., m.s. and 
t.l.c. to that previously prepared.
165.
--OAc
OAc
(124)
3a ,4/? -Piacetoxy-IO/3 -bromo-9a -15-oxa-trichothec-12-ene (124)
To a suspension of WClg (802 mg, 2.02 mmol) in THF (5.2 ml) at 
—78°C was added n.BuLi (2.4 M in hexane, 2.1 ml, 5.04 mmol). The 
cooling bath was removed and the mixture allowed to come to room 
temperature when it became dark brown and homogeneous. The solution 
was recooled to -78°C whereupon the epoxide (123) (300 mg, 0.67 mmol) 
in THF (8.5 ml) was added. After being heated under reflux for 3.5 h. 
the reaction mixture was diluted with hexane, washed once with a 
solution 2 M in NaOH and 1.5 M in sodium tartrate and once with water. 
The organic extract was dried (MgSO^) and concentrated in vacuo. 
Purification by dry column flash chromatography (EtOAc—pet.ether) 
gave 285 mg (98%) of the desired olefin as a white crystalline solid: 
mp 102—106°C (60:80 pet.ether); O  1 D -18.2 (C 0.94, CHClg); Rf
0.45 (1:1 EtOAc-pet.ether), v (CClJ 2980, 2940, 2870, 1745, 1370,max 4 '
1240, 1230, 1100, 1050, 910 cm"1.
XH n.m.r. (CDClg, 200 MHz) 8 5.53 (1H, d, J 3.5 Hz, H-4), 5.25 
(1H, s, H—13a), 4.91 (1H, dd, J 5.0, 3.5 Hz, H-3), 4.82 (1H, s, H-13b) 
4.57 (1H, d, J 5.0 Hz, H-2), 4.25 (1H, dd, J 8.6, 1.6 Hz, H-il), 4.14
166.
(1H, dd, J 8.6, 2.4 Hz, H-10), 3.98 (1H, dd, J 9.7, 2.7 Hz, H-15a),
3.71 (1H, d, J 9.7 Hz, H-15b), 2.28-2.16 (1H, m, H-8/?), 2.13 (3H, 
s, CH3C0), 2.04 (3H, s, CHgCO), 1.92-1.65 (2H, m, H-7), 1.42-1.20 
(1H, m, H-8a), 1.26 (3H, s, H-16), 0.79 (3H, s, H-14).
13C n.m.r. (CDClg, 50 MHz) 5 170.3 (CH3C0), 170.1 (CH3C0), 147.3 
(C—12), 109.3 (C—13), 78.3 (C-2), 78.1 (C-3), 78.1 (C-4), 73.3 (C-9),
68.2 (C-ll), 66.3 (C—15), 54.8 (C-10), 49.1 (C-5), 41.5 (C-6), 27.8 
(C—8), 24.2 (C—16), 21.0 (CH3C0), 20.7 (CH3C0), 18.7 (C-7), 9.48 
(C—14).
Mass spectrum, m/z found: 430.0810 and 428.0830 (M+ , ClrkHOI_0_Br
— — 19 25 6
requires 430.0815 and 428.0835).
167.
--OAc
OAc
(125)
301,4/3 —Diacetoxy—lOffi-bromo—9a, 15—oxa-12—oxonortrichothecane (125 )
Ozone was bubbled through a solution of olefin (124) (530 mg,
1.24 mmol) in dry CH^Cl^ (50 ml) at —78°C until the solution became 
blue in colour. The solution was left to stand at — 78°C for 15 m.
If the blue colour had disappeared the above procedure was repeated 
until the blue colour remained after standing. Nitrogen was then 
bubbled through the solution to expel excess ozone. Triethylamine 
(0.34 ml, 2.47 mmol) was then added and the mixture stirred overnight 
at room temperature. The solution was then filtered through silica 
and concentrated in vacuo to give 462 mg (87%) of the norketone (125) 
(pure by t.l.c. and n.m.r.) which could be used without further 
purification.
The norketone can be recrystallised from ether—pet.ether: 
mp 187-190°C; C « D d °+65° ° ’36’ CHC13 )i Rf 0.41 (1:1 EtOAc-pet.
ether); v (CC1J 2980, 2940, 2875, 1770, 1750, 1450, 1370, 1230, 
max 4
1215, 1180, 1125, 1095, 1060, 1050, 910 cm"1 .
XH n.m.r. (CDC13 ) 5 5.71 (1H, d, J 3.8 Hz, H-4), 5.08 (1H, dd,
J 5.0, 3.8 Hz, H—3), 4.37 (1H, dd, J 8.6, 2.1 Hz, H-10), 4.27
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(1H, dd, J 8.6, 1.6 Hz, H-ll), 4.22 (1H, d, J 5.0 Hz, H-2), 4.06
(1H, dd, J 9.5, 2.6 Hz, H-15a), 3.67 (1H, d, J 9.5 Hz, H-15b),
2.3-2.0 (1H, m, H-80), 2.18 (3H, s, CH CO), 2.06 (3H, s, CHoC0),
J  O
1.9-1.5 (3H, m, H—7 and H-8a), 1.28 (3H, s, H-16), 0.76 (3H, s, H-14).
1C n.m.r. (CDC13 , 50 MHz) 6 207.8 (C-12), 170.0 ( C H^O), 169.6
(CH3C0), 77.2, 75.8, 73.8 (C-2, C-3 and C-4), 73.8 (C-9), 68.2 (C-ll),
65.4 (C—15), 55.6 (C-5), 53.5 (C-10), 48.2 (C-6), 27.5 (C-8), 24.0
(C—16), 20.8 (CH3C0) 20.6 (CH^O), 18.7 (C-7), 6.4 (C-14).
Mass spectrum, m/z found: 390.0500 and 388.0524 (M^-C^H^O
ClcHol0 J r  requires 390.0502 and 388.0522).
16 21 6
Microanalysis, found: C, 50.01; H, 5.38; Br, 18.47% (C H 0 Br
JLo /
requires: C, 50.11; H, 5.38; Br, 18.53%).
169.
(126)
3 a  ,4/ff -Dihydro:xy-10-bromo-9 a  , 15-oxa-12,13-epiepoxytrichothecane
(126)
METHOD 1 (from ketone (125) )
To a stirred suspension of Me^S+ I (560 mg, 2.75 mmol) in THF
(11 ml) under nitrogen was added n—BuLi (2.4M in hexane, 1.15 ml,
2.75 mmol). The solution became clear; it was stirred at 0°C
for 1 h. when a solution of ketone (125) (148 mg, 0.344 mmol) in
THF (5.5 ml) was added. After stirring for a further hour the
mixture was diluted with ether, washed with saturated NH^Cl solution
4
and brine, dried (MgSO^) and concentrated in vacuo. Purification
by flash chromatography (EtOAc) gave the diol (126) as a white
crystalline solid (43 mg, 35%): mp 207-8°C (Et0Ac-60—80 pet.ether);
r a l f 0-51.6° (c 0.51, MeOH); R_ 0.07 (4:1 EtOAc-pet.ether); u
D f max
(KBr) 3600-3200 (br), 2980, 2940, 2910, 2880, 1455, 1385, 1375, 1180, 
1120, 1100, 1090, 1060, 950, 870, 840 cm"1 .
1H n.m.r. (CDC13 , 200 MHz) 64.22 (1H, dd, J 8.6, 1.4 Hz, H-ll),
4.14 (1H, dd, J 8.6, 1.8 Hz, H-10), 4.05 (1H, d, J 2.9 Hz, H-4)
3.97 (1H, dd, J 4.7, 2.9 Hz, H-3), 3.72 (1H, d, J 9.3 Hz, H-15b),
3.70 (1H, d, J 4.7 Hz, H-2), 3.62 (1H, dd, J 9.3, 1.5 Hz, H-15a),
2.70 and 2.40 (2H, ABq, J 4.5 Hz, H-13) 2.37-2.10 (2H, m, H-70  
and H-8/? ), 1.80-1.45 (2H, m, H-7a and H-8a ), 1.22 (3H, s, H-16),
170.
0.56 (3H, s, H—14).
13
C n.m.r. (CDC13 , 50 MHz) 679.6 (C-4), 78.4 (C-3), 78.0
(C-2), 74.0 (C-9), 68.4 (C-ll), 66.3 (C-15), 62.6 (C-12), 54.5
(C-10), 45.5 (C—13), 45.2 (C-5), 39.8 (C-6), 28.0 (C-8), 24.3
(C-16), 19.4 (C—7), 7.1 (C—14).
Mass spectrum, m/z found: 362.0545 and 360.0570 (M+ ,
Cn_Ho10_Br requires 362.0553 and 360.0573). 
lb 21 b
Microanalysis, found: C, 49.83; H, 5.92; Br. 21.91%
C1cHo10cBr requires: C, 49.86; H, 5.86; Br, 22.13%).
.Lb 21 b
METHOD 2 (from bistriethylsilylether (132) )
To a solution of the bistriethylsilylether (132) (114 mg, 
0.194 mmol) in dry THF (6 ml) at 0°C under nitrogen was added 
a solution of Bu^N+F (1M in THF, 0.78 ml, 0.78 mmol). The 
mixture was stirred at 0°C for 2 h. when it was diluted with 
EtOAc, washed with brine, dried (MgSO^) and concentrated in vacuo. 
Purification by flash chromatography (EtOAc) gave 61 mg (87%) of 
the diol (126) as white crystalline solid identical with material 
previously prepared (by ^H n.m.r., i.r., m.s., t.l.c).
171.
(127)
3 q  ,4(3 -Diacetoxy-10/? -bromo—9 a , 15—oxa—12,13—epiepoxytrichothecane
(127)
Diol (126) (87 mg, 0.24 mmol) was acetylated by the normal
procedure. Purification by flash chromatography (1:1 EtOAc-pet.ether)
gave 103 mg (96%) of the diacetate (127) as a white crystalline solid:
mp 160-161°C (ether—60:80 pet.ether); 0.33 (1:1 EtOAc—pet.ether)
C a l ^ 0-42.2° (c 0.45, CHC1 ); v (CClJ 2990, 2960, 2940, 2880, u -JD 3 max 4
1755, 1460, 1375, 1240, 1220, 1110, 1065, 1055, 980 cm”1 .
1H n.m.r. (CDC13> 200 MHz) 6 5.50 (1H, d, J 3.5 Hz, H-4),
5.12 (1H, dd, J 4.8, 3.5 Hz, H-3), 4.29 (1H, dd, J 8.5, 1.7 Hz,
J-ll), 4.19 (1H, dd, J 8.5, 2.2 Hz, H-10), 4.00 (1H, d, J 4.8 Hz,
H—2), 3.93 (1H, dd, J 9.7, 2.8 Hz, H-15a); 3.75 (1H, d, J 9.7 Hz,
H—15b), 2.75 and 2.54 (2H, ABq, J 4.5 Hz, H-13), 2.47-2.17 (2H, m,
H—7/0 and H-8/0 ), 2.14 (3H, s, CHgCO), 2.07 (3H, s, C H ^ O ) , 1.85-1.45
(2H, m, H-7a and H-8a ), 1.28 (3H, s, H-16), 0.54 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 6170.0 (2 x CH^O), 77.7 (C-2),
77.5 (C-3), 75.5 (C-4), 73.9 (C-9), 68.8 (C-ll), 66.2 (C-15), 62.3 
(C—12), 54.2 (C-10), 45.3 (C-13), 44.6 (C-5), 40.5 (C-6), 28.0 (C-8),
24.3 (C-16), 20.9 (CHgCO), 20.7 (CH3C0), 19.6 (C-7), 7.23 (C-14).
172.
Mass spectrum, m/z found: 446.0748 and 444.0781 (M+. _4HOI_0r_Br
— — 3 iy /
requires 446.0764 and 444.0784).
Microanalysis, found: C, 51.14; H, 5.64; Br 17.64% (C_ JH^O^Br
19 2b /
requires: C, 51.23; H, 5.66; Br, 17.95%).
173.
-OAc
OAc
(128)
3 «  ,4/3 ,15-Triacetoxy-12,13—epJ.-epoxytrichothec-9-ene (128)
Preparation of Zn/Ag couple
To a stirred, warmed suspension of AgOAc (23 mg) in glacial
acetic acid (23 ml) was added zinc powder (4.16 g) all at once.
After stirring for 30 s. the acetic acid was decanted off and the
Zn/Ag couple rinsed with glacial acetic acid (lxll ml) and dry
ether (4x11 ml) before use.
Use of Zn/Ag couple
To the freshly prepared Zn/Ag couple was added dry ether
(11 ml) and then the bromo-ether (127) (118 mg, 0.265 mmol) in
THF (21 ml) and ethanol (4 ml). The mixture was stirred at 55°C
for 2 h. and on cooling it was concentrated in vacuo. The residue
was taken up in acetone and then filtered through a pad of Celite.
After concentration the crude product was acetylated by the normal
procedure. Purification of the triacetate by flash chromatography
(EtOAc-pet.ether) gave 87 mg (81%) of epi-epoxide (128) as a white
crystalline solid: mp 169-170°C (benzene-hexane); 0.33 (1:1 EtOAc-
pet.ether); f ot +7.9° (c 0.81, CHC10); V (CClJ 2970, 2930,
D 3 max 4
2910, 1750, 1370, 1240, 1220, 1090, 1060, 1025, 970 cm”1 .
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1H n.m.r. (CDC13 , 200 MHz) 55.71 (1H, d, J 3.2 Hz, H-4), 5.47
(1H, br.d, H—10), 5.02 (1H, dd, J 4.8, 3.2 Hz, H-3), 4.20 and
4.06 (2H, ABq, J 12.4 Hz, H-15), 4.05 (1H, br.d, J 5.8 Hz,
H—11), 3.83 (1H, d, J 4.8Hz, H-2), 2.81 and 2.50 (2H, ABq, J 4.6
Hz, H—13), 2.14 (3H, s, CHgCO), 2.08 (3H, s, CH^O), 2.06 (3H, s,
CH3CO), 1.71 (3H, br.s, H-16), 0.76 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 5170.6 (CH^O), 170.1 (CH^O),
169.9 (CH3C0), 140.6 (C-9), 118.2 (C-10), 78.5 (C-2), 76.6 (C-3),
76.1 (C-4), 68.1 (C-ll), 63.8 (C-15), 62.7 (C-12), 47.1 (C-5)
45.7 (C—13), 42.8 (C-6), 27.8 (C-8), 23.2 (C-16), 21.1 (C-7),
21.0 (CH3C0), 20.9 (CH3C0), 20.7 (CH3C0), 8.13 (C-14).
Mass spectrum, m/z found: 348.1579 (M+-CHoC00H, Cn_Hoyl0„
'  O 19 D
requires 348.1573).
Microanalysis, found: C, 61.76; H, 6.69% (C_nH 0 requires:
cl CO o
C, 61.74; H, 6.91%).
The structure was confirmed by x-ray crystallographic analysis 
(Appendix 2).
175.
-OH
(129)
3 or ,A0 -Dihydroxy—10)3 -bromo-9ar ,15-oxa-trichothec—12-ene (129)
To a solution of the diacetate (124) (151 mg, 0.35 mmol) in
methanol (9 ml) and water (1 ml) was added ^00^(2 g). The mixture
was stirred for 2 hr. when it was concentrated in vacuo. The
concentrate was taken up in water and extracted three times with
EtOAc. The combined organic extracts were dried (MgSO^) and
concentrated in vacuo. Purification by flash chromatography (EtOAc)
gave 103 mg (85%) of the diol (129) as a white crystalline solid:
mp 122-3°C (ether-hexane) [ a  ] p°-34.6° (c 0.78, MeOH) ; Rf 0.16
(4:1 EtOAc—60:80 pet.ether); "0 (CClJ 3600-3200 (br), 2980,
max 4
2940, 2880, 1455, 1385, 1220, 1125, 1100, 1060, 910 cm"1 .
1H n.m.r. (CDClg, 200 MHz) 65.17 (1H, s, H-13a), 4.78 
(1H, s, 13b), 4.4-3.6 (9H, m, H-2, H-3, H-4, H-10, H-Oil and 2xOH),
2.25-2.05, 1.95-1.60, 1.45-1.25, (4H, m, H-7 and H-8), 1.25 
(3H, s, H—16), 0.86 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 6148.6 (C-12), 108.7 (C-13),
81.08, 79.87, 79.47 (C-2, C-3 and C-4), 73.5 (C-9), 68.1 (C-ll),
176.
66.5 (C—15), 55.1 (C-10), 49.9 (C-5), 40.8 (C-6), 27.8 (C-8),
24.3 (C—16), 18.7 (C-7), 10.0 (C-14).
Mass spectrum, m/z found: 346.0596 and 344.0633 (M+ ,C__H_n0 .Br
- - 15 21 4
requires 346.0604 and 344.0624).
Microanalysis, found: C, 52.19; H, 6.12; Br, 23.35%
(C15H2104Br requires C 52.19; H, 6.13; Br, 23.15%).
177.
— OTES
OTES
(130)
3 a  ,4/3 -Bistriethylsilyloxy-lOff -bromo-9a  ,15-oxa-trichothec—12-ene
(130)
To a solution of the diol (129) (225 rag, 0.65 mmol) in pyridine 
(15 ml) was added DMAP (32 mg, 0.26 mmol) and triethylsilyl :chloride 
(0.44 ml, 2.62 mmol). The resulting mixture was stirred overnight
under nitrogen then it was diluted with CH^Cl^ and washed with
half saturated NaHCO^ solution. The organic extract was dried 
(Na^SO^) and concentrated in vacuo. Purification by dry column flash 
chromatography (EtOAc-pet.ether) gave 327 mg (86%) of the 
bistriethylsilylether (130) as a white crystalline solid: mp 51—2°C
(EtOAc/MeOH); [ >  U p 0-33° (c 1.09, CHC13 ); Rf 0.75 (1:1 EtOAc 
pet.ether); y (CC14 ) 2980, 2935, 2910, 2880, 1460, 1410, 1380, 1240,
1110, 1100, 905, 870 cm"1.
1H n.m.r. (CDC13 , 200 MHz) 8 5.10 (1H, s, H-13a), 4.70 (1H, s, 
H-13b), 4.20 (1H, d, J 4.8 Hz, H-2), 4.16 (2H, m, H-10 and H-ll),
4.09 (1H, d, J 2.5 Hz, H-4), 3.80 (1H, dd, J 4.8, 2.5 Hz, H-3),
3.72 (2H, br.s, H-15), 2.25-2.10, 1.95-1.60, 1.4-1.2 (4H, m, H-7 
and H-8), 1.25 (3H, s, H-16), 0.95 (6H, 2 x t (overlapping), J 8 Hz,
2 x CH^H^Si), 0.77 (3H, s, H-14), 0.64 (4H, 2 x q (overlapping),
178.
J 8 Hz, 2 x CH3CH2Si).
13C n.m.r. (CDC13 , 50 MHz) <5149.7 (C-12), 107.6 (C-13), 
83.2, 81.6, 80.1 (C-2, C-3 and C-4), 73.3 (C-9), 67.6 (C-ll),
66.7 (C-15), 55.0 (C-10), 50.0 (C-5), 41.0 (C-6), 27.8 (C-8),
24.4 (C—16), 18.9 (C—7), 10.3 (C-14), 6.9 (2 x CHgCH^i), 5.0 
and 4.9 (2 x CH3CH2Si).
Mass spectrum, m/z found: 574.2317 and 572.2342
(M+' C27H49°4Si2Br requires 574.2333 and 572.2353).
Microanalysis, found: C, 56.33, H, 8.41; Br, 13.45%.
(C27H4g04Si2Br requires C, 56.52; H, 8.61; Br, 13.94%).
179.
OTES
(131)
3a, 4ft-Bistriethylsilyloxy—10ft-bromo-9a, 15-oxa—12-oxo—trichothecane
(131)
Ozone was bubbled through a solution of the olefin (130)
(327 mg, 0.57 mmol), in dry CH^Cl^SO mi) —78°C until the solution
became blue in colour. The solution was left to stand at —78°C for
15 m. If the blue colour had disappeared the above procedure was
repeated until the blue colour remained after standing. Nitrogen
was then bubbled through the solution to expel excess ozone.
Triethylamine (0.25 ml, 1.79 mmol) was added to the solution and the
resulting mixture was left to stir overnight at room temperature.
The solution was then filtered through silica and concentrated in vacuo.
Purification by dry column flash chromatography (EtOAc-pet.ether) gave
275 mg (84%) of norketone (131) as a white crystalline solid: mp 90—91°C
(ether-methanol); []a]]p^+33.30 (c 0.63, CHCl^); 0.74 (1:1 EtOAc-
pet.ether); v (CC1.) 2960, 2940, 2920, 2880, 1765, 1460, 1130, 1115, mdx 4
1100, 1010, 885, 870, 860 cm-1.
■'’H n.m.r. (CDC13 , 200 MHz) 54.4 (1H, dd, J 8.8, 2.2 Hz, H-10), 4.26 
(1H, d, J 2.6 Hz, H—4), 4.18 (1H, dd, J 8.8, 1.6 Hz, H-ll), 3.92
180.
(1H, dd, J 5.0, 2.6Hz, H-3), 3.85 (1H, d, J 5.0 Hz, H-2), 3.76
(1H, dd, J 9.2, 2.4 Hz, H-15a), 3.67 (1H, d, J 9.2 Hz, H-15b),
2.27-2.10 (1H, m, H-8/?), 1.84-1.45 (3H, m, H-8a and H-7), 1.26
(3H, s, H—16), 0.96 (6H, 2 x t (overlapping), J 8.3 Hz, 2 x CH3CH2Si),
0.78 (3H, s, H-14), 0.64 (4H, 2 x q (overlapping), J 8.3 Hz,
2 x CH3CH2Si).
13C n.m.r. (CDClg, 50 MHz) 5 211.2 (C-12), 80.0, '79,3, 79.0 (C-2,
C-3, C-4), 73.8 (C—9), 67.5 (C-ll), 65.8 (C-15), 57.2 (C-5), 53.6
(C-10), 47.3 (C—6), 27.5 (C-8), 24.2 (C-16), 19.0 (C-7), 7.0 (C-14),
6.8 (2 x CH3CH2Si), 4.9 (CH3CH2Si), 4.8 (CH^H^Si).
Mass spectrum, m/z found: 576.2148 and 574.2155 (M+ ,
C_^H ._,0_SioBr requires 576.2126 and 574.2146).2b 4/ b 2
Microanalysis, found: C, 54.13; H, 8.13; Br 13.72%
(C__H-„0cSioBr requires C, 54.24, H, 8.23; Br, 13.89%).
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181.
--OTES
OTES 
(132)
3 a  ,4ft -Bistriethylsilyloxy-10/3 -bromo-9o: , 15—oxa—12,13— 
epiepoxytrichothecane (132)
To a suspension of Me^S+I (141 mg, 0.70 mmol) in THF (10 ml)
under nitrogen at 0°C was added nBuLi (2.4M in hexane, 0.305 ml,
0.735 mmol). The solution became clear and was left to stir at 0°C
for 1 hour when a solution of ketone (131) (290 mg, 0.496 mmol) in
THF (6 ml) was added. The mixture was left to stir for 1 hour when
it was diluted with ether, washed with saturated NH^Cl solution,
dried (Na^SO^) and concentrated in vacuo. Purification by flash
chromatography (pet.ether then 9:1 pet.ether-EtOAc) gave 191 mg
20 o
(64%) of the epiepoxide (132) as a colourless oil: 33^ —27.1
(c 0.35 CHC1„); R~ 0.72 (1:1 EtOAc-pet.ether); v (CC1 ) 2955,
3 f max 4
2940, 2910, 2880, 1450, 1410, 1380, 1360, 1240, 1200, 1190, 1180, 
1165, 1120, 1100, 1075, 1060, 1005, 980, 955, 925, 915, 890, 870, 
860 cm
"Si n.m.r. (CDC13 , 200 MHz)54.24 (1H, dd, J 8.7, 2.1 Hz, H-10),
4.15 (1H, dd, J 8.7, 1.5 Hz, H-ll), 4.05 (1H, d, J 2.5 Hz, H-4), 
3.96 (1H, dd, J 4.8, 2.5 Hz, H-3), 3.75 (1H, d, J 9.1 Hz, H-15a),
182.
3.63 (2H, d + dd, J 4.8 Hz and J 9.1, 2.6 Hz, H-2 and H-15b), 
2.66 and 2.38 (2H, ABq, J 4.6 Hz, H-13), 2.42-2.12 (2H, m, H-7/? 
and H—8/?), 1.80-1.61 (1H, m, H-7a), 1.60-1.44 (1H, m, H-8a),
1.25 (3H, s, H—16), 0.95 (6H, 2 x t, CH2CH3 ), 0.60 (4H, 2 x q, 
CH2CH3 ), 0.55 (3H, s, H—14).
13C n.m.r. (CDC13 , 50 MHz) §80.9 (C-3), 80.7 (C-4), 79.7 
(C-ll), 73.8 (C—9), 68.0 (C-2), 66.5 (C-15), 62.6 (C-12), 54.4 
(C-10), 45.5 (C—13), 45.4 (C-5), 39.9 (C-6), 28.0 (C-8), 24.5 
(C—16), 19.7 (C—7), 7.6 (C-14), 6.8 (2 x CH3CH2), 4.9 (CH3CH2 ),
4.8 (CH3CH2).
Mass spectrum, m/z found: 561.1891 and 559.1913
(M+-C2H5 , C H 0 Si Br requires 561.1891 and 559.1911).
183.
OMs
(135)
3 ol , 4 0  —Bismesyloxy—10 (3 —bromo—9 Qt , 15—oxa—12,13—epoxytrichothecane 
(135)
To a solution of anguidine (9) (374 mg, 1.02 mmol) in THF 
(8 ml) and MeOH (5 ml) was added NaOH solution (1M, 10 ml, 10 mmol). 
The resulting mixture was stirred for 15 m. then passed through a 
column packed with Amberlite IR-120(H) ion exchange resin (10 g) — 
the product being eluted with a MeOH-water mixture (1:4). 
Concentration in vacuo gave scirpenetriol which was used without 
further purification.
To scirpenetriol (1.02 mmol, assumed) in dry CH^CN (20 ml) 
was added recrystallised NBS (213 mg, 1.20 mmol). The mixture 
was stirred for 15 m., then concentrated in vacuo. The crude 
bromo-ether (134) was used without further purification.
The crude bromo-ether (134) (1.02 mmol) was dissolved in 
pyridine (6 ml) and cooled to 0°C. To the solution was added 
methanesulphonyl chloride (3 ml) and the resulting mixture was 
stoppered and left at 4°C overnight. The reaction mixture was 
then poured on to ice water, acidified with IN HC1 (15 ml) and
184.
then extracted with EtOAc. The organic extracts were dried
(MgSO^) and then concentrated in vacuo. Purification by dry
column flash chromatography (EtOAc-pet.ether) gave 486 mg (92% from
anguidine) of the bismesylate (135) as an off-white amorphous 
20
solid: -17.3 (0.52, CHC13 ); Rf 0.28 (1:1 EtOAc-pet.ether) ;
V (CC1J 2980, 2940, 2880, 1375, 1180, 1050, 1035, 970, 960, 
max 4
910, 870, 860 cm-1.
1H n.m.r. (CDC13 , 200 MHz) 5 5.36 (1H, d, J 3.3 Hz, H-4),
5.22 (1H, dd, J 4.9, 3.3 Hz, H-3), 4.25 (1H, dd, J 8.6, 1.7 Hz,
H—11), 4.01 (1H, d, J 4.9 Hz, H-2), 3.99 (1H, dd, J 8.6, 2.3 Hz,
H—10), 3.84 (1H, dd, J 10.0, 2.6 Hz, H-15a), 3.73 (1H, d, J 10.0 Hz,
H—15b), 3.09 and 2.80 (2H, ABq, J 3.8 Hz, H-13), 3.16 (3H, s,
-0S02CH3 ), 3.15 (3H, s, -0S02CH3), 2.22 (1H, dd, J 12.8, 9.8 Hz,
H-8/?), 2.15-1.96 (1H, m, H-7/?), 1.90-1.70 (1H, m, H-7«), 1.63- 
1.46 (1H, m, H-8a), 1.27 (3H, s, H-16), 0.75 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 585.0 (C-4), 82.7 (C-3), 78.5 
(C-2), 73.8 (C-9), 68.6 (C-ll), 65.5 (C-15), 63.1 (C-12), 53.5 
(C-10), 46.7 (C-5), 46.5 (C-13), 42.1 (C-6), 39.1 (-0S02CH3 ),
38.1 (-0S02CH3 ), 27.7 (C-8), 24.1 (C-16), 19.4 (C-7), 6.6 (C-14).
Mass spectrum, m/z found: 518.0082 and 516.0149 (M+ ,
C^Ji2 0 S2Br requires 518.0104 and 516.0124).
185.
(136)
10/3 —Bromo—9 a  ,15—oxa—3—oxo—12,13—epoxytrichothecane (136)
The bismesylate (135) (214 mg, 0.41 mmol) in methanol (3 ml)
was added to freshly prepared NaOMe in methanol (from 150 mg sodium
in 12 ml methanol). The mixture was heated under reflux for 2 h .
and on cooling was diluted with water, extracted with CHCl^, dried
(MgSO^) and concentrated in vacuo. Purification by dry column flash
chromatography (EtOAc-pet.ether) gave 118 mg (83%) of ketone (136)
as a white crystalline solid: mp 92-94°C (hygroscopic; ether-pet.
ether); [ a  3^-176° (c 0.33, CHCl^) ; R^ . 0.39 (1:1 EtOAc-pet. ether);
V (CHC1q) 2975, 2940, 2875, 1770, 1450, 1380, 1260, 1215, 1200, 1190,nidx o
1135, 1100, 1090, 1065, 1050, 1000, 975, 960, 925 cm”1 .
1H n.m.r. (CDC13 , 200 MHz) 64.17 (1H, dd, J 8.5, 1.6 Hz, H-ll),
3.98 (1H, dd, J 8.5, 2.3 Hz, H-10), 3.76 (1H, d, J 9.4 Hz, H-15b),
3.61 (1H, dd, J 9.4, 2.6 Hz, H-15a), 3.51 (1H, s, H-2), 3.22 and
3.02 (2H, ABq, J 3.8, H-13) 2.59 and 2.25 (2H, ABq, J 9.0 Hz, H-4),
2.25-2.01 (2H, m, H-8), 1.88-1.55 (2H, m, H-7), 1.26 (3H, s, H-16),
0.82 (3H, s, H—14).
13C n.m.r. (CDClg, 50 MHz) 5 210.6 (C-3), 80.2 (C-2), 73.4 (C-9),
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69.9 (C-ll), 66.0 (C—15), 63.6 (C-12), 53.8 (C-10), 48.0 (C-13),
46.4 (C-4), 43.0 (C-5) 41.2 (C-6), 27.7 (C-8), 24.0 (C-16), 18.5 
(C—7), 11.0 (C—14).
Mass spectrum, m/z found: 344.0448 and 342.0471 (M+ ,
C^H^gO^Br requires 344.0447 and 342.0467).
Microanalysis, found: C, 52.68; H, 5.67; Br, 23.64%
C^l5H19°4Br re<*uires c » 52.47; H, 5.58; Br, 23.29%).
187.
--0H
3 a-Hydroxy-10 -bromo-9 oc ,15-oxa—12,13—epoxytrichothecane (137)
To a solution of ketone (136) (118 mg, 0.344 mmol) in aqueous
methanol (4 ml water in 10 ml MeOH) at 0°C was added NaBH,
4
(0.5 g, 13.2 mmol). The mixture was stirred for 15 m. when it was 
diluted with EtOAc and washed with water. The aqueous phase was 
re—extracted with EtOAc and the combined organic extracts were dried 
(MgSO^) and concentrated in vacuo. Purification by dry column flash 
chromatography (EtOAc—pet.ether) gave 117 mg (99%) of alcohol (137) 
as a white crystalline solid: mp 127-130°C (EtOAc—hexane); 
r«l^°-39.0° (c 1.0, CHC10); R„ 0.12 (1:1 EtOAc-pet.ether);
D o I
V (CHC10) 3600, 3050, 2980, 2940, 2880, 1460, 1410, 1380, 1230, 
max o
1195, 1180, 1135, 1050, 950, 900 cm"1 .
1H n.m.r. (CDC13 , 200 MHz) 64.45 (1H, m, H-3), 4.43 (1H, dd,
J 8.6, 3.2 Hz, H—10), 4.26 (1H, dd, J 8.6, 2.7 Hz, H-ll), 3.67 (2H, 
br.s, H—15), 3.62 (1H, d, J 4.6 Hz, H-2), 3.08 and 2.79 (2H, ABq,
J 3.9 Hz, H—13), 2.42 (1H, br.d, J 3.3 Hz, H-8 0 ), 2.30 (1H, dd,
J 12.9, 10.0 Hz, H-4a), 2.13-1.90 (3H, m, H-4/?, H-7/? and -OH), 
1.84-1.65 (1H, m, H-8«), 1.60-1.43 (1H, m, H-7a), 1.27 (3H, s, H-16),
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0.64 (3H, s, H—14).
13
C n.m.r. (CDClg, 50 MHz) 680.7 (C-2), 73.7 (C-9). 69.2 (C-3),
68.6 (C-ll), 66.6 (C—15)t 65.3 (C-12), 55.0 (C-10), 47.8 (C-13), 43.0 
(C—5), 40.8 (C—4 and C-6), 28.1 (C-8), 24.3 (C-16), 19.4 (C-7), 11.2 
(C—14).
Mass spectrum, m/z found: 346.0599 and 344.0631 (M+ , H n Br
— — 15 21 4
requires: 346.0604 and 344.0624).
Microanalysis, found: C, 52.28; H, 6.15; Br, 23.42% (C., _H_., 0 .Br
15 21 4
requires: C, 52.17; H, 6.13; Br, 23.16%).
189.
--OAc
3 a  —Acetoxy—10/ff —bromo—9ot ,15—oxa—12,13—epoxytrichothecane (138)
Alcohol (137) (130 mg, 0.38 mmol) was acetylated in the normal 
way. Purification by dry column flash chromatography (EtOAc—pet.ether) 
gave 136 mg (93%) of acetate (138) as a white crystalline solid: 
mp 119-123°C (benzene-60:80 pet.ether): £of] ^ -35.6 (c 0.62, CHCl^);
0.41 (1:1 EtOAc-pet.ether); V (CC1 ) 2980, 2940, 2880, 1750, 
f * ' max 4 ’ * * 1
1455, 1385, 1360, 1240, 1210, 1200, 1190, 1135, 1100, 1050, 965 cm”1 .
1H n.m.r. (CDC13 , 200 MHz) 6 5.20 (1H, ddd, J 10.0, 5.0, 5.0 Hz, 
H-3), 4.25 (2H, br.s, H-10 and H-ll), 3.84 (1H, d, J 5.0 Hz, H-2),
3.69 (1H, d, J 9.3 Hz, H-15a), 3.61 (1H, dd, J 9.3, 2.6 Hz, H-15b),
3.09 and 2.80 (2H, ABq, J 3.9 Hz, H-13), 2.10 (3H, s, CH^O), 2.30-1.35 
6H, m, H—4, H—7 and H-8), 1.26 (3H, s, H-16), 0.64 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 5170.3 (CH3C0), 79.0 (C-2), 73.8 (C-9),
70.8 (C—3), 68.6 (C-ll), 66.5 (C-15), 64.6 (C-12), 54.8 (C-10), 47.7 
(C-13), 42.5 (C—5), 40.8 (C-6), 38.2 (C-4), 28.0 (C-8), 24.2 (C-16),
21.0 (CH3C0), 19.0 (C—7), 11.06 (C-14).
Mass spectrum, m/z found: 307.1552 (M+-Br, ^ ^ H  0 recluires
307.1545).
190.
Microanalysis, found: C, 52.93; H, 5.84; Br, 20.60%
(C17H23°5Br recluires: C, 52.70; H, 5.99; Br, 20.64%).
191.
H H
OAc
(5)
3a ,15-Diacetoxy—12,13-epoxytrichothec-9—ene (calonectrin) (5)
Preparation of Zn/Ag couple
To a stirred warmed suspension of AgOAc (118 mg) in glacial acetic 
acid (120 ml) was added zinc powder (21.5 g) all at once. After 
stirring for 30 s. the acetic acid was decanted off and the Zn/Ag 
couple rinsed with glacial acetic acid (1 x 55 ml) and dry ether 
(4 x 55 ml) before use.
Use of Zn/Ag couple
To the freshly prepared Zn/Ag couple was added dry ether (55 ml) 
and then the bromo-ether (138) (531 mg, 1.37 mmol) in THF (105 ml) 
and ethanol (20 ml). The mixture was stirred at 55°C for 1% h. On 
cooling it was concentrated in vacuo. The residue was taken up in 
acetone and filtered through a pad of Celite. After concentration 
the crude product was acetylated by the normal procedure.
Purification by dry column flash chromatography gave 377 mg (79%) of 
calonectrin (5) as a colourless oil which could not be recrystallised:
£ a  Dp1*- 2.9° (c 0.76, CHC13 ), lit.36 £ a  1 ^ 7+ 5.8*
192.
(1:1 EtOAc-pet.ether); v (CClJ 2980, 2940, 2920, 1750, 1450,
max 4
1375, 1365, 1240, 1210, 1160, 1060, 1040, 960 cm"1 .
1H n.m.r. (CDC13 , 200 MHz) 6 5.42 (1H, br.d, J 4.4 Hz, H-10),
5.12 (1H, ddd, 9.3, 4.8, 4.8 Hz, H-3), 4.04 and 3.79 (2H, ABq,
J 12.2 Hz, H—15), 3.97 (1H, br.d, J 4.4 Hz, H-ll), 3.71 (1H, d,
J 4.8 Hz, H—2) 3.05 and 2.81 (2H, ABq, J 4.0 Hz, H-13), 2.07 
(3H, s, CH3C0), 2.00 (3H, s, CH3C0), 1.68 (3H, br.s, H-16), 0.79 
(3H, s, H—14).
13C n.m.r. (CDC13 , 50 MHz) 5 170.8 (CH3C0), 170.3 (CH^O),
140.2 (C—9), 118.8 (C-10), 77.9 (C-2), 71.1 (C-3), 68.0 (C-ll),
64.9 (C—12), 63.5 (C-15), 48.4 (C-13), 45.2 (C-5), 42.8 (C-6),
39.2 (C—4), 28.1 (C-8), 23.1 (C-16), 20.9 (CH3C0), 20.9 (CH3C0
and C—7), 12.0 (C-14).
Mass spectrum, m/z found: 350.1737 (M+ , C-,_Ho_0_ requires— — ±9 <£6 6
350.1729).
193.
--OAc
OAc 
(64)
3 a  ,40 ,15—Triacetoxy—12,13—epoxytrichothec—9—en—8—one (64)
To a suspension of freshly prepared py^CrO^ (4.7g, 18.2 mmol)
in dry CH^Cl^ (20 ml) was added a solution of triacetoxyscirpene
(63) (137 mg, 0.33 mmol) in dry CH^Cl^ (5 ml) and the resulting
mixture was stirred for 4 d. under nitrogen. Saturated NaHCO^
solution was then added to the mixture to dissolve the solid
residues formed during reaction. The organic layer was separated
and the remaining aqueous layer was carefully extracted with EtOAc.
The combined organic layers were dried (MgSO^) and concentrated
in vacuo. Purification by flash chromatography (1:1 EtOAc—pet.ether)
gave 86 mg (60%) of enone (64) as a white crystalline solid: mp
139—140°C (EtOAc—40:60 pet.ether); C « ] p 0+80.4° (c 0.56, CHC13 );
R_ 0.30 (1:1 EtOAc-pet.ether); v (CClJ 2990, 2960, 2930, 1750, f max 4 * *
1690, 1450, 1430, 1370, 1240, 1220, 1165, 1085, 1060, 1050, 965 cm-1;
\Et0H 226 nm ( e = 9000). 
max
1H n.m.r. (CDClg, 200 MHz) 5 6.54 (1H, dq, J 5.8, 1.5 Hz, H-10),
5.71 (1H, d, J 3.3 Hz,H—4), 5.22 (1H, dd, J 4.9, 3.3 Hz, H-3), 4.37
194.
(1H, br.d, J 5.8 Hz, H-ll), 4.31 and 4.13 (2H, ABq, J 12.5 Hz, H-15),
3.94 (1H, d, J 4.9 Hz, H-2), 3.08 and 2.82 (2H, ABq, J 3.9 Hz, H-13),
2.87 (1H, d, J 15.9 Hz, H-7/?), 2.45 (1H, dd, J 15.9, 1.6 Hz, H-7a) ,
2.16 (3H, s, CH CO), 2.10 (3H, s, CHoC0), 1.99 (3H, s, CHoC0), 1.82
o o o
(3H, dd, J 1.5, 0.7 Hz, H-16), 0.72 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 5 196.3 (C-8), 170.0 (2 x CHgCO), 169.7 
(CH3C0), 138.8 (C—9), 136.4 (C-10), 78.2,(C-2) 78.1 (C-3), 77.6 (C-4),
68.2 (C-ll), 64.3 (C-15), 64.1 (C-12), 48.7 (C-5), 47.5 (C-6), 46.8 
(C—13) , 38.2 (C—7), 20.8 (CH3C0), 20.7 (CH3C0), 20.6 (CH^O), 15.4 (C-16) ,
5.9 (C—14).
Mass spectrum, m/z found: 422.1582 (M+ , ^21^26^9 re<lu^res
422.1577).
Microanalysis, found: C, 59.58: H, 6.12% (ColH „ 0 r. requires21 2o y
C, 59.69; H, 6.21%).
195.
--OAc
AcO
(139)
30t ,15-Diacetoxy-12,13-epoxytrichothec-9-en-8—one (139)
To a suspension of freshly prepared py^CrOg (12.9 g, 49.9 mmol) 
in dry CH^Cl^ (30 ml) under nitrogen was added a solution of 
calonectrin (5) (185 mg, 0.53 mmol) in dry CH^Cl^ (5 ml) and the
resulting mixture stirred for 1 day at room temperature. Saturated 
NaHCOg solution was then added to the mixture to dissolve the solid 
residues formed during reaction. The organic layer was separated 
and the remaining aqueous phase was carefully extracted with EtOAc.
The combined organic layers were dried (MgSO^) and concentrated 
in vacuo. Purification by flash column chromatography gave 141 mg
(73%) of enone (139) as a white crystallise solid: mp 139-140°C
20
(ether); [a]D +61.6 (c 0.54, CHClg); Rf 0.27 (1:1 EtOAc-pet.ether);
V (CC1J 2980, 2920, 1750, 1680, 1450, 1375, 1365, 1230 (br), 1160 
max 4
1045, 960 cm-1; XEt°H 225 run (e= 8900). max
XH n.m.r. (CDC13 , 200 MHz) 56.54 (1H, dq, J 5.8, 1.5 Hz, H-10), 
5.21 (1H, ddd, J 10.0, 5.0, 5.0 Hz, H-3), 4.45 (1H, br.d,
J 5.8 Hz, H—11), 4.11 and 4.02 (2H, ABq, J 12.0 Hz, H-15), 3.84 
(1H, d, J 5.0 Hz, H—2), 3.11 and 2.88 (2H, ABq, J 3.9 Hz, H-13),
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2.86 (1H, d, J 15.8 Hz, H-7/3), 2.51 (1H, dd, J 15.8, 1.4 Hz, H-7a),
2.30-2.06 (2H, m, H-4), 2.13 (3H, s, CH CO), 1.96, (3H, s, CH CO),
o o
1.82 (3H, dd, J 1.5, 0.8 Hz, H-16), 0.81 (3H, s, H-14).
13C n.m.r. (CDC13 , 50 MHz) 5197.1 (C-8), 170.3 (CH^O), 170.2 
(CHgCO), 138.4 (C—9), 137.1 (C-10), 77.9 (C-2), 70.9 (C-3), 68.6 
(C-ll), 64.9 (C—12), 64.9 (C-15), 48.2 (C-13), 46.4 (C-5), 45.2 (C-6),
38.4 (C—4), 38.1 (C—7), 20.9 (CH^O), 20.6 (CH^O), 15.5 (C-16), 11.2 
(C—14).
Mass spectrum, m/z found: 364.1520 (M+ , c^gH24^7 reQu:*-res
364.1522).
Microanalysis, found: C, 62.56; H, 6.78% ^ i g H24^7 re<lu;*-res
C, 62.61; H, 6.64%).
197.
--0H
(140)
3 a. ,15-Dihydroxy—12,13—epoxytrichothec-9-en-8-one (140)
To the diacetate (139) (81 mg, 0-223 mmol) in wet methanol
(0.5 ml water in 10 ml MeOH) was added K^CO^ (0.5 g). The mixture
was stirred for 1 h. when it was concentrated in vacuo. The residue
was taken up in water and extracted thoroughly with EtOAc. The
combined organic layers were dried (MgSO^) and concentrated in vacuo.
Purification by flash chromatography (EtOAc) gave 56 mg (90%) of diol
(140) as a white solid: Rf> 0.06 (4:1 EtOAc-pet.ether): vx max
(KBr) 3600-3200 (br), 2960, 2920, 2850, 1680,1660, 1450, 1425, 1380,
1350, 1260, 1165, 1090, 1070, 1060, 1030, 1020, 950, 840 cm-1.
hi n.m.r. (CDC13 + 1 drop MeOD, 90 MHz) 6 6.65 (1H, br.d,
J 6 Hz, H-10), 4.70 (1H, br.d, J 6 Hz, H-ll), 4.50 (1H, ddd, 11, 6,
6 Hz, H-3), 3.65 (2H, br.s, H-15), 3.60 (1H, d, J 6 Hz, H-2), 3.10
and 2.90 (2H, ABq, J 4.0 Hz, H-13), 2.9-2.1 (4H, m, H-4 and H-7),
1.85 (3H, br.s, H-16), 0.85 (3H, s, H-14).
Mass spectrum, m/z found: 280.1317 (M+ , C.,_Ho_0_ requires
— — JLo 20 b
280.1311).
198.
--OTMS
3 a  ,15-Bistrimethylsilyloxy-12,13-epoxytrichothec-9-en-8-one (141)
To the diol (140) (55 mg, 0.196 mmol) in ether (3 ml) and 
pyridine (6 ml) was added excess TMSC1. The mixture was stirred 
overnight at room temperature then diluted with ether, washed once 
with water, dried (Na^SO^) and concentrated in vacuo. Purification 
by flash chromatography (1:9 EtOAc-pet.ether) gave 75 mg (90%) of 
the bissilylether (141) as a colourless oil: R^ . 0.64 (1:1 EtOAc—
pet.ether); v (CC14 ) 2970, 2940, 2920, 1680, 1455, 1370, 1260, 
1175, 1150, 1110 (br), 970, 940, 880, 850 cm"1 .
^  n.m.r. (CDC13 , 200 MHz) 5 6.57 (1H, dq, J 5.8, 1.5 Hz, H-10),
4.75 (1H, br.d, J 5.8 Hz, H-ll), 4.40 (1H, ddd, J 10.5,4.6, 4.0 Hz, 
H—3), 3.53 (2H, s, H-15), 3.47 (1H, d, J 4.6 Hz, H-2), 3.05 and 2.84 
(2H, ABq, J 4.0 Hz, H-13), 2.78 (1H, d, J 15.9 Hz, H-70), 2.37 (1H, 
dd, J 15.9, 1.4 Hz, H-7a), 2.24 (1H, dd, J 14.3, 4.0 Hz, H-4a), 2.04 
(1H, dd, J 14.3, 10.5 Hz, H-4/?), 1.81 (3H, dd, J 1.4, 0.8 Hz, H-16), 
0.77 (3H, s, H—14), 0.15 (9H, s, Si-CH3 ), 0.01 (9H, s, Si-CHg).
13C n.m.r. (CDC13> 50 MHz) 5198.3 (C-8), 138.0 (C-9 + C-10),
79.9 (C—3), 69.5 (C-2), 68.6 (C-ll), 66.0 (C-12), 64.1 (C-15),
199.
48.2 (C—13), 47.4 (C-5), 45.2 (C-6), 42.6 (C-4), 38.5 (C-7),
15.5 (C—16), 11.2 (C—14), 0.41 (Si-CH ), -0.99 (Si-CH ).
o o
Mass spectrum, m/z found: 424.2126 (M+ , C_..H__0_Sio
~ - 21 36 b 2
requires 424.2111).
200.
- -0TMS
3 a  ,7a ,15—Tristrimethylsilyloxy—12,13—epoxytrichothec—9—en—8—one 
(143)
A solution of TMSC1 (0.17 ml, 1.3 mmol) in Tiff (2 ml) cooled 
to —78°C was added to freshly prepared LDA (0.36 M in THF, 0.94 ml, 
0.33 mmol) at —78°C. To this solution was added enone (141) (46 mg, 
0.11 mmol) in THF (2 ml). The reaction was quenched after 1 m. by 
addition of Et^N (0.5 ml). The reaction mixture was diluted with 
pet.ether, washed once with water, dried (Na^SO^) and concentrated 
in vacuo to give enol ether (142).
n.m.r. (CC14 , 90 MHz) 5 5.70 (1H, br.d, J 6.0 Hz, H-10),
4.60 (1H, br.s, H-7), 4.45 (1H, br.d, J 6.0 Hz, H-ll), 4.25 (1H, 
ddd, J 10.0, 5.0, 5.0 Hz, H-3), 3.50 and 3.20 (2H, ABq, J 12 Hz,
H—15), 3.10 (1H, d, J 6.0 Hz, H-2), 2.75 (2H, ABq, J 4.0 Hz, H-13), 
2.60-1.80 (2H, m, H-4), 1.9 (3H, br.s, H-16), 0.85 (3H, s, H-14).
To the crude silyl enol ether (142) (0.11 mmol, assumed) in 
hexane (8 ml) at -15°C was added mcpba (80%, 30 mg, 0.14 mmol).
After stirring at -15°C for 30 m, the solution was then warmed at 
30°C for 2 h, after which time it was concentrated in vacuo.
201.
Purification by flash chromatography (1:9 EtOAc-pet.ether) gave 
14 mg (25%) of the desired a-silyloxyketone (143) along with 24 mg 
(50%) of the ring opened product (144).
The a-silyloxyketone (143) was obtained as a colourless oil:
R 0.70 (1:1 EtOAc-pet.ether); v (CC1 ) 2955, 2920, 2900, 1695,X IRcOC 4
1260, 1250, 1175, 1160, 1100, 1035, 960, 900, 870, 850 cm-1.
1H n.m.r. (CDC13> 200 MHz) 6 6.50 (1H, dq, J 6.0, 1.4 Hz, H-10),
4.96 (1H, br.d, J 6.0 Hz, H-ll), 4.38 (1H, ddd, J 10.8, 4.3, 4.3 Hz,
H—3), 3.75 and 3.67 (2H, ABq, J 10.7 Hz, H-15), 3.53 (1H, d, J 4.3 
Hz, H—2), 3.08 and 2.99 (2H, ABq, J 4.5 Hz, H-13), 2.38 (1H, dd,
J 14.5, 4.3 Hz, H-4a), 1.95 (1H, dd, J 14.5, 10.8 Hz, H-4/3), 1.80 
(3H, dd,J L.4, 0.7Hz, H-16), 1.00 (3H, s, H-14), 0.16 (9H, s, Si-CH3 ), 
0.15 (9H, s, Si-CH3), 0.00 (9H, s, Si-CH3 ), 4.91 (1H, s, H-7).
13C n.m.r. (CDC13> 50 MHz) 5199.1 (C-8), 137.2 (C-10), 136.3 
(C—9), 80.85 (C—7), 76.8 (C-2), 70.6 (C-ll), 69.3 (C-3), 65.8 (C-12),
61.0 (C—15), 52.6 (C—5), 47.2 (C-13), 45.8 (C-6) 45.2 (C-4), 15.5 
(C—16), 14.0 (C—14), 1.31 (Si-CH3 ), 0.09 (Si-CH3 ), -0.95 (Si-CH3 ).
Mass spectrum, m/z found: 512.2453 (M+, C24H44° gSig requires
512.2446).
The ring-opened product was also obtained as a colourless oil
R_ 0.51 (1:1 EtOAc-pet.ether); v (CC1.) 3600, 3450 (br), 2960, 
f max 4
2930, 2910, 2880, 1700, 1450, 1390, 1370, 1265, 1255, 1175, 1140,
1100 (br), 1050, 980, 970, 945, 875, 845 cm-1.
1H n.m.r. (CDClg, 200 MHz) 5 6.62 (1H, dq, J 5.7, 1.5 Hz, H-10),
4.52 (1H, ddd, J 10.3, 4.5, 4.5 Hz, H-3), 4.42 (1H, br.d, J 5.7,
H-ll), 4.06 (1H, d, J 2.1 Hz, H-7), 3.93 (1H, d, J 11.5 Hz, H-13a),
3.87 (1H, d, J 4.5 Hz, H-2), 3.60 (1H, d, J 11.5 Hz, H-13b), 3.53 
and 3.36 (2H, ABq, J 11.0 Hz, H-15), 2.14 (1H, dd, J 14.5, 10.2 Hz,
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H-4/5), 1.94 (1H, dd, J 14.5, 4.3 Hz, H-4a), 1.84 (3H, dd, J 1.5,
0.7 Hz, H—16), 1.12 (3H, s, H-14), 0.13 (9H, s, Si-CH3 ), -0.02 
(9H, s, Si-CH3 ).
13C n.m.r. (CDC13 , 50 MHz) 5 194.6 (C-8), 139.2 (C-10), 135.6 
(C-9), 83.0 (C—7), 75.7 (C-2), 74.6 (C-12), 70.1 (C-ll), 68.6 (C-3),
66.8 (C-13), 61.9 (C—15), 45.7 (C-5), 45.5 (C-6), 41.9 (C-4), 15.7 
(C—16), 12.2 (C—14), 0.14 (Si-CH ), -1.14 (Si-CH ).
O o
Mass spectrum, m/z found: 440.2041 (M+ , C2^H0gOgSi2 requires
440.2050).
The semi-synthetic tris-TMS ether (143) was identical by both
GLC and GCMS analyses with a sample prepared by silylation of
107
natural deoxynivalenol (23) using Regisil 323 - a commercially
available mixture of bis-trimethylsilyltrifluoroacetamide, 
trimethylchlorosilane and trimethylsilylimidazole.
Capillary column GLC was performed with a Hewlett-Packard 
5880A gas chromatograph equipped with SE-54 and CP Sil 5 CB fused- 
silica capillary columns (25 m x 0.32 mm ID) and Grob—type injectors 
operated in split mode (50:1). Both columns were temperature 
programmed to operate at 230°C; the helium carrier and make-up 
gas flow rates were 3 ml/min and 25 ml/min for both columns 
respectively.
The respective retention times for the tris-TMS ether on these 
columns were 24.2 m and 19.3 m.
GCMS was carried out with an LKB 9000 instrument fitted with 
a DB-1 fused-silica capillary column, 60 m x 0.32 mm ID and a 
falling needle injector. The helium carrier and make-up gas flow 
rates were 7 ml/min (measured at ambient temperature) and 25 ml/min
203.
respectively. The column was operated at a temperature of 210°C.
Mass spectra (22 eV) were recorded under electron—impact conditions; 
accelerating voltage, 3.5 kV; filament current, 4A; trap current,
60 fiA; source and separator temperatures, 270°C. Both the semi­
synthetic and naturally derived tris-TMS ethers possessed identical 
mass spectral profiles.
204.
--0H
(23)
3 a , 7 a  ,15—Trihydroxy-12,13-epoxytrichothec-9-en-8-one (23)
To the tristrimethylsilyl ether (143) (25 mg, 0.048 mmol) in aqueous 
MeCN (1 ml H^O and 1 ml MeCN) was added 3 drops of 40% HF. After 
30 m. K2CO3 (0.5 g) was added. The reaction mixture was diluted with 
brine and the aqueous phase was extracted with EtOAc (4 x 15 ml).
The combined organic layers were dried (MgSO^) and concentrated 
in vacuo. Purification by flash chromatography gave 15 mg (100%) 
of the triol (23) as a white solid: 0.11 (4:1 EtOAc-petwether).
"Si n.m.r. (CDC13 , 200 MHz) 6 6.57 (1H, m, H-10), 4.80 (2H, s + 
br.d, H-7 + H-ll), 4.51 (1H, ddd, J 10.6, 4.5, 4.5 Hz, H-3), 3.88 
and 3.71 (2H, ABq, J 11.7 Hz, H-15), 3.61 (1H, d, J 4.5 Hz, H-2),
3.15 and 3.07 (2H, ABq, J 4.3, H-13), 2.20 (1H, dd, J 10.6, 4.5 Hz, 
H-4/?), 2.05 (1H, dd, J 14.7, 10.6 Hz, H-4a), 1.68 (3H, dd, J 1.3,
0.6 Hz, H—16), 1.11 (3H, s, H-14).
Mass spectrum, m/z found: 296.1250 (M+ , Cn_H__0_ requires
—  —  15 20 o
296.1250).
This material was fully characterised as the triacetate (120).
205.
--0TES
TESO
OAc
(145)
3 <X , 15-Bis(triethylsilyloxy)—4 (3 —acetoxy—12,13—epoxytrichothec—9-ene 
(145)
To a stirred solution of 4—acetoxyscirpenediol (48) (202 mg,
0.62 mmol) and DMAP (31 mg, 0.25 mmol) in dry pyridine (15 ml) was
added triethylsilyl chloride (0.44 ml, 2.63 mmol). The mixture was
stirred overnight at room temperature. It was then diluted with
CH Cl (100 ml) and washed with half-saturated NaHCO (40 ml). The
organic extract was dried (Na^SO^) and concentrated in vacuo.
Purification by dry column flash chromatography (EtOAc—pet.ether)
gave the bis-TES ether as a colourless oil: R^ . 0.62 (1:1 EtOAc-
pet. ether); v (CC1J 2955, 2910, 2880, 1740, 1460, 1415, 1370, 
max 4
1240, 1175, 1170, 1120, 1085, 1020, 1010, 970, 930, 855 cm-1.
1H n.m.r. (CDClg, 200 MHz) 65.48 (1H, d, J 3.1 Hz, H-4),
5.41 (1H, br.d, J 5.5 Hz, H-10), 4.26 (1H, dd, J 4.9, 3.1 Hz, H-3), 
3.98 and 3.41 (2H, ABq, J 10.7 Hz, H-15), 3.94 (1H, br.d, J 5.5 Hz, 
H-ll), 3.45 (1H, d, J 4.9 Hz, H-2), 2.98 and 2.74 (2H, ABq, J 4.1 
Hz, H—13), 2.05-1.75 (4H, m, H-7 + H-8), 1.70 (3H, s, H-16), 1.00- 
0.85 (18H, m, SiCH^Hg), 0.72 (3H, s, H-14), 0.65-0.45 (12H, m,
206.
SiCH2CH3).
13
C n.m.r. (CDC13> 50 MHz) 6170.4 (CH^O), 140.9 (C-9), 118.7
(C-10), 83.9 (C—4), 79.6 (C-2), 77.7 (C-3), 68.2 (C-ll), 65.0 (C-12),
61.6 (C—15), 49.1 (C—5), 47.0 (C-13), 45.9 (C-6), 28.4 (C-8), 23.3
C-16), 20.8 (CH3C0), 20.6 (C-7), 6.8, 6.7 and 6.5 (C-14 + 2 x
SiCH2CH3 ), 4.5 (SiCH2CH3 ), 4.1 (SiCH2CH3 ).
Mass spectrum, m/z found: 524.3002 (M+-C0H , C H._0„Sio
  2 4 2/ 48 6 2
requires 524.2989).
207.
- -0TE S
TESO
(146)
3 a  ,15—Bistriethylsilyloxy—4/3-hydroxy—12,13-epoxytrichothec-9-ene (146)
To the mono—acetate (145) (881 mg, 1.6 mmol) in wet methanol (7 ml
water in 70 ml MeOH) was added K^CO^ (6 g). The mixture was stirred
for 4 d. when it was concentrated in vacuo. The residue was taken up
in water and extracted thoroughly with EtOAc. The combined organic
layers were dried (Na^SO^) and concentrated in vacuo. Purification
by dry column flash chromatography (EtOAc-pet.ether) gave 319 mg (40%)
of the C-4 mono-ol (146) as a colourless oil: 0.39 (1:1 EtOAc-pet.
ether); V (CClJ 3600, 3450 (br), 2960, 2915, 2880, 1460, 1450, 1415, max 4 > » » » » » »
1380, 1250, 1220, 1130, 1115, 1080, 1040, 1015, 960, 930, 910, 850 cm"1 .
XH n.m.r. (CDC13 , 200 MHz) 65.48 (1H, br.d, J 5.5 Hz, H-10), 4.50 
(1H, br.s, H—3)*, 4.18 (1H, br.s, H-4)*, 3.91 (1H, br.d, J 5.5 Hz, H-ll), 
3.66 and 3.43 (2H, ABq, H 10.9 Hz, H-15), 3.58 (1H, d, J 4.9 Hz, H-2),
3.00 and 2.73 (2H, ABq, J 3.9 Hz, H-13), 2.2-1.8 (4H, m, H-7 + H-8),
1.69 (3H, br.s, H-16), 0.92 (18H, 2xt (overlapping), J 7.9 Hz, SiCH2CH3 ),
0.84 (3H, s, H—14), 0.55 (12H, 2 x q (overlapping), J 7.9 Hz, Si2CH2CH3 ).
13C n.m.r. (CDC13 , 50 MHz) 6 140.6 (C-9), 118.7 (C-10), 81.9 (C-4),
80.7 (C-2), 78.9 (C-3), 68.2 (C-ll), 65.1 (C-12), 62.1 (C-15) 49.0 (C-5),
208.
47.0 (C—13), 44.6 (C-6), 28.1 (C-8), 23.2 (C-16), 21.9 (C-7), 6.8
(C—14 + 2 x SiCH2CH3 ), 4.2 (2 x S i a y ^ ) .
Mass spectrum (M.S.12), m/z found 396.1 (M+-(CH3CH2)3Si+l,
ColHo„0rSi requires 396.2).
21 ob b
In addition to the title compound, 119 mg of a more polar compound 
was obtained. This compound upon acetylation gave triacetoxyscirpene 
(63). The more polar compound was thus believed to be scirpenetriol 
(7) (26% yield).
♦These assignments were made on the basis of the 90 MHz n.m.r. 
spectrum which showed the signal at 64.5 to be a doublet (J 3.5 Hz) 
and the signal at 64.18 to be a double-doublet (J 5.5, 3.5 Hz).
APPENDIX 1
209.
0 >  - -R3
Ri R2 R3
1 H H H 12,13 epoxytrichothec—9—ene
2 H OH H Trichodermol (Roridin C)
3 H OAc H Trichodermin
4 OH H OAc 15-Deacetylcalonectrin
5 OAc H OAc Calonectrin
6 OAc OAc H Di-O-acetylverrucarol
7 OH OH OH Scirpenetriol
8 OAc OH OH Monoacetoxyscirpenol
9 OAc OAc OH Diacetoxyscirpenol
210.
Ri --Rs
Ri R2 R3 R4 R5
10 H OH OAc OAc OH 7—Hydroxydiacetoxy—
scirpenol
11 OH H H OH H
12 OH H OH OH OH T—2 Tetraol
13 01Val H OAc OH OH HT-2 Toxin
14 O'Sfal H OAc OAc OH T—2 Toxin
15 01Val H OAc OAc OAc Acetyl T—2 Toxin
16 OH H OAc OAc OH Solaniol (Neosolaniol)
17 OH OH OAc OAc OH 7,8 Dihydroxy—
diacetoxyscirpenol
18 OAc OH OAc OAc OH
19 OAc H OH OAc OH
i-Val= -C0CH2CH(CH3 )2
(20) Crotocin
211.
--FU
R1 R2 R3 H4
21 H H OH H Trichothecolone
22 H H OCrot H Trichothecin
23 OH OH H OH Vomitoxin (Deoxynivalenol)
24 OH OH H OAc Deoxynivalenol monoacetate
25 OH OH OH OH Nivalenol
26 OH OH OAc OH Fusarenon—X
27 OH OAc OAc OH Nivalenol diacetate
Crot = -C0CH=CHCH3
APPENDIX 2
X-ray crystallographic analysis of 3a ,4/3 ,15-triacetoxy—12,13-epi-
epoxytrichothec-9-ene (128)
Crystal data:
ColH_o0o, M = 408.5, orthorhombic, P2_2_2_, a = 9.375(1),to o —r X X X
b = 13.682(2), c = 16.207(2) A, V = 2078.6 A3 , Z = 4, D = 1.30 gem"3
m
Cu-Ka, A= 1.5418A, /X= 7.61 cm""1 , F(000) = 872, T = 291 K, final 
R = 0.053 for 2343 observed reflections.
A large, cube-shaped, colourless crystal measuring ca 1.1 mm 
x 0 . 8 m m x 0 . 7 m m  was used in data collection on an Enraf Nonius 
CAD-4 diffractometer. 2435 independent reflections collected with 
a 6 limit of 70°. Structure solved by direct phasing techniques 
using MITHRIL (Gilmore, 1984). Full—matrix least—squares on F of 
co-ordinates and anisotropic thermal parameters for non—H atoms 
converged to R and WR of 0.053 and 0.078. H—atom co-ordinates 
from difference Fourier synthesis were included, but not refined 
in final two cycles of full-matrix least—squares. 2343 independent 
reflections, 1^3<7^, used.
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